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Chapter 1 
General Introduction 
1.  Membranes: the barriers of life 
 
The basic building block of life is the cell that with no exception is surrounded by at least one 
membrane. The cytoplasmic membrane forms a physical barrier between the outside world 
and the cytoplasm, containing molecules specific to the cell or organism. The membrane is a 
two-dimensional crystalline matrix composed of a double-layer of many different kinds of lipids 
and packed with an enormous amount and variety of proteins (Devaux and Seigneuret, 1985). 
The weight ratio of lipid to protein varies among cellular and organellar membranes but is 
typically in the range of 1 to 1, implying that each membrane protein (complex) is only 
surrounded by a few shells of lipid molecules. It is remarkable that despite this huge protein 
content, the semi-permeable and insulating character of the lipid bilayer remains conserved. 
The function of the cytoplasmic membrane is three-fold: i) to prevent uncontrolled diffusion of 
(mostly hydrophilic) molecules into and out of the cytoplasm, ii) to control the energy status of 
the cell by producing and maintaining electrochemical ion gradients, and iii) to form a matrix for 
a variety of enzymes. 
In prokaryotes, the chemiosmotic ion gradient is often formed by the respiratory chains that, at 
the expense of redox energy, pump protons or sodium ions out of the cell (Nicholls and 
Ferguson, 1992). This results in a pH (and/or sodium) gradient and a membrane potential 
(inside negative), the sum of which is termed the proton- (or sodium) motive force (PMF or 
SMF). Dedicated membrane proteins use this inwardly-directed ion gradient to transport 
solutes into or out of the cell, or to generate the universal energy currency of life, ATP, via the 
proton driven FoF1-ATPase/synthase (Fig. 1; Nicholls and Ferguson, 1992). Under anaerobic 
conditions, or in organisms lacking an electron transport chain, metabolic energy can be 
supplied in the form of ATP by substrate level phosphorylation (Konings, 2002). ATP is then 
hydrolysed by the FoF1-ATPase/synthase in order to generate a PMF. 
In eukaryotic cells ATP is generated by mitochondria in a way similar to aerobic bacteria, and 
transported into the cytoplasm by dedicated mitochondrial carriers (i.e. ATP/ADP exchangers; 
Nicholls and Ferguson, 1992; Kunji et al., 2004). P-type ATPases then generate 
electrochemical gradients across the cytoplasmic membrane (Stein, 2002). Plants have, in 
addition, chloroplasts that harbour thylakoid membranes containing photosystems, composed 
of antennae responsible for the trapping of photons, and reaction centers, to which the light 
energy is directed and where the photoinduced charge separation takes place (Nicholls and 
Ferguson, 1992). The light-dependent electron transfer by the reaction centers together with 
electron transfer proteins drives the pumping of protons into the thylakoid lumen and results in 
The abbreviations used are: ABC, ATP-binding cassette; GUV, Giant Unilamellar Vesicle; LUV, Large 
Unilamellar Vesicle; MF, Major Facilitator; NBD, nucleotide-binding domain; PEP, phosphoenolpyruvate; PMF, 
proton motive force; PTS, phosphotransferase system; SBP, substrate-binding protein; SMF, sodium motive 
force; TMD, transmembrane domain; TMS, transmembrane segment. Chapter 1 
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a PMF. The PMF is used by the ATP-synthase in the thylakoid membrane to synthesize ATP, 
which is released in the stroma. ATP/ADP carriers and solute pores have been identified in the 
inner and outer chloroplast membrane, respectively, allowing shuttling of ATP and ADP 
between the cytoplasmic and stromal compartments (Neuhaus and Wagner, 2000). In the 
dark, ATP is imported into chloroplasts and used for anabolic reactions or starch degradation. 
Algae and photosynthetic bacteria also contain photosystems to generate an electrochemical 
proton gradient (Nicholls and Ferguson, 1992). Finally, halophilic Archaea use the light-driven 
proton pump bacteriorhodopsin to generate a PMF across the cytoplasmic membrane (Pebay-
Peyroula et al., 2000). 
As, in principle, most membrane transport processes are reversible, different energy sources 
(PMF or other (electro)chemical gradients and ATP (∆GATP)) can be interconverted depending 
on the environmental conditions and energy needs of the cell. 
 
 
2.  Membrane transport proteins 
  
Based on which energy source they use, membrane transport proteins can be classified into 
four groups (Saier, 2000). i) Primary transporters use light (e.g., the proton pump 
bacteriorhodopsin) or the chemical energy stored in ATP to drive solute translocation. The 
largest superfamily of primary transporters are the ATP-binding cassette (ABC) transporters 
(Fig. 1; Higgins, 1992). Members of this superfamily facilitate the unidirectional movement of a 
 
 
Fig. 1. Interplay between various energy transducing processes in the cytoplasmic membrane of aerobic 
bacteria. See text for details. 
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solute into or out of cells or specialized compartments at the expense of, most likely, 2 ATP 
molecules (Patzlaff et al., 2003).  P-type ATPases (e.g., the H+, Na+/H+-,  K+/H+-, and Ca2+-
ATPases; Fig. 1) are primary transporters as well (Stein, 2002). ii) Secondary transporters 
utilize (electro)chemical gradients to translocate a solute down its concentration gradient 
(facilitated diffusion), or they couple the transport of one molecule, often a proton or sodium 
ion, down its gradient to the uptake (symport) or excretion (antiport) of another solute against 
its gradient (Fig. 1; Poolman and Konings, 1993). The largest group of secondary transporters 
is formed by the members of the Major Facilitator (MF) superfamily (Pao et al., 1998). The 
ABC and MF superfamilies constitute the two most abundant and widely spread classes of 
membrane transport proteins, having been identified in every life form ranging from bacteria to 
man. iii) Group translocators couple the uptake of substrate to its chemical modification (Fig. 
1). This group consists of the bacterial phosphoenolpyruvate phosphotransferase systems 
(PEP-PTS), that transfer a phosphoryl group from the high energy donor PEP via a cascade of 
phosphoryl transfer proteins onto the translocated solute (Postma et al., 1993). Finally, iv) 
channels and pores do not couple energy utilization to the translocation process (Fig. 1), 
although they can be gated by ion gradients (voltage-gated channels), ATP or other ligands 
(ligand-gated ion channels), or a mechanic stimulus (mechanosensitive channels; Kung and 
Blount, 2004). As a consequence, they can not accumulate but only transport solutes down 
their concentration gradient. They can form selective or non-selective pores in the membrane 
allowing ions or other low-molecular weight molecules to pass, and are continuously open or 
gated by external signals. 
 
3.  The oligopeptide ABC transporter 
 
ABC transporters are composed of two transmembrane domains (TMDs) plus two nucleotide-
binding domains (NBDs) bound to the cytosolic face of the TMDs (for an extensive overview of 
ABC transporter domain architecture, mechanism and regulation see Chapter 2). Bacterial 
ABC uptake systems use extracytoplasmic substrate-binding proteins (SBPs) that scavenge 
for substrates and deliver these to the translocator. The oligopeptide translocator is composed 
of two TMDs, OppB and OppC, each consisting of six transmembrane spanning α-helical 
segments (TMSs; Pearce et al., 1992), N- and C-termini inside, and two NBDs, OppD and 
OppF. OppA functions as the SBP that binds oligopeptides and delivers them to OppBCDF 
where substrate is internalized. The oligopeptide transporter was first identified and 
characterized in Salmonella typhimurium and Escherichia coli, Gram-negative organisms in 
which OppA is present as a soluble protein in the periplasmic space (Higgins and Hardie, 
1983; Guyer et al., 1986; Pearce et al., 1992; Tame et al., 1994). Subsequently, oligopeptide 
transporters of Gram-positive organisms attracted much attention due to their involvement in 
signalling pathways, affecting for example sporulation in Bacillus subtilis (Perego et al., 1991; 
Koide and Hoch, 1994; Levdikov et al., 2005), and their vital role in nutrition in the industrially 
important bacteria Streptococcus thermophilus (Garault et al., 2002; Juille et al., 2005) and 
Lactococcus lactis (Tynkkynen et al., 1993; Kunji et al., 1995, 1998; Detmers et al., 1998, 
2000; Lanfermeijer et al., 1999, 2000; Picon et al., 2000; Charbonnel et al., 2003; Lamarque et 
al., 2004; Sanz et al., 2004;  Doeven et al., 2004, 2005; for a detailed overview see Chapter 
4). In these organisms, lacking a periplasmic space, OppA is anchored to the cell envelope via 
coupling of an N-terminal cysteine to a lipid moiety (Sutcliffe and Russel, 1995). This coupling 
is thought to occur in three subsequent steps: i) diacylglyceryl modification of the cysteine S-H Chapter 1 
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group, ii) cleavage of the signal peptide, and iii) N-acylation (Sankaran and Wu, 1994). Also, 
many pathogens have been found to encode Opp systems, often employed with multiple 
OppAs to broaden substrate specificity, and involved in virulence development (Samen et al., 
2004; Wang et al., 2004). Examples are Borrelia burgdorferi, the causative agent in lyme-
disease, and Bacillus anthracis, that contain 5 and 16 different OppA variants, respectively (Lin 
et al., 2001; Read et al., 2003). Although several Archaeal gene clusters have been annotated 
opp, they have not been characterized as such yet. In Pyrococcus furiosus and Sulfolobus 
solfataricus,  transporters belonging to the Opp family of ABC transporters have been shown to 
transport a range of oligo β-glucosides rather than oligopeptides (Elferink et al., 2001; Koning 
et al., 2001).  
 
4.  Scope of this thesis 
 
This thesis deals with the molecular mechanism of substrate-binding and translocation by ABC 
transporters. As a model system the oligopeptide transporter from the lactic acid bacterium 
Lactococcus lactis was studied. Chapter 2 gives a detailed overview of ABC transporter 
structure, mechanism and modulation by accessory domains. Whereas the basic architecture 
of ABC transporters appears conserved throughout all kingdoms of life, several (sub)families of 
transporters use additional domains that are vital for transport function and/or regulation, or 
perform additional catalytic activities. Chapter 3 deals with the overexpression, purification, 
and functional reconstitution of the oligopeptide ABC transporter in an artificial liposomal 
system (Large Unilamellar Vesicles (LUVs); average diameter ~ 200 nm). Transport selectivity 
was found to be largely determined by the specificity of the oligopeptide-binding protein OppA. 
Taken together with other recent findings, this work clarified discrepancies in older literature on 
substrate specificity and mechanism of ABC-type peptide transporters. The wider implications 
for the field of peptide transport in L. lactis and other microorganisms are described in Chapter 
4. The proposed peptide-binding mechanism of OppA remains somewhat controversial in 
respect to the generally accepted view that ABC transporter SBPs enclose their substrate 
completely. In lactococcal OppA, the C-terminus of long peptides (> 6 residues) is thought to 
protrude out of the protein and interact with its surface. Chapter 5 describes the crystallization 
of OppA in complex with a high affinity nonapeptide ligand as an initial step towards structure 
determination. Also, the association state and hydrodyamic radius of OppA in the absence and 
presence of ligand, as analysed by analytical ultracentrifugation, are reported. Chapter 6 deals 
with the functional incorporation of membrane proteins, amongst which the oligopeptide ABC 
transporter, into Giant Unilamellar Vesicles (GUVs; diameter ranging from ~ 5 – 100 µM).  
GUVs are formed by subjecting lipids to a drying/rehydration cycle and are widely used to 
study the physical properties of lipids and lipid mixtures, for example lipid lateral mobility and 
domain (raft) formation. We took advantage of the stabilizing effects of sugars on proteins and 
membranes during drying to develop a method that opens up the GUV field to the study of 
membrane proteins. In Chapter 7 proteo-GUVs are used to investigate protein:protein 
interactions in the oligopeptide ABC transporter by fluorescence correlation and cross-
correlation spectroscopy, yielding detailed information on the catalytic cycle of this ABC uptake 
system. Chapter 8 summarizes the most important findings presented in this thesis, puts them 
into perspective and ends with an outlook and some suggestions for future research.   
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Chapter 2 
ABC transporter architecture and regulatory roles of 
accessory domains 
Mark K. Doeven#, Esther Biemans-Oldehinkel#, and Bert Poolman 
Abstract 
We present an overview of the architecture of ABC transporters and dissect the 
systems in core and accessory domains. The ABC transporter core is formed by the 
transmembrane domains (TMDs) and the nucleotide binding domains (NBDs) that 
constitute the actual translocator. The accessory domains include the substrate-binding 
proteins, that function as high affinity receptors in ABC type uptake systems, and 
regulatory or catalytic domains that can be fused to either the TMDs or NBDs. The 
regulatory domains add unique functions to the transporters allowing the systems to 
act as channel conductance regulators, osmosensors/regulators, and assemble into 
macromolecular complexes with specific properties. 
Introduction 
ATP-binding cassette (ABC) transporters are vital to any living system and are involved in the 
translocation of a wide variety of substrates ranging from ions, sugars, amino acids, vitamins, 
lipids, antibiotics and drugs to larger molecules such as oligosaccharides, oligopeptides and 
even high molecular weight proteins (Higgins, 1992). Owing to their function ABC transporters 
are involved in many crucial processes, including nutrient uptake, lipid trafficking, drug and 
antibiotic excretion, secretion of macromolecules, antigen presentation to cytotoxic T cells, and 
cell volume regulation, and they are often major players in complex pathways affecting gene 
expression (e.g., sporulation, competence and virulence development). In humans a still 
growing number of diseases is related to (dys)function of ABC transporters, the most common 
known examples being cystic fibrosis caused by defects in the Cystic Fibrosis Transmembrane 
conductance Regulator (CFTR/ABCC7), an ABC-type chloride channel, and multidrug-
resistance conferred to tumor cells by P-glycoprotein (P-gp/MDR1/ABCB1) activity.  
Irrespective of the direction of transport (uptake or excretion), the nature of the transported 
substrate (low or high molecular weight molecule), or the physiological function, ABC 
transporters are composed of two hydrophobic transmembrane domains (TMDs)  and two 
#Both authors contributed equally to this chapter. The abbreviations used are: ABC, ATP-binding cassette; 
CBS, cystathionine-β-synthase; CFTR, Cystic Fibrosis Transmembrane conductance Regulator; ECD, 
extracytoplasmic domain; ICD, intracellular domain;  NBD, nucleotide-binding domain; PTS, 
phosphotransferase system; SBD, substrate-binding domain; SBP, substrate-binding protein; TAP, transporter 
associated with antigen processing; TMD, transmembrane domain; TMS, transmembrane segment.  Chapter 2 
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water soluble nucleotide-binding domains (NBDs) bound to the cytosolic face of the TMDs 
(Fig. 1). In addition to these core domains, hereafter referred to as the translocator or 
translocation unit, accessory domains or proteins can be part of the ABC transporter. In this 
chapter we review the architecture of ABC transporters, with emphasis on the types of 
accessory domains associated with the translocator. These accessory domains provide 
additional, often regulatory, functionalities to the transporters. The accessory domains can be 
recognized as additional transmembrane segments or internal or external domains linked to 
the TMDs, or extensions added to the NBDs. In many cases, it has been shown that the 
accessory domains can be deleted without affecting the translocation function, confirming that 
they do not form part of the core of the translocator. 
 
Architecture of ABC uptake systems 
 
The first identified components of ABC transporters were the substrate-binding proteins 
(SBPs) of ABC uptake systems that reside in the periplasmic space of Gram-negative bacteria, 
from which they could be released by cold osmotic shock (Neu and Heppel, 1965; Pardee, 
1968; Berger, 1973; Berger et al., 1974) . These water soluble proteins bind the substrate in a 
cleft between two lobes and deliver it to the translocator in the cytoplasmic membrane. In 
Gram-positive bacteria and Archaea, i.e., microorganisms lacking an outer membrane, SBPs 
are exposed on the cell surface and attached to the cytoplasmic membrane via a lipid-anchor 
or a transmembrane-peptide (to date, the latter has been only observed in Archaea), or they 
can be fused to the TMDs resulting in two substrate-binding domains (SBDs) per functional 
complex (Fig. 1B; OpuA). In some cases, two SBDs fused in tandem are linked to the TMDs 
and these systems have a total of four extracytoplasmic substrate-binding sites (e.g., GlnPQ). 
Systems with SBDs fused to the TMDs can be also found in Gram-negative bacteria but less 
frequently than in Gram-positives (van der Heide and Poolman, 2002). 
In terms of number of different subunits, the most complex ABC type uptake systems known 
are the nickel- and (oligo)peptide transporters, in which each domain is present as a separate 
polypeptide, giving a total of (at least) five unique proteins required for transport (Fig. 1A and 
B; Nik and Opp). In many cases, two copies of the same NBD plus two different TMDs (e.g., 
the maltose, histidine, and glucose transporters) or, less frequently, two copies of one NBD 
plus one TMD are present (the vitamin B12 transporter Btu). Occasionally, the NBDs or TMDs 
are fused (e.g., siderophore/haem and ribose transporters) such that in total only three unique 
proteins are used (Fig. 1A). The smallest number of unique subunits of which ABC uptake 
systems are composed, known to date, is two (Fig. 1B). This is the case for the glycine betaine 
and glutamine/glutamic acid transporters in which the SBPs are fused to either the N- or C-
terminus of their cognate TMDs, and the second unique subunit is formed by the NBD (van der 
Heide and Poolman, 2002).  
 
Architecture of ABC efflux systems 
 
In contrast to ABC uptake systems, which are present in the cytoplasmic membrane of 
prokaryotic species (bacteria and Archaea), ABC efflux systems are found in every life-form 
ranging from microorganisms to man. ABC efflux pumps can be found in the cytoplasmic 
membrane of prokaryotes and eukaryotes, as well as in the organellar membranes of the 
higher organisms, that are, the endoplasmic reticulum, inner mitochondrial membrane, ABC transporters 
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peroxisomal and vacuolar membranes. Although the common four-domain structure of the 
translocator (two TMDs plus two NBDs) is conserved, ABC efflux pumps are somewhat less 
complex compared to ABC uptake systems in that they do not require a SBP for function (Fig. 
1 C and D). The direction of transport can be deduced from the presence or not of this latter 
component. An exception to this rule has yet to be found. Even more frequently than in ABC 
uptake systems, the four core-domains of the translocator are fused, yielding only one or two 
unique polypeptides forming the functional unit (Fig. 1C and D). The most common 
organization is the “half-size transporter” in which a single TMD is fused to the N- or C-
terminus of a NBD. The functional complex is either a homo- or heterodimer of two half-
transporters (e.g., the lipid flippases, multi-drug transporters, cysteine exporter, and peptide 
transporters; Fig. 1C and D). Finally, all four core-domains (two half-transporters) can also be 
fused as is the case for the multi-drug transporters (e.g., P-gp, MRP1 and 2, and PDR5), and 
the ABC type chloride channel CFTR (Fig. 1D),  and these are termed “full-length 
transporters”. 
 
Fig. 1. Domain architecture of ABC transporters. Schematically indicated are: SBPs (Pac-man shaped), 
TMDs (rectangles), and NBDs (ovals). (A) Gram-negative bacteria (all the examples are from Escherichia coli): 
Nik, nickel transporter; Mal, maltose/maltodextrin transporter; Btu, vitamin B12 transporter; Fhu, 
siderophore/haem/vitamin B12 transporter; Rbs, ribose transporter. (B) Gram-positive bacteria and Archaea: 
Opp, oligopeptide transporter from Lactococcus lactis; Glc, glucose transporter from Sulfolobus solfataricus; 
OpuA, glycine betaine transporter from Lactococcus lactis; Gln, glutamine/glutamic acid transporter from 
Lactococcus lactis. (C) and (D) Functional and structural homologues are present in all three kingdoms of life. 
(C) Msb, lipid flippase from Escherichia coli; Cyd, cysteine exporter from Escherichia coli. (D) Mdl, 
mitochondrial peptide transporter from Saccharomyces cerevisiae; TAP1/2 (ABCB2/3), human peptide 
transporter; PDR5, yeast pleiotropic drug resistance transporter; P-gp (MDR1/ABCB1), human multidrug 
transporter. Chapter 2 
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Transmembrane domains 
 
The TMDs are two highly hydrophobic proteins or protein domains that create the channel 
through which the substrate passes during translocation (Fig. 1). In ABC uptake systems they 
form the docking site for the SBP and transduce a signal to the NBDs to bind and hydrolyze 
ATP. The TMDs are bundles of α-helices that traverse the membrane multiple times in a zig-
zag fashion. Many typical ABC transporters conform to the paradigmatic “two-times-six” α-
helices structure, yielding a total of 12 transmembrane segments (TMSs) per functional unit 
(Table 1). However, the number of TMSs may vary from anywhere between 5 to 11 for each 
individual TMD.  
Whereas the NBDs show considerable sequence identity (see below), the TMDs (as well as 
the SBPs) have been less well conserved during evolution, reflecting the large diversity of 
substrates transported. TMDs of ABC uptake systems contain the so-called EAA motif (L-
loop), which usually is found in the cytoplasmic loop between TMS 5 and 6 (Saurin and Dassa, 
1994). This motif is absent in ABC exporters.  
In ABC efflux systems, the TMDs harbor the substrate-binding site(s). Evidence for the 
existence of a substrate-binding site in the TMDs of ABC uptake systems came from the 
analysis of SBP-independent mutants (Treptow and Shuman, 1985; Speiser and Ames, 1991; 
Petronilli and Ames, 1991; Covitz et al., 1994). Mutations in the NBD of the histidine 
transporter (HisP) or the TMDs of the maltose transporter (MalF and G) resulted in an 
uncoupled phenotype, in which the SBP no longer interacted with the TMDs and the NBDs 
hydrolyzed ATP constitutively. In addition, a SBP-independent maltose transporter with a 
truncated form of MalF had its substrate specificity changed from maltose to lactose, albeit 
with very high affinity constants (Merino and Shuman, 1998). Finally, the crystal structure of 
the BtuCD translocator revealed a cleft in the periplasmic half of the TMDs that could 
accommodate a vitamin B12 molecule and represent a genuine substrate-binding site (Locher 
et al., 2002). 
 
Nucleotide-binding domains 
 
The engines of ABC transporters are the NBDs as these power substrate translocation by 
ATP-binding and hydrolysis. Whereas the SBPs and TMDs are poorly conserved, the NBDs 
are more closely related and group the different transporter families in the ABC superfamily. 
They contain the ATP-binding cassettes, hence the name ABC transporters. Many crystal 
structures of isolated NBDs are available, yielding detailed information about the overall fold 
and the nucleotide-binding site(s) (Davidson and Chen, 2004). An NBD consists of two 
domains, a RecA-like and a helical domain, the latter being specific for ABC transporters. In 
the NBD monomer, the ATP-binding site is formed by two conserved sequences, the Walker A 
(P-loop) and Walker B motifs, present in many ATP-binding proteins and not restricted to ABC 
proteins (Walker et al., 1982). These motifs bind the phosphates of ATP and ADP, and 
coordinate a Mg2+-ion via H2O in the nucleotide-binding site, respectively. A glutamate directly 
following the Walker B motif might be the catalytic base for hydrolysis, since it binds to the 
attacking water and Mg2+-ion, and mutation of this residue leads to loss of ATPase activity 
(Davidson and Chen, 2004). The Q-loop also forms hydrogen bonds with Mg2+  and the 
attacking water. A conserved histidine in the H motif hydrogen bonds with the γ-phosphate of 
ATP. In the NBD dimer the signature sequence, LSGGQ, (the motif that distinguishes ABC  ABC transporters 
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Table 1. Overview of TMD topology in well characterized ABC transporters 
Number of TMSs   
 
TMD Transport  substrate 
N-
terminal 
Core-
domain 
C-
terminal 
Total number 
of TMSs 
Reference 
HisQ 
HisM 
Histidine   5 
5 
  10 (2 x 5)  Kerppola et al., 1992 
GlnP Glutamine/ 
glutamic acid 
  5a    10 (2 x 5)  Schuurman-Wolters 
and Poolman, 2005 
ProW Glycine  betaine/Proline 
betaine 
2  5    14 (2 x 7)  Haardt and Bremer, 
1996 
OpuABC Gycine  betaine  2 5  1b  16 (2 x 8)  van der Heide and 
Poolman, 2002  
OppB 
OppC 
Oligopeptides   6 
6 
 12 (2 x 6)  Pearce et al., 1992 
MalF 
MalG 
Maltose/ maltodextrins  2 
 
6 
6 
 14 (8 + 6)  Boyd et al., 1987 
Dassa and Muir, 1993 
RbsC Ribose    10c   20 (2 x 10)  Stewart and 
Hermodson, 2003 
BtuC Vitamin  B12    10   20 (2 x 10)  Locher et al., 2002 
A
B
C
 
u
p
t
a
k
e
 
s
y
s
t
e
m
s
 
FhuB Siderophores/haem/ 
vitamin B12 
  10 x 2    20  Groeger and Köster, 
1998 
LmrA Drugs    6d   12 (2 x 6)  van Veen et al., 1996 
BmrA Drugs    6d   12 (2 x 6)  Steinfels et al., 2004 
MsbA Lipids    6   12  (2 x 6)  Chang and Roth, 
2001 
CydC 
CydD 
Cysteine/GSH   6 
6 
  12 (2 x 6)  Cruz-Ramos et al., 
2004 
HlyB Haemolysin  (2)e  6  12-16e 
(2 x 6-8) 
Wang et al., 1991 
Gentshev and 
Goebel, 1992 
H
a
l
f
-
t
r
a
n
s
p
o
r
t
e
r
s
 
TAP1(ABCB2) 
TAP2(ABCB3) 
Antigenic 
peptides 
4 
3 
6 
6 
  19 (10 + 9)  Koch et al., 2004 
P-gp 
(MDR1/ABCB1) 
Drugs   6 x 2    12  Loo and Clarke, 1999 
BCRP 
(ABCG2) 
Drugs   6 x 2    12  Leslie et al., 2005 
MRP1 (ABCC1)  Drugs  5  6 x 2    17 (5 + 12)  Leslie et al., 2005 
MRP2 (ABCC2)  Drugs  5  6 x 2    17 (5 + 12)  Leslie et al., 2005 
SUR1 (ABCC8)  None/unknownf  5  6 x 2    17 (5 + 12)  Conti et al., 2001 
CFTR 
(ABCC7)g 
Chloride     6 x 2    12  Sheppard and Welsh, 
1999 
Ste6 Mating  pheromone   6 x 2h   12  Geller et al., 1996 
A
B
C
 
e
f
f
l
u
x
 
s
y
s
t
e
m
s
 
F
u
l
l
-
l
e
n
g
t
h
 
t
r
a
n
s
p
o
r
t
e
r
s
 
ABCR (ABCA4)  Retinal/retinal-
phosphatidylethanolamine 
  6 x 2i   12  Bungert et al., 2001 
aTwo SBDs are fused in tandem to the first TMS. The N-terminal signal sequence, preceding the SBDs, is cleaved off. bThe 
SBD is fused to a C-terminal signal anchor sequence (the 8th TMS). cInitially claimed to have 6 TMSs (Park and Park, 
1999); later shown to possess 10 TMSs (Stewart and Hermodson, 2003). dNo experimental evidence; topology based on 
homology with other multidrug-efflux systems. eHlyB is thought to contain 6-8 TMSs; the presence of two N-terminal TMSs 
has not been unambiguously determined. fSulfonylurea receptors (SURx) associate with KIR6.x to form ATP-sensitive 
potassium channels. gCFTR is a chloride channel rather than transporter although it has the classical two TMDs plus two 
NBDs structure observed for genuine ABC transporters. hExperimental data only for the N-terminal TMD. iTwo large 
extracytoplasmic glycosylated domains are inserted between the first and second TMS of both the N- and C-terminal 
TMDs. 
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proteins from other nucleotide-binding proteins) of one NBD binds to the γ-phosphate of ATP 
bound to the other NBD, thereby completing the nucleotide-binding sites (Davidson and Chen,  
2004). Thus, two ATPs are sandwiched in head-to-tail orientation between two NBDs in the 
catalytically active dimer. 
 
ABC transporter mechanism 
 
Given the conserved architecture of two TMDs plus two NBDs across the entire ABC 
transporter superfamily, one could expect a common translocation mechanism for ABC uptake 
and efflux systems. Indeed, from the culmination of vast amounts of functional data, in 
combination with the recent X-ray structures of complete ABC transporters (for both efflux and 
uptake systems; Chang and Roth, 2001; Locher et al., 2002; Chang, 2003; Davidson and 
Chen, 2004; Higgins and Linton, 2004; Locher, 2004; van der Does and Tampé, 2004; Reyes 
and Chang, 2005), a consensus mechanism is emerging. The simplest model of SBP-
dependent uptake encompasses four steps (Fig. 2): i) substrate binds to the SBP; ii) the 
closed, liganded SBP docks onto the TMDs and signals the NBDs to cooperatively bind ATP; 
iii) upon ATP-binding, a binding site in the TMDs is made available to the outside, the SBP 
opens and substrate is transferred to the binding site in the TMDs; and iv) ATP hydrolysis 
dissociates the NBD dimer and results in reorientation of the binding site from an outward- to 
an inward-facing conformation. The substrate arrives in the cytoplasm and the SBP is released 
from the TMDs. Alternatively, it cannot be ruled out that upon ATP binding the substrate is 
transferred directly to the cytoplasm (step iii) and ATP hydrolysis in combination with 
dissociation of ADP and inorganic phosphate is solely used to reset the system for another 
translocation cycle. Whereas step i) is unique to SBP-dependent uptake systems, steps ii-iv) 
could be envisaged for ABC efflux systems as well. In step ii) a substrate bound to the inward-
facing binding site would signal the NBDs to bind ATP. Subsequently, step iii), ATP-binding 
reorients the binding site and substrate is released to the outside. iv) ATP-hydrolysis resets the 
system by converting the TMDs back to the inward-facing conformation. 
Although ABC uptake and efflux systems could share a common translocation mechanism, 
there are some indications that things might be more complicated. First of all, although in 
nature TMDs and NBDs appear as separate modules or fused together in almost any possible 
combination (Fig. 1), to the best of our knowledge, no ABC uptake systems are known that 
have a TMD fused to a NBD as is the case with half- or full-length efflux systems. For ABC 
efflux systems, this latter architecture seems to be a universal feature. Second, the conserved 
EAA motif (see above) is found exclusively in ABC uptake systems. This motif is thought to be 
important for the interaction of the TMDs with the NBDs. Third, the structures of the ABC efflux 
system MsbA showed an additional intracellular domain (ICD) between the TMD and NBD that 
was not present in the structure of the SBP-dependent vitamin B12 uptake system BtuCD 
(Chang and Roth, 2001; Locher et al., 2002; Chang, 2003; Reyes and Chang, 2005). Fourth, 
NBD2 of CFTR was shown, in addition to hydrolyzing ATP (Mg-ATP + H2O → Mg-ADP + Pi), 
to display adenylate kinase activity (Mg-ATP + AMP ↔ Mg-ADP + ADP), which influenced 
channel activity (Randak and Welsh, 2005). It remains to be established whether the adenylate 
kinase activity is unique to CFTR or ABC efflux systems, but some important structural 
differences between ABC uptake and efflux systems seem to exist. The significance of these 
observations in terms of a general ABC transport mechanism awaits further experimentation. 
 ABC transporters 
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Accessory domains in ABC transporters 
 
In addition to the ubiquitous four core-domains, that are two TMDs plus two NBDs, accessory 
domains can be found in several ABC transporters (Fig. 3). These extra domains often perform 
different functions and can be found separate from, attached to, or integrated into different 
parts of the core ABC transporter. On the basis of their location (extrinsic or intrinsic to the 
membrane) and function (regulatory or catalytic) within the cognate transporters, we divide the 
well characterized accessory domains of ABC transporters into four different groups: i) 
extracytoplasmic domains; ii) membrane-embedded domains; iii) cytosolic regulatory domains; 
and iv) cytosolic catalytic domains. 
 
Extracytoplasmic domains. One of the characteristics of accessory domains is that they are 
not part of the general ABC transporter core complex. There are three main examples of 
known extracytoplasmic domains or proteins that can be considered accessory units i) the 
large extracytoplasmic domains (ECDs) found in members of the ABCA family; ii) the 
extracellular N-terminal domain of ProW (and closely related homologues), the membrane 
component of the ProU system from E. coli; and iii) the substrate-binding domains or proteins 
found in prokaryotes.  
 
 
Fig. 2. Model of the translocation mechanism of a SBP-dependent ABC transporter. For explanation, 
see text. 
 Chapter 2 
  16
Members of the ABCA family are full-length transporters consisting of two TMDs of 6 TMSs 
each and two NBDs, each located C-terminal of one of the TMDs (Table 1; Peelman et al., 
2003). The two ECDs are predicted after the first TMS of the N- and C-terminal half of the 
transporter (Fig. 3C) and are 600 and 275 amino acids long in ABCA4 (ABCR; Bungert et al., 
2001). Eight N-glycosylation sites were mapped by mutagenesis onto the ECDs of ABCA4, 
four in the N-terminal half and four in the C-terminal half of the protein (Bungert et al., 2001). 
Removal of these N-glycosylation sites resulted in reduced expression levels, although the 
mutants retained the capacity to bind ATP. It has been postulated that the two ECDs are linked 
by at least one disulfide bridge. Intra- and intermolecular crosslinking of cysteine residues in an 
ECD was shown for ABCG2 (BCRP; Henriksen et al., 2005), a halftransporter with the ECD 
located between TMS 5 and TMS 6. Two ABCG2 subunits were linked by a disulfide bridge, 
and two remaining cysteine residues formed intramolecular disulfide bonds within the ECD. 
Although mutations in the ECDs have been shown to influence the substrate specificity of the 
transporters, a distinct function is not known for these relatively large extracytoplasmic 
domains. 
The second example of an extracytoplasmic domain is found in the proline and glycine betaine 
transport system (ProU) of E. coli. Here the membrane component, ProW, is composed of an 
extended N-terminal region of about 100 amino acid residues followed by 7 TMS (Table 1). 
The function of the N-terminal region is unknown, but a phoA and LacZ fusion study showed 
that its location is periplasmic (Haardt and Bremer, 1996).   
The best-studied extracytoplasmic domains or proteins are the substrate-binding domains or 
proteins of ABC-type uptake systems. These domains or proteins are considered to be 
accessory, because these components are not intrinsic to the translocation process as has 
been demonstrated for ABC transporter mutants that function in the absence of SBPs (see 
section ‘Transmembrane domains’). SBPs are the main determinants of substrate specificity of 
ABC uptake systems and confer high-affinity on the transport process with dissociation 
constants (Kd) in the (sub)micromolar range. They have been a gold-mine for structural studies 
due to their well behavior during overexpression, purification and crystallization trials. Although 
some early experiments suggested that SBPs might self-associate to form dimers or higher 
order oligomers (Antonov et al., 1976; Rashed et al., 1976; Richarme, 1982, 1983), crystal 
structures of numerous SBPs have led to the generally accepted view that they are monomers 
with one substrate-binding site per molecule (Quiocho and Ledvina, 1996). Even though 
systems are known that use multiple SBPs to broaden the substrate specificity of the 
transporter (several peptide transporters; Alloing et al., 1994; Lin et al., 2001; Doeven et al., 
2005), only a single SBP is required for transport function. The high resolution structure of the 
vitamin B12 importer BtuCD confirmed that there is space for only a single SBP to dock onto 
the TMDs (Borths et al., 2002). The ABC transporters with one or two SBDs fused to the TMD 
are thought to function similarly, except for that the presence of a second, third or fourth SBD 
might affect the kinetics of the translocation process (Biemans-Oldehinkel and Poolman, 2003) 
or perhaps broaden the substrate specificity. 
The archetype SBP consists of two domains or lobes connected by a flexible linker. The two 
lobes close and engulf the ligand upon substrate-binding (Venus’s Flytrap model; Mao et al., 
1982). Structures are available of SBPs in open-unliganded, closed-unliganded, open-
liganded, and closed-liganded forms (Tame et al., 1994; Nickitenko et al., 1995; Heddle et al., 
2003; Karpowich et al., 2003; Trakhanov et al., 2005), of which the latter conformation is 
thought to productively interact with the membrane complex (Prossnitz et al., 1989; Dean et ABC transporters 
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al., 1992; Doeven et al., 2004). In some cases, unliganded SBPs also have access to the 
TMDs, thereby inhibiting ABC transporter function (e.g., in case of the maltose- and histidine-
binding proteins; Merino et al., 1995; Ames et al., 1996). These observations, however, could 
not be confirmed in similar experiments performed with the oligopeptide ABC transporter 
(Doeven et al., 2004). Mutational and suppressor analyses suggested that each lobe of the 
SBP binds to one of the TMDs (Treptow and Shuman, 1985; Park et al., 1999). Site-directed 
mutagenesis and pre-steady state kinetic analysis indicated that donation of the substrate by 
the SBP to the TMDs is the rate-limiting step during the ABC uptake catalytic cycle of the 
oligopeptide transporter Opp (Lanfermeijer et al., 1999; Picon et al., 2000). 
Although a typical SBP consist of two lobes (domains) that are connected by a flexible hinge 
(Quiocho and Ledvina, 1996), exceptions to this rule are the SBPs of the nickel/oligopeptide 
transporter family (Fig. 3A). OppA contains an extra, third domain (Tame et al., 1994). The 
function of this additional domain is unknown, although in AppA, an OppA homologue from 
Bacillus subtilis, it has been shown to form part of the binding site for nonameric peptides 
(Levdikov et al., 2005). 
Two ABC transporter families (OTCN and PAO) are known in which one or two SBPs are 
fused to either the N- or C-terminus of one TMD, yielding a total of two or four SBDs per 
functional complex (Fig. 1B, OpuA and GlnPQ; van der Heide and Poolman, 2002). Two SBDs 
are present in OpuA, the osmoregulatory ABC transporter from Lactococcus lactis, although 
for activity only one SBD is needed. The SBDs of OpuA interact in a cooperative manner by 
stimulating either the docking of one domain onto the TMDs or substrate donation to the TMDs 
(Fig. 2, steps ii) and iii), respectively; Biemans-Oldehinkel and Poolman, 2003). However, this 
cooperative interaction has not been established for other SBP dependent ABC transporters, 
e.g., the glutamate/glutamine transporter GlnPQ from L. lactis, containing four SBDs 
(Schuurman-Wolters and Poolman, 2005). In GlnPQ, the SBD in the primary sequence nearest 
to the translocator domain (SBD2) is used as high affinity receptor that delivers the substrate 
to the TMDs. SBD1, on the contrary, is not required for high affinity transport and is not 
sufficient for transport but does bind glutamine with a low affinity (dissociation constant in the 
(sub)millimolar instead of micromolar range; Schuurman-Wolters, unpublished results). 
 
Membrane-embedded domains. The majority of ABC transporters are predicted to have six 
TMSs per TMD core (Table 1). Thus, in a typical transporter a total of 12 TMSs are present. 
Exceptions are known for ABC uptake systems that contain 5 or 10 TMSs as a single TMD 
core that is both essential and sufficient for transport. In addition to this somewhat variable 
number of TMSs in the TMDs, several ABC transporters contain extra TMSs that are not part 
of the core TMD and can be considered as accessory domains. Although this phenomenon 
frequently occurs, the function of these extra domains is in many cases unknown. For 
example, within the OTCN family of ABC transporters (Dassa and Bouige, 2001), sequence 
alignments reveal a core TMD of 5 TMSs but homologues can have in total either 5, 6 or 8 
TMSs. The core TMSs are generally much better conserved than the accessory TMSs (van 
der Heide and Poolman, 2002; unpublished results). Within the OTCN family, some 
polypeptides (f.i., the OpuABC subunit of OpuA, Fig. 3B, van der Heide and Poolman, 2002; 
and the ProW subunit of ProU, Haardt and Bremer, 1996) have two extra TMSs N-terminal of 
the TMD core but their function is unknown. In addition, some members have an 8th TMS (or 
6th TMS in case the first two are missing), C-terminal of the TMD core, that serves as signal 
anchor sequence for the translocation of the extracytoplasmic SBD. Also, members of the OSP  Chapter 2 
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Fig. 3. Well-characterized accessory domains in ABC transporters. TMD core domains are boxed (grey 
lines). (A) Structure of the oligopeptide-binding protein AppA from Bacillus subtilis (PDB accession number 
1XOC). Domain I and III (blue and red, respectively) are common to SBPs. The extra domain (II, orange) 
contributes with a few residues to the binding site by interacting with the N-terminal part of the bound 
nonameric peptide (yellow). (B) Topology of OpuABC, TMD with SBP fused to C-terminus, of the glycine 
betaine transporter OpuA from Lactococcus lactis. The NBD is a separate protein (Fig. 1B). (C) Topology of 
members of the ABCA family. Extracellular loops (ECD-1 and ECD-2) and cytosolic regulatory domains (R1 
and R2) are shown. (D) TMD topology of TAP1 and 2 half-transporters. (E) Topology of the SUR/MRP 
(ABCC) family. The extra TMD (TMD0) and L0-loop are indicated. (F) Structure of dimeric nucleotide-bound 
MalK from Escherichia coli (PDB accession number 1Q12), the NBD of the maltose/maltodextrin transporter. 
The common helical and RecA-like domains are shown in red and orange for the first monomer and dark 
purple and blue for the second, respectively. Two ATPs (yellow) are sandwiched between the NBDs. The 
additional C-terminal domain is shown in yellow for the first and bright purple for the second dimer subunit. (G) 
Structure of a tandem CBS domain from Thermotoga maritima (PDB accession number 1O50) as present in 
the C-terminal part of the NBD of OpuA (OpuAA). The N- and C-terminal halves are colored red and blue, 
respectively. (H) Topology of CFTR. The N-tail and regulatory (R) domain are indicated. (I) Putative TMD 
topology of LcnC, a bacteriocin exporter with an N-terminal peptidase-like domain.  
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family to which the maltose transporter belongs can have two extra N-terminal TMSs (MalF; 
Boyd et al., 1987). For the maltose transporter, the extra TMSs of MalF have been proposed to 
be an export signal, but most of the two TMSs could be removed without any effect on maltose 
transport activity (Boyd et al., 1987; Ehrmann et al., 1990; Ehrmann and Beckwith, 1991).  
A system in which a clear function could be assigned to the accessory TMSs is the transporter 
associated with antigen processing (TAP), present in the endoplasmic reticulum membrane. 
Based on hydrophobicity analysis and sequence alignments 10 (4 accessory plus 6 core) and 
9 (3 accessory plus 6 core) TMSs were predicted for human TAP1 and TAP2, respectively 
(Table 1 and Fig. 3D; Abele and Tampé, 1999; Koch et al., 2004). Although the core-TAP 
complex (the C-terminal 6 TMSs from TAP1 and TAP2 combined) represented the minimal 
functional unit for transport, the N-terminal domains of TAP1 and TAP2 were essential for 
recruitment of tapasin (Koch et al., 2004; Procko et al., 2005), a glycoprotein known to mediate 
association between TAP and MHC class I molecules (Bangia et al., 1999). Consequently, the 
extra domains were proposed to mediate the assembly of the macromolecular peptide-loading 
complex.  Subsequently, it was shown that in TAP2 the tapasin-binding site is exclusively 
located in the N-terminal domain. Upon deletion of the N-terminal domain of TAP1, tapasin 
could still interact with the TAP1 TMD core (Leonhardt et al., 2005). TAP variants lacking the 
N-terminal domain of TAP2, but not of TAP1, were disturbed in the quality control of MHC I 
loading, and formed peptide loading complexes that were disturbed in their physical interaction 
with calreticulin, calnexin, and ER60. 
In stead of a few extra TMSs, some ABC systems, including the sulfonylurea receptors SUR1 
and SUR2, and the multidrug-resistance proteins MRP1, 2, 3, 6 and 7, have 5 accessory 
TMSs that may form a domain by itself (Table 1 and Fig. 3E; Bakos et al., 1996; Stride et al., 
1996; Tusnády et al., 1997). These transporters belong to the ABCC family of the ABC 
transporter superfamily. The core complex in this subfamily is a full-length transporter 
composed of two TMDs (TMD1 and TMD2, each containing 6 TMSs) and two NBDs (NBD1 
and NBD2) that follow TMD1 and TMD2, respectively. The extra TMSs (indicated as TMD0) 
are linked via a cytoplasmic loop (L0) to the N-terminus of TMD1 (Fig. 3E). In MRP1, the entire 
TMD0 could be deleted without having any effect on transport activity or on the trafficking and 
insertion of the protein into the basolateral membrane (Bakos et al., 1998; Westlake et al., 
2003). This contrasted results obtained with SUR1 and MRP2, where deletion of TMD0 
affected channel activity, processing and trafficking (Sharma et al., 1999; Nies et al., 2002; 
Fernandez et al., 2002; Babenko et al., 2003; Chan et al., 2003). Recent studies revealed that 
TMD0 is needed for trafficking if the C-terminal region of MRP1 is mutated or deleted (Weslake 
et al., 2005). It seems that in MRP1 TMD0 and the C-terminal region contain redundant 
trafficking signals that become essential when one or the other region is missing or mutated.  
In SUR, TMD0 is required for activation of the inwardly rectifying potassium channel (KIR) 
subunits and anchoring of the KIR subunits to the ABC transporter core of SUR, thereby 
generating functional KATP channels (Babenko et al., 2003; Chan et al., 2003). Thus, similar to 
the TAP system, the accessory membrane-embedded domains of SUR provide additional 
protein interaction sites and serve a regulatory purpose. 
 
Cytosolic regulatory domains. Regulation of many ABC transporters takes place at the level 
of gene expression. Most ABC transporter operons encode a transcriptional regulator that 
connects the level of protein to environmental conditions. Expression of the osmoregulatory 
ABC transporter OpuA from Lactococcus lactis is, for example, regulated in response to Chapter 2 
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osmotic stress via the transcription factor OpuR (Romeo et al., 2003). However, the activity of 
ABC transporters, once expressed, may also be regulated. For this purpose, additional 
(autoregulatory) domains in the transporter itself are required. Examples are the L0 linker in 
MRP1 and SUR, the C-terminal domain of MalK of the maltose transporter from E. coli and S. 
typhimurium, the tandem cystathionine-β-synthase (CBS) domains of OpuA from L. lactis and 
other members of the OTCN family, and the R-domain of CFTR (Fig. 3E, F, G, and H, 
respectively). Although these domains all regulate ABC transporter activity, they use different 
mechanisms to do so.  
The maltose/maltodextrin transporter from E.coli and S. typhimurium is directly involved in 
transcriptional regulation of, amongst others, itself. The regulation takes place at the C-
terminal domain of MalK, the NBD of the transporter (Fig. 1A (Mal) and 3F; Chen et al., 2003). 
Crystal structures are available of MalK (Böhm et al., 2002), and GlcV, the NBD of the glucose 
transporter from Sulfolobus solfataricus (Verdon et al., 2003). These NBDs contain an 
accessory C-terminal domain with a common tertiary  fold. The C-terminal domain of MalK is 
involved in two regulatory processes, at least in enteric bacteria (Böhm and Boos, 2004). First, 
via its C-terminal domain, MalK is subject to regulation by IIAglc, a component of the bacterial 
phosphoenolpyruvate-dependent sugar:phosphotransferase system (PTS) (Nelson and 
Postma, 1984; Dean et al., 1991; Böhm et al., 2002). IIAglc can be in the unphosphorylated and 
phosphorylated state, depending on the availability of PTS sugars. In the unphosphorylated 
form, i.e., when a PTS sugar such as glucose is present, IIAglc binds to MalK and thereby 
prevents maltose uptake. The inhibition is relieved when glucose is exhausted and IIAglc 
becomes phosphorylated. This regulatory process determines the hierarchy of sugar utilization 
and is known as inducer exclusion mechanism. GlcV is unlikely to be involved in this type of 
regulation, since Archaea lack a PTS. Second, MalK inhibits the activity of MalT, the positive 
regulator of the maltose regulon, by competing with MalT for maltotriose binding (Reyes and 
Shuman, 1988; Panagiotidis et al., 1998; Boos and Böhm, 2000; Böhm et al., 2002). Binding of 
maltotriose to MalT is required for oligomerization of the transcription factor, a prerequisite for 
the interaction of MalT with its DNA binding sites (Schreiber and Richet, 1999; Danot, 2001). In 
addition to MalK, two other proteins, MalY and Aes, can also bind MalT (Schreiber et al., 2000; 
Joly et al., 2002), creating an intricate regulatory network that will not be detailed further in this 
chapter. MalK is thought to possess two distinct protein binding sites, one for MalT and one for 
IIAglc, because mutations in MalK affecting inducer exclusion do not interfere with MalT 
inactivation (Nelson and Postma, 1984; Kühnau et al., 1991). By mapping known mutations 
onto the structure of MalK (the one from Thermococcus litoralis), the MalT interaction site has 
been proposed to be located on an exposed surface of the C-terminal regulatory domain. Point 
mutations that confer an inducer exclusion insensitive phenotype form a patch adjacent to and 
oriented perpendicularly to the MalT interaction site (Böhm et al., 2002). 
The osmoregulatory ABC transporter OpuA protects the cell against hyperosmotic stress, 
ultimately plasmolysis, through uptake of the compatible solute glycine betaine, and thereby 
reverses the osmotic shrinkage of the cell (van der Heide and Poolman, 2000). When 
reconstituted in proteoliposomes, OpuA is activated by increasing internal ionic strength. The 
threshold for activation by ions is dependent on the ionic lipid content (charge density) of the 
membrane, indicating that the ionic signal is transduced to the transporter via critical 
interactions of protein domains with membrane lipids (van der Heide et al., 2001). The ABC 
transporter OpuA, as do other members of the OTCN family, has two CBS domains (Fig. 3G) 
in tandem at the C-terminal end of the ATPase subunit OpuAA. With two ATPase subunits per ABC transporters 
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translocation unit, a total of four CBS domains are present in OpuA. This so-called CBS 
module of OpuA constitutes the sensor that switches the transporter between an inactive, 
electrostatically locked and an active, thermally relaxed state, by interacting with the 
negatively-charged membrane surface in response to the ionic strength (unpublished results). 
The switching mechanism is an effective means for cells to respond to osmotic shifts, as an 
increase in medium osmolality will result in a decrease in cell volume, and the accompanying 
increase in cytoplasmic ionic strength will activate the transporter. Glycine betaine 
accumulation, followed by water influx, will increase the cell volume and decrease the ionic 
strength in due time, and the transporter will ultimately be switched off. This inherent feedback 
mechanism prevents over-accumulation of glycine betaine and couples transporter activity with 
ionic strength in the cell.   
CFTR is an ABC-type chloride channel that is regulated by protein kinase A-mediated 
phosphorylation of its cytoplasmic regulatory (R) domain (Rich et al., 1991). The R-domain is 
located between NBD1 and TMD2 of the full-length transporter (Fig. 3G), and contains a 
number of charged residues and multiple consensus phosphorylation sites (Gadsby and Nairn, 
1999; Dahan et al., 2001). The unphosphorylated R-domain is thought to inhibit channel 
activity by interaction with the CFTR core transporter. Release of the R-domain by 
phosphorylation would activate the channel (Rich et al., 1993; Csanády et al., 2000; 
Baldursson et al., 2001). Thus far, phosphorylation dependent release of the R-domain has not 
been demonstrated unequivocally. Correspondingly, a recent study strongly suggested that 
phosphorylation results in enhanced association of the R-domain with the transporter rather 
than in its release (Chappe et al., 2005). The mechanism of regulation suggested by Chappe 
et al. was that binding of the R-domain to the transporter induces intramolecular 
rearrangements that allow nucleotide-induced conformational changes to be transmitted from 
the NBDs to the TMDs. A second system that was shown to be regulated by phosphorylation 
of a cytoplasmic domain is ABCA1 (Roosbeek et al., 2004). This half transporter is a member 
of the ABCA family in which the R-domains (R1 and R2) are located C-terminal of the NBDs of 
the C- and N-terminal half of the transporter, respectively (Fig. 3C). Phosphorylation of the R1 
domain of ABCA1 diminished the phospholipid flip-flop, apolipoprotein binding, and 
cholesterol/lipid extrusion activities.  
The N-terminal tail of CFTR (N-tail; Fig. 3H), next to its R-domain, also plays a role in 
regulating CFTR channel activity. It modulates the rate of channel openings, probably by 
interacting with components of CFTR (R-domain or NBD), or with the pore itself (Fu and Kirk, 
2001). Next to a suggested physical interaction with a portion of the R-domain (Naren et al., 
1999), the N-tail and the C-terminal tails of CFTR have been shown to bind several inhibitors 
and stimulators (physical modulators) of CFTR activity (Li and Naren, 2005). These interaction 
partners either bind directly to CFTR or mediated through various PDZ domain-containing 
proteins. One of the PDZ containing proteins is the Na+/H+ exchanger regulatory factor 
(NHERF) that can form homo- and hetero-oligomers between CFTR and other membrane 
proteins, e.g., the β2-adrenergic receptor (Wang et al., 2000; Naren et al., 2003). It has been 
recently shown that the assembly of the C-terminal domains of CFTR is regulated by ezrin, an 
actin binding protein (Li et al., 2005). The dimeric CFTR-NHERF-ezrin interaction would 
provide a pathway to regulate CFTR activity via the cytoskeleton actin network. Moreover, 
there is evidence that when two subunits of CFTR are brought in close proximity by NHERF, 
the open probability of the channels is increased (Raghuram et al., 2003). Finally, the 
increasing number of proteins interacting with CFTR suggests that the chloride conductor is Chapter 2 
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not only regulated itself, but that CFTR might also regulate the activities of other ion channels, 
receptors, or transporters. 
The N-tail of CFTR contains a cluster of acidic residues which are located onto one face of a 
predicted α-helix (Naren et al., 1999; Fu et al., 2001). A similar amphipatic α-helix has been 
predicted for the L0 linker in the sulfonylurea receptor SUR (Bakos et al., 2000). This linker is 
located between TMD0 and TMD1 (Fig. 3E), and consequently links TMD1 and TMD2 of SUR 
to the TMD0/KIR complex. Interaction of the N-terminus of KIR with L0 has a bidirectional effect 
on the open probability of the KATP channel, i.e. structurally distinct segments of the linker can 
saturate or attenuate the open probability of the channel (Babenko and Bryan, 2002, 2003; 
Bryan et al., 2004). Additionally, the L0 linker has been reported to be involved in the binding of 
the sulfonylurea glibenclamide which inhibits KATP channels (Mikhailov et al., 2001). Similar to 
CFTR, there is an increasing number of proteins known to interact with KATP channels (Dhar-
Chowdhury et al., 2005). Although these proteins do not bind directly to the ABC component, 
the sulfonylurea receptor, they form part of the same supramolecular complex. A variety of 
glycolytic enzymes, adenylate kinase and creatine kinase have been shown to be part of the 
KATP channel complex and regulate its function. 
The requirement of the L0 linker for transport function has also been demonstrated for MRP1 
(Bakos et al., 2000). In MRP1, two α-helices have been predicted in L0, although the first one 
with low probability (Westlake et al., 2003). L0, and especially the second helix in the loop, are 
absolutely essential for MRP1 function (Bakos et al., 1998; Gao et al., 1998; Ren et al., 2001; 
Qian et al., 2001), and might be required for correct folding and trafficking of the protein 
(Westlake et al., 2003). L0 has been proposed to interact both with the core domains of MRP1 
and with the hydrophobic membrane regions of other proteins, or with the membrane itself 
(Westlake et al., 2003; Bakos et al., 2000). In addition, it has been suggested that at least part 
of the glutathione binding site is located in L0, although there is no direct evidence for this 
notion (Haimeur et al., 2004). 
 
Accessory catalytic domains. The type I secretion pathway is used to export competence-
stimulating peptides, bacteriocins, haemolysins, and non-proteinaceous material, independent 
of the Sec system (Holo et al., 1991; Hui and Morrison, 1991; Juranka et al., 1992; Fath et al., 
1993). In this pathway, ABC transporters have dual functions, that are, export of polypeptides 
and removal of leader peptides. Similar to the Sec pathway, the (poly)peptides are synthesized 
ribosomally and targeted for export by an N-terminal sequence of between 15-30 amino-acids 
(Dirix et al., 2004), that is removed upon secretion across the membrane. Removal of this 
signal sequence is taken care of by a peptidase domain associated with dedicated ABC 
transporters. The signal sequences with the consensus LSXXELXXIXGG are usually cleaved 
after the two conserved glycine residues (Havarstein et al., 1994) and are therefore called 
double-glycine-type leader peptides. The polypeptides that are released from the cell, after 
processing of the leader peptide, range in length between 17 and 80 amino acids (Dirix et al., 
2004) and often require post-translational modification prior to secretion to become biologically 
active. The secreted peptides rarely share significant homology, which is reflective of their 
functions as molecules that act in a strain- or species-specific manner, typically as 
competence-stimulating peptides (ComA in Streptococcus pneumoniae) or as class I 
(lantibiotics) or class-II (non-lantibiotics) bacteriocins. 
The secretion of ComA and bacteriocins is mediated by dedicated ABC half transporters that 
possess an accessory N-terminal domain of approximately 160 amino acids to remove the ABC transporters 
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leader peptide (Havarstein et al., 1995). The peptidase domain has characteristics of a 
cysteine protease, including conserved cysteine and histidine residues in the active site that 
are essential for proteolytic activity (Wu et al., 2004). How the peptidase domain interacts with 
the other components of the transporter to promote secretion is unknown.  For LcnC, the ABC 
transporter responsible for export of the bacteriocin LcnA, the peptidase domain was located at 
the cytoplasmic face of the membrane on the basis of PhoA and LacZ fusion studies (Fig. 3I; 
Franke et al., 1999).  
In Gram-negative bacteria, the type I secretion systems are composed of a protein complex 
that spans the cytoplasmic membrane (ABC transporter), periplasm (membrane fusion protein) 
and outer membrane (porin-like structure). The best characterized system is the one for 
secretion of HlyA, a 110 kDa haemolytic toxin, in E. coli. This system is composed of the ABC 
transporter HlyB, the membrane fusion protein HlyD, and the outer membrane factor TolC. 
Contrary to the type I secretions systems for peptides and bacteriocins, HlyB does not contain 
a peptidase like domain and HlyA does not contain a leader peptide. In stead, type I proteins 
like haemolysin contain a poorly conserved C-terminal secretion signal (Chervaux et al., 1996). 
The secretion signal domain of HlyA has been shown to interact with the NBD in vitro 
(Benabdelhak et al., 2003), but the possibility cannot be excluded that the signal region of HlyA 
may interact with the TMD of HlyB. Also for the interaction between HlyB and HlyD there is not 
a clearly defined region or domain in the ABC transporter.  
 
ABC transporter domains in other systems 
 
Whereas accessory domains in ABC transporters carry out important regulatory and catalytic 
functions, (core) components of ABC transporters can have dual functions or be integrated into 
completely different systems where they are vital for function. The ABC Walker A and B motifs 
are found in many proteins (Walker et al., 1982), the best known examples probably being 
myosin, and the DNA repair enzymes Rad50 and MutS. Moreover, Rad50 and MutS not only 
contain the Walker A and B motifs but also the ABC signature sequence LSGGQ and are 
genuine ABC proteins, albeit without transport function. In fact, a subset of ABC proteins is 
involved in DNA maintenance and protein synthesis, e.g., recombination, DNA repair, 
chromosome condensation and segregation, and translation elongation. These latter proteins 
exert their functions in the cytoplasm and/or nucleus rather than in the membrane (Holland et 
al., 2003).  
SBPs of bacterial uptake systems have been shown to act as chaperones (Richarme and 
Caldas, 1997), and can be used as chemotaxis receptors (Kokoeva et al., 2002). In addition, 
SBP-dependent secondary transporters have been discovered (Driessen et al., 2000), but an 
evolutionary relatedness of these SBPs to those of ABC transporters is not evident. Finally, 
domains homologous to prokaryotic SBPs function as receptors in ionotropic glutamate 
receptors present in the central nervous system of higher eukaryotes (Madden, 2002; Gouaux, 
2003). 
 
Conclusions 
 
The core complex of an ABC transporter is composed of two nucleotide binding  and two 
transmembrane domains, each in most cases with five or six transmembrane α-helical 
segments. A notable exception to this rule is the vitamin B12 transporter BtuCD with two times Chapter 2 
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ten TMSs in the TMDs, that, on the basis of the crystal structure, all seem critical for the 
formation of the translocation path. The RbsC and FhuB transporters may also conform to this 
exception. Additional TMSs associated with the core ABC complex seem to play regulatory 
roles as is best documented for the transporter involved in antigen presentation and the TMD0 
domain of the sulfonylurea receptors. 
The SBPs are accessory components of the ABC uptake systems that have evolved to signal 
substrate availability to (the activation of) the ATPase, following the binding of liganded SBPs 
to the TMDs. Moreover, the SBPs increase the affinity of the transporters for their substrate(s) 
by several orders of magnitude. For a number of SBPs, functions are known that are not 
related to transport, including chaperoning and signal transduction. Several ABC transporters 
have evolved to play crucial roles in processes such as cell volume regulation, control of 
channel activity and antigen presentation and therefore acquired accessory regulatory 
functions. The CBS domains, protein modules linked to a wide variety of proteins (channels, 
transporters, enzymes and transcription factors), in OpuA and ProU add osmosensing and 
osmoregulatory functions to the transporters. Finally, ABC transporters (type I secretion 
systems) can have a peptidase domain that cleaves off the signal sequence prior to 
translocating the mature peptide (bacteriocin) or protein. 
 
Acknowledgements 
 
We thank Barry Holland for valuable discussion on the type I secretion systems. This work was 
supported by a “Top-subsidie” grant (NWO-CW, grant number 700-50-302). 
 
References 
 
Abele, R. and Tampé, R. (1999) Function of the transport complex TAP in cellular immune recognition. Biochim. 
Biophys. Acta 1461, 405-419. 
Alloing, G., De Philip, P., and Claverys, J.-P. (1994) Three highly homologous membrane-bound lipoproteins 
participate in oligopeptide transport by the Ami system of the Gram-positive Streptococcus pneumoniae. J. Mol. 
Biol. 241, 44-58. 
 
Ames, G. F-L., Liu, C. E., Joshi, A. K., and Nikaido, K. (1996) Liganded and unliganded receptors interact with 
equal affinity with the membrane complex of periplasmic permeases, a subfamily of traffic ATPases. J. Biol. 
Chem. 271, 14264-14270. 
 
Antonov, V. K., Alexandrov, S. L., and Vorotyntseva, T. I. (1976) Reversible association as a possible regulatory 
mechanism for controlling the activity of the non-specific leucine-binding protein from Escherichia coli. Adv. 
Enzyme Regul. 14, 269-278. 
 
Babenko, A. P., and Bryan, J. (2002) SUR-dependent modulation of KATP channels by an N-terminal KIR6.2 
peptide. Defining intersubunit gating interactions. J. Biol. Chem. 277, 43997-44004. 
Babenko, A. P., and Bryan, J. (2003) Sur domains that associate with and gate KATP pores define a novel 
gatekeeper. J. Biol. Chem. 278, 41577-41580. 
Bakos, E., Hegedus, T., Hollo, Z., Welker, E., Tusnády, G. E., Zaman, G. J., Flens, M. J., Varadi, A., and 
Sarkadi, B. (1996) Membrane topology and glycosylation of the human multidrug resistance-associated protein. 
J. Biol. Chem. 271, 12322-12326. ABC transporters 
    25
Bakos, E., Evers, R., Szakacs, G., Tusnády, G. E., Welker, E., Szabo, K., de Haas, M., van Deemter, L., Borst, 
P., Varadi, A., and Sarkadi, B. (1998) Functional multidrug resistance protein (MRP1) lacking the N-terminal 
transmembrane domain. J. Biol. Chem. 273, 32167-32175. 
Bakos, E., Evers, R., Calenda, G., Tusnády, G. E., Szakacs, G., Varadi, A., and Sarkadi, B. (2000) 
Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1). J. Cell Sci. 
113, 4451-4461. 
Baldursson, O., Ostedgaard, L. S., Rokhlina, T., Cotten, J. F., and Welsh, M. J. (2001) Cystic fibrosis 
transmembrane conductance regulator Cl- channels with R domain deletions and translocations show 
phosphorylation-dependent and -independent activity. J. Biol. Chem. 276, 1904-1910. 
Benabdelhak, H., Kiontke, S., Horn, C., Ernst, R., Blight, M.A., Holland I.B., and Schmitt, L. (2003) A specific 
interaction between the NBD of the ABC-transporter HlyB and a C-terminal fragment of its transport substrate 
haemolysin A. J. Mol. Biol. 327, 1169-79. 
 
Bangia, N., Lehner, P. J., Hughes, E. A., Surman, M., and Cresswell, P. (1999) The N-terminal region of tapasin 
is required to stabilize the MHC class I loading complex. Eur. J. Immunol. 29, 1858-1870. 
Berger, E. A. (1973) Different mechanisms of energy coupling for the active transport of proline and glutamine in 
Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 70, 1514-1518. 
 
Berger, E. A., and Heppel, L. A. (1974) Different mechanisms of energy coupling for the shock-sensitive and 
shock-resistant amino acid permeases of Escherichia coli. J. Biol. Chem. 249, 7747-7755. 
 
Biemans-Oldehinkel, E., and Poolman, B. (2003) On the role of the two extracytoplasmic substrate-binding 
domains in the ABC transporter OpuA. EMBO J. 22, 5983-5993. 
Böhm, A., Diez, J., Diederichs, K., Welte, W., and Boos, W. (2002) Structural model of MalK, the ABC subunit of 
the maltose transporter of Escherichia coli: implications for mal gene regulation, inducer exclusion, and subunit 
assembly. J. Biol. Chem. 277, 3708-3717. 
Böhm, A., and Boos, W. (2004) Gene regulation in prokaryotes by subcellular relocalization of transcription 
factors. Curr. Opin. Microbiol. 7, 51-56. 
Boos, W., and Böhm, A. (2000) Learning new tricks from an old dog: MalT of the Escherichia coli maltose 
system is part of a complex regulatory network. Trends Genet. 16, 404-409. 
Borths, E. L., Locher, K. P., Lee, A. T., and Rees, D. C. (2002) The structure of Escherichia coli BtuF and 
binding to its cognate ATP binding cassette transporter. Proc. Nat. Acad. Sci. U. S. A. 99, 16642-16647. 
 
Boyd, D., Manoil, C., and Beckwith, J. (1987) Determinants of membrane protein topology. Proc. Natl. Acad. 
Sci. U. S. A. 84, 8525-8529. 
 
Bryan, J., Vila-Carriles, W. H., Zhao, G., Babenko, A. P., and Aguilar-Bryan, L. (2004) Toward linking structure 
with function in ATP-sensitive K+ channels. Diabetes 53 Suppl. 3, S104-112. 
Bungert, S., Molday, L. L., and Molday, R. S. (2001) Membrane topology of the ATP binding cassette 
transporter ABCR and its relationship to ABC1 and related ABCA transporters. Identification of N-linked 
glycosylation sites. J. Biol. Chem. 276, 23539-23546. 
 
Chan, K. W., Zhang, H., and Logothetis, D. E. (2003) N-terminal transmembrane domain of the SUR controls 
trafficking and gating of Kir6 channel subunits. EMBO J. 22, 3833-3843. 
Chang, G., and Roth, C. B. (2001) Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP 
binding cassette (ABC) transporters. Science 293, 1793-1800. Chapter 2 
  26
 
Chang, G. (2003) Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a 
closed conformation. J. Mol. Biol. 330, 419-430. 
 
Chappe, V., Irvine, T., Liao, J., Evagelidis, A., and Hanrahan, J. W. (2005) Phosphorylation of CFTR by PKA 
promotes binding of the regulatory domain. EMBO J. 24, 2730-2740.  
 
Chen, J., Lu, G., Lin, J., Davidson, A. L., and Quiocho, F. A. (2003) A tweezers-like motion of the ATP-binding 
cassette dimer in an ABC transport cycle. Mol. Cell 12, 651-661. 
Chervaux, C., and Holland, I.B. (1996) Random and directed mutagenesis to elucidate the functional importance 
of helix II and F-989 in the C-terminal secretion signal of Escherichia coli hemolysin. J. Bacteriol. 178, 1232-
1236. 
 
Conti, L. R., Radeke, C. M., Shyng, S-L., and Vandenberg, C. A. (2001) Transmembrane topology of the 
sulfonurea receptor SUR1. J. Biol. Chem. 276, 41270-41278. 
 
Covitz, K. M., Panagiotidis, C. H., Hor, L. I., Reyes, M., Treptow, N. A., and Shuman, H. A. (1994) Mutations 
that alter the transmembrane signalling pathway in an ATP binding cassette (ABC) transporter. EMBO J. 13, 
1752-1759. 
 
Cruz-Ramos, H., Cook, G. M., Wu, G., Cleeter, M. W., and Poole, R. K. (2004) Membrane topology and 
mutational analysis of Escherichia coli CydDC, an ABC-type cysteine exporter required for cytochrome 
assembly. Microbiology 150, 3415-3427. 
 
Csanády, L., Chan, K. W., Seto-Young, D., Kopsco, D. C., Nairn, A. C., and Gadsby, D. C. (2000) Severed 
channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic 
domains. J. Gen .Physiol. 116, 477-500. 
Dahan, D., Evagelidis, A., Hanrahan, J. W., Hinkson, D. A., Jia, Y., Luo, J., and Zhu, T. (2001) Regulation of the 
CFTR channel by phosphorylation. Pflugers Arch. 443 Suppl. 1, S92-96. 
Danot, O. (2001) A complex signaling module governs the activity of MalT, the prototype of an emerging 
transactivator family. Proc. Natl. Acad. Sci. U.S.A. 98, 435-440. 
Dassa, E., and Muir, S. (1993) Membrane topology of MalG, an inner membrane protein from the maltose 
transport system of Escherichia coli. Mol. Microbiol. 7, 29-38. 
 
Dassa, E., and Bouige, P. (2001) The ABC of ABCs: a phylogenetic and functional classification of ABC 
systems in living organisms. Res. Microbiol. 152, 211–229. 
 
Davidson, A. L., and Chen, J. (2004) ATP-binding cassette transporters in bacteria. Annu. Rev. Biochem. 73, 
241-268. 
 
Dean, D.A., Reizer, J., Nikaido, H., and Saier, M.H. Jr. (1991) Regulation of the maltose transport system of 
Escherichia coli by the glucose-specific enzyme III of the phosphoenolpyruvate-sugar phosphotransferase 
system. Characterization of inducer exclusion-resistant mutants and reconstitution of inducer exclusion in 
proteoliposomes. J. Biol. Chem. 265, 21005-21010. 
Dean, D. A., Hor, L. I., Shuman, H. A., and Nikaido, H. (1992) Interaction between maltose-binding protein and 
the membrane-associated maltose transporter complex in Escherichia coli. Mol. Microbiol. 6, 2033-2040. 
 
Dhar-Chowdhury, P., Harrell, M.D., Han, S.Y., Jankowska, D., Parachuru, L., Morrissey, A., Srivastava, S., Liu, 
W., Malester, B., Yoshida, H., and Coetzee, W.A. (2005) The glycolytic enzymes, glyceraldehyde-3-phosphate ABC transporters 
    27
dehydrogenase, triose-phosphate isomerase, and pyruvate kinase are components of the KATP channel 
macromolecular complex and regulate its function. J. Biol. Chem. 280, 38464-38470. 
 
Dirix, G., Monsieurs, P., Marchal, K., Vanderleyden, J., and Michiels, J. (2004). Screening genomes of Gram-
positive bacteria for double-glycine-motif-containing peptides. Microbiology 110, 617-620. 
 
Doeven, M. K., Abele, R., Tampé, R., and Poolman, B. (2004) The binding specificity of OppA determines the 
selectivity of the oligopeptide ATP-binding cassette transporter. J. Biol. Chem. 279, 32301-32307. 
 
Doeven, M. K., Kok, J., and Poolman, B. (2005) Specificity and selectivity determinants of peptide transport in 
Lactococcus lactis and other microorganisms. Mol. Microbiol. 57, 640-649. 
 
Driessen, A. J. M., Rosen, B. P., and Konings, W. N. (2000) Diversity of transport mechanisms: common 
structural principles. Trends Biochem. Sci. 25, 397-401. 
 
Ehrmann, M., Boyd, D., and Beckwith, J. (1990) Genetic analysis of membrane protein topology by a sandwich 
gene fusion approach. Proc. Natl. Acad. Sci. U.S.A. 87, 7574-7578. 
Ehrmann, M., and Beckwith, J. (1991) Proper insertion of a complex membrane protein in the absence of its 
amino-terminal export signal. J. Biol. Chem. 266, 16530-16533. 
Fath, M. J., and Kolter, R. (1993) ABC transporters: bacterial exporters. Microbiol. Rev. 57, 995-1017. 
Fernandez, S.B., Hollo, Z., Kern, A., Bakos, E., Fischer, P.A., and Borst, P. (2002) Role of the N-terminal 
transmembrane region of the multidrug resistance protein MRP2 in routing to the apical membrane in MDCKII 
cells. J. Biol. Chem. 277, 31048-31055. 
Franke, C. M., Tiemersma, J., Venema, G., and Kok, J. (1999) Membrane topology of the lactococcal 
bacteriocin ATP-binding cassette transporter protein LcnC. Involvement of LcnC in lactococcin a maturation. J. 
Biol. Chem. 274, 8484-8490. 
Fu, J., Ji, H. L., Naren, A. P., and Kirk, K. L. (2001) A cluster of negative charges at the amino terminal tail of 
CFTR regulates ATP-dependent channel gating. J. Physiol. 536, 459-470. 
Fu, J., and Kirk, K. L. (2001) Cysteine substitutions reveal dual functions of the amino-terminal tail in cystic 
fibrosis transmembrane conductance regulator channel gating. J. Biol. Chem. 276, 35660-35668. 
Gadsby, D. C., and Nairn, A. C. (1999) Control of CFTR channel gating by phosphorylation and nucleotide 
hydrolysis. Physiol. Rev. 79, S77-S107. 
Gao, M., Yamazaki, M., Loe, D. W., Westlake, C. J., Grant, C. E., Cole, S. P., and Deeley, R. G. (1998) 
Multidrug resistance protein. Identification of regions required for active transport of leukotriene C4. J. Biol. 
Chem. 273, 10733-10740. 
Geller, D., Taglicht, D., Edgar, R., Tam, A., Pines, O., Michaelis, S., and Bibi, E. (1996) Comparative topology 
studies in Saccharomyces cerevisiae and in Escherichia coli. The N-terminal halve of the yeast ABC protein 
Ste6. J. Biol. Chem. 271, 13746-13753. 
 
Gentschev, I., and Goebel, W. (1992) Topological and functional studies on HlyB of Escherichia coli. Mol. Gen. 
Genet. 232, 40-48. 
 
Gouaux, E. (2003) Structure and function of AMPA receptors. J. Physiol. 554.2, 249-253. 
 Chapter 2 
  28
Groeger, W., and Köster, W. (1998) Transmembrane topology of the two FhuB domains representing the 
hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and 
vitamin B12. Microbiology 144, 2759-2769. 
 
Haardt, M., and Bremer, E. (1996) Use of phoA and lacZ fusions to study the membrane topology of ProW, a 
component of the osmoregulated ProU transport system of Escherichia coli. J. Bacteriol. 178, 5370-5381. 
 
Haimeur, A., Conseil, G., Deeley, R.G., and Cole, S.P.C. (2004) The MRP-related and BCRP/ABCG2 multidrug 
resistance proteins: Biology, substrate specificity and regulation. Curr. Drug Metab. 5, 21-53. 
Havarstein, L. S., Holo, H., and Nes, I. F. (1994) The leader peptide of colicin V shares consensus sequences 
with leader peptides that are common among peptide bacteriocins produced by gram-positive bacteria. 
Microbiology 140, 2383-2389. 
Havarstein, L. S., Diep, D. B., and Nes, I. F. (1995) A family of bacteriocin ABC transporters carry out proteolytic 
processing of their substrates concomitant with export. Mol. Microbiol. 16, 229-240. 
Heddle, J., Scott, D. J., Unzai, S., Park, S-Y., and Tame, J. R. H. (2003) Crystal structures of the liganded and 
unliganded nickel-binding protein NikA from Escherichia coli. J. Biol. Chem. 278, 50322-50329. 
 
Henriksen, U., Fog, J.U., Litman, T., and Gether, U. (2005) Identification of intra- and intermolecular disulfide 
bridges in the multidrug resistance transporter ABCG2. J. Biol. Chem. 280, 36926-36934.  
 
Higgins, C. F. (1992) ABC transporters: from microorganisms to man. Annu. Rev. Cell. Biol. 8, 67-113. 
 
Higgins, C. F., and Linton, K. J. (2004) The ATP switch model for ABC transporters. Nat. Struct. Mol. Biol. 11, 
918-926. 
 
Holland, I.B., Cole, S.P.C., Kuchler, K., and Higgins, C.F. (2003) ABC proteins; From bacteria to man, Elsevier 
Science Ltd. London. 
 
Holo, H., Nilssen, O., and Nes I.F. (1991) Lactococcin A, a new bacteriocin from Lactococcus lactis subsp. 
cremoris: isolation and characterization of the protein and its gene. J. Bacteriol. 173, 3879-3887. 
Hui, F. M., and Morrison, D. A. (1991) Genetic transformation in Streptococcus pneumoniae: nucleotide 
sequence analysis shows comA, a gene required for competence induction, to be a member of the bacterial 
ATP-dependent transport protein family. J. Bacteriol. 173, 372-381. 
Joly N., Danot O., Schlegel A., Boos W., and Richet E. (2002) The Aes protein directly controls the activity of 
MalT, the central transcriptional activator of the Escherichia coli maltose regulon. J. Biol. Chem. 277, 16606-
16613. 
Juranka, P., Zhang, F., Kulpa, J., Endicott, J., Blight, M., Holland, I. B., and Ling, V. (1992) Characterization of 
the hemolysin transporter, HlyB, using an epitope insertion. J. Biol. Chem. 267, 3764-3770. 
Karpowich, N. K., Huang, H. H., Smith, P. C., and Hunt, J. F. (2003) Crystal structures of the BtuF periplasmic-
binding protein for vitamin B12 suggest a functionally important reduction in protein mobility upon ligand binding. 
J. Biol. Chem. 278, 8429-8434. 
 
Kerppola, R. E., and Ames, G. F-L. (1992) Topology of the hydrophobic membrane-bound components of the 
histidine periplasmic permease. Comparison with other members of the family. J. Biol. Chem. 267, 2329-2336. 
 
Koch, J., Guntrum, R., Heintke, S., Kyritsis, C., and Tampé, R. (2004) Functional dissection of the 
transmembrane domains of the transporter associated with antigen processing (TAP). J. Biol. Chem. 279, 
10142-10147. ABC transporters 
    29
Kokoeva, M. V., Storch, K-F., Klein, C., and Oesterhelt, D. (2002) A novel mode of sensory transduction in 
archaea: binding protein-mediated chemotaxis towards osmoprotectants and amino acids. EMBO J. 21, 2312-
2322. 
 
Kühnau, S., Reyes, M., Sievertsen, A., Shuman, H.A., and Boos W. (1991) The activities of the Escherichia coli 
MalK protein in maltose transport, regulation, and inducer exclusion can be separated by mutations. J. Bacteriol. 
173, 2180-2186. 
 
Lanfermeijer, F. C., Picon, A., Konings, W. N., and Poolman, B. (1999) Kinetics and consequences of binding of 
nona- and dodecapeptides to the oligopeptide binding protein (OppA) of Lactococcus lactis. Biochemistry 38, 
14440-14450. 
 
Leonhardt, R.M., Keusekotten, K., Bekpen, C., and Knittler, M.R. (2005) Critical role for the tapasin-docking site 
of TAP2 in the functional integrity of the MHC class I-peptide-loading complex. J. Immunol. 175, 5104-5114. 
 
Leslie, E. M., Deeley, R. G., and Cole, S. P. C. (2005) Multidrug resistance proteins: role of P-glycoprotein, 
MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204, 216-237. 
 
Levdikov, V.M., Blagova, E.V., Brannigan, J.A., Wright, L., Vagin, A.A., and Wilkinson AJ. (2005) The structure 
of the oligopeptide-binding protein, AppA, from Bacillus subtilis in complex with a nonapeptide. J. Mol. Biol. 345, 
879-892. 
 
Li, C., and Naren, A. P. (2005) Macromolecular complexes of cystic fibrosis transmembrane conductance 
regulator and its interacting partners. Pharmacol. Ther. 108, 208-23.  
Li, J., Dai, Z., Jana, D., Callaway, D. J. E., and Bu, Z. (2005) Ezrin controls the macromolecular complexes 
formed between an adapter protein Na+/H+ exchanger regulatory factor and the cystic fibrosis transmembrane 
conductance regulator. J. Biol. Chem. 280, 37634-37643. 
 
Lin, B., Short, S. A., Eskildsen, M., Klempner, M.S., and Hu, L. T. (2001) Functional testing of putative 
oligopeptide permease (Opp) proteins of Borrelia burgdorferi: a complementation model in opp- Escherichia coli. 
Biochim. Biophys. Acta 1499, 222-231. 
 
Locher, K. P., Lee, A. T., and Rees, D. C. (2002) The E. coli BtuCD structure: a framework for ABC transporter 
architecture and mechanism. Science 296, 1091-1098. 
 
Locher, K. P. (2004) Structure and mechanism of ABC transporters. Curr. Opin. Struct. Biol. 14, 426-431. 
 
Loo, T. W., and Clarke, D. M. (1999) Determining the structure and mechanism of the human multidrug 
resistance P-glycoprotein using cysteine-scanning mutagenesis and thiol-modification techniques. Biochim. 
Biophys. Acta 1461, 315-325. 
 
Madden, D. (2002) The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci. 3, 91-
101. 
 
Mao, B., Pear, M. R., and McCammon, J. A. (1982) Hinge-bending in L-arabinose-binding protein. The 
„Venus’s-flytrap“ model. J. Biol. Chem. 257, 1131-1133. 
 
Merino, G., Boos, W., Shuman, H. A., and Bohl, E. (1995) The inhibition of maltose transport by the unliganded 
form of the maltose-binding protein of Escherichia coli: experimental findings and mathematical treatment. J. 
Theor. Biol. 177, 171-179. 
 
Merino, G., and Shuman, H. A. (1998) Truncation of MalF results in lactose transport via the maltose transport 
system of Escherichia coli. J. Biol. Chem. 273, 2435-2444. 
 Chapter 2 
  30
Mikhailov, M. V., Mikhailova, E. A., and Ashcroft, S. J. (2001) Molecular structure of the glibenclamide binding 
site of the beta-cell K(ATP) channel. FEBS Lett. 499, 154-160. 
Naren, A. P., Cormet-Boyaka, E., Fu, J., Villain, M., Blalock, J. E., Quick, M. W., and Kirk, K. L. (1999) CFTR 
chloride channel regulation by an interdomain interaction. Science 286, 544-548. 
Naren, A.P., Cobb, B., Li, C., Roy, K., Nelson, D., Heda, G.D., Liao, J., Kirk, K.L., Sorscher, E.J., Hanrahan, J., 
and Clancy, J.P. (2003) A macromolecular complex of beta 2 adrenergic receptor, CFTR, and 
ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc. Natl. Acad. Sci. U. S. A. 100, 342-
346. 
 
Nelson, S. O., and Postma, P.W. (1984) Interactions in vivo between IIIGlc of the phosphoenolpyruvate:sugar 
phosphotransferase system and the glycerol and maltose uptake systems of Salmonella typhimurium. Eur. J. 
Biochem. 139, 29-34. 
 
Neu, H. C., and Heppel, L. A. (1965) The release of enzymes from Escherichia coli by osmotic shock during the 
formation of spheroplasts. J. Biol. Chem. 240, 3685-3692. 
 
Nickitenko, A. V., Trakhanov, S., and Quiocho, F. A. (1995) 2 Å resolution structure of DppA, a periplasmic 
dipeptide transport/chemosensory receptor. Biochemistry 34, 16585-16595.  
 
Nies, A. T., Konig, J., Cui, Y., Brom, M., Spring, H., and Keppler, D. (2002) Structural requirements for the 
apical sorting of human multidrug resistance protein 2 (ABCC2). Eur. J. Biochem. 269, 1866-1876. 
Panagiotidis, C. H., Boos, W., and Shuman, H. A. (1998) The ATP-binding cassette subunit of the maltose 
transporter MalK antagonizes MalT, the activator of the Escherichia coli mal regulon. Mol. Microbiol. 30, 535-
546. 
 
Pardee, A. B. (1968) Membrane transport proteins. Proteins that appear to be parts of membrane transport 
systems are being isolated and characterized. Science 162, 632-637. 
 
Park, Y., Cho, Y-J., Ahn, T., and Park., C. (1999) Molecular interactions in ribose transport: the binding protein 
module symmetrically associates with the homodimeric membrane transporter. EMBO J. 18, 4149-4156. 
 
Park, Y., and Park, C. (1999) Topology of RbsC, a membrane component of the ribose transporter, belonging to 
the AraH superfamily. J. Bacteriol. 181, 1039-1042. 
 
Pearce, S. R., Mimmack, M. L., Gallagher, M. P., Gileadi, U., Hyde, S. C., and Higgins, C. F. (1992) Membrane 
topology of the integral membrane components, OppB and OppC, of the oligopeptide permease of Salmonella 
typhimurium. Mol. Microbiol. 6, 47-57. 
 
Peelman, F., Labeur, C., Vanloo, B., Roosbeek, S., Devaud, C., Duverger, N., Denefle, P., Rosier, M., 
Vandekerckhove, J., and Rosseneu, M. (2003) Characterization of the ABCA transporter subfamily: 
Identification of prokaryotic and eukaryotic members, phylogeny and topology. J. Mol. Biol. 325, 259-274.  
 
Petronilli, V., and Ames, G. F-L. (1991) Binding protein-independent histidine permease mutants. Uncoupling of 
ATP hydrolysis from transmembrane signaling. J. Biol. Chem. 266, 16293-16296. 
 
Picon, A., Kunji, E. R. S., Lanfermeijer, F. C., Konings, W. N., and Poolman, B. (2000) Specificity mutants of the 
binding protein of the oligopeptide transport system of Lactococcus lactis. J. Bacteriol. 182, 1600-1608. 
 
Procko, E., Raghuraman, G., Wiley, D.C., Raghavan, M., and Gaudet, R. (2005) Identification of domain 
boundaries within the N-termini of TAP1 and TAP2 and their importance in tapasin binding and tapasin-
mediated increase in peptide loading of MHC class I. Immunol. Cell Biol. 83, 475-482. 
 ABC transporters 
    31
Prossnitz, E., Gee, A., and Ames, G. F-L. (1989) Reconstitution of the histidine periplasmic transport system in 
membrane vesicles. Energy coupling and interaction between the binding protein and the membrane complex. 
J. Biol. Chem. 264, 5006-5014. 
 
Qian, Y. M., Qiu, W., Gao, M., Westlake, C. J., Cole, S. P., and Deeley, R. G. (2001) Characterization of binding 
of leukotriene C4 by human multidrug resistance protein 1: evidence of differential interactions with NH2- and 
COOH-proximal halves of the protein. J. Biol. Chem. 276, 38636-38644. 
Quiocho, F. A., and Ledvina, P. S. (1996) Atomic structure and specificity of bacterial periplasmic receptors for 
active transport and chemotaxis: variation of common themes. Mol. Microbiol. 20, 17-25. 
 
Raghuram, V., Hormuth, H., and Foskett, J.K. (2003) A kinase-regulated mechanism controls CFTR channel 
gating by disrupting bivalent PDZ domain interactions Proc. Natl. Acad. Sci. U. S. A. 100, 9620-9625. 
 
Randak, C. O., and Welsh, M. J. (2005) Adenylate kinase activity in ABC transporters. J. Biol. Chem. 280, 
34385-34388. 
 
Rashed, I., Shuman, H., and Boos, W. (1976) The dimer of the Escherichia coli galactose-binding protein. Eur. 
J. Biochem. 69, 545-550. 
 
Ren, X. Q., Furukawa, T., Aoki, S., Nakajima, T., Sumizawa, T., Haraguchi, M., Chen, Z. S., Kobayashi, M., and 
Akiyama, S. (2001) Glutathione-dependent binding of a photoaffinity analog of agosterol A to the C-terminal half 
of human multidrug resistance protein. J. Biol. Chem. 276, 23197-23206. 
Reyes M., and Shuman H.A. (1988) Overproduction of MalK protein prevents expression of the Escherichia coli 
mal regulon. J. Bacteriol. 170, 4598-4602. 
 
Reyes, C. L., and Chang, G. (2005) Structure of the ABC transporter MsbA in complex with ADP·vanadate and 
lipopolysaccharide. Science 308, 1028-1031. 
 
Rich, D. P., Gregory, R. J., Anderson, M. P., Manavalan, P., Smith, A. E., and Welsh, M. J. (1991) Effect of 
deleting the R domain on CFTR-generated chloride channels. Science 253, 205-207. 
Rich, D. P., Berger, H. A., Cheng, S. H., Travis, S. M., Saxena, M., Smith, A. E., and Welsh, M. J. (1993) 
Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R 
domain. J. Biol. Chem. 268, 20259-20267. 
Richarme, G. (1982) Associative properties of the Escherichia coli galactose binding protein and maltose 
binding protein. Biochem. Biophys. Res. Commun. 105, 476-481. 
 
Richarme, G. (1983) Associative properties of the Escherichia coli galactose-binding protein and maltose-
binding protein. Biochim. Biophys. Acta 748, 99-108. 
 
Richarme, G., and Caldas, T. D. (1997) Chaperone properties of the bacterial periplasmic substrate-binding 
proteins. J. Biol. Chem. 272, 15607-15612. 
 
Romeo, Y., Obis D., Bouvier J., Guillot A., Fourcans A., Bouvier I., Gutierrez C., and Mistou M. Y. (2003) 
Osmoregulation in Lactococcus lactis: BusR, a transcriptional repressor of the glycine betaine uptake system 
BusA. Mol. Microbiol. 47, 1135-1147. 
Roosbeek, S., Peelman, F., Verhee, A., Labeur, C., Caster, H., Lensink, M.F., Cirulli, C., Grooten, J., Cochet, C. 
Vandekerckhove, J., Amoresano, A., Chimini, G., Tavernier, J., and Rosseneu, M. (2004) Phosphorylation by 
protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J. Biol. Chem. 279, 
37779-37788. Chapter 2 
  32
Saurin, W., and Dassa, E. (1994) Sequence relationships between integral inner membrane proteins of binding 
protein-dependent transport systems: evolution by recurrent gene duplications. Protein Sci. 3, 325-344. 
 
Schreiber, V., and Richet, E. (1999) Self-association of the Escherichia coli transcription activator MalT in the 
presence of maltotriose and ATP. J. Biol. Chem. 274, 33220-33226. 
Schreiber V., Steegborn C., Clausen T., Boos W., and Richet E. (2000) A new mechanism for the control of a 
prokaryotic transcriptional regulator: antagonistic binding of positive and negative effectors. Mol. Microbiol. 35, 
65-76. 
Schuurman-Wolters, G. K., and Poolman, B. (2005) Substrate specificity and ionic regulation of GlnPQ from 
Lactococcus lactis. J. Biol. Chem. 280, 23785-23790. 
 
Sharma, N., Crane, A., Clement, J. P. t., Gonzalez, G., Babenko, A. P., Bryan, J., and Aguilar-Bryan, L. (1999) 
The C terminus of SUR1 is required for trafficking of KATP channels. J. Biol. Chem. 274, 20628-20632. 
Sheppard, D. N., and Welsh, M. J. (1999) Structure and function of the CFTR chloride channel. Physiol. Rev. 
79(1 Suppl), S23-45. 
 
Speiser, D. M., and Ames, G. F-L. (1991) Salmonella typhimurium histidine periplasmic permease mutations 
that allow transport in the absence of histidine-binding proteins. J. Bacteriol. 173, 1444-1451. 
 
Steinfels, E., Orelle, C., Fantino, J-R., Dalmas, O., Rigaud, J-L., Denizot, F., Di Pietro, A., and Jault, J-M. (2004) 
Characterization of YvvC (BmrA), a multidrug ABC transporter constitutively expressed in Bacillus subtilis. 
Biochemistry 43, 7491-7502. 
 
Stewart, J. B., and Hermodson, M. A. (2003) Topology of RbsC, the membrane component of the Escherichia 
coli ribose transporter. J. Bacteriol. 185, 5234-5239. 
 
Stride, B. D., Valdimarsson, G., Gerlach, J. H., Wilson, G. M., Cole, S. P., and Deeley, R. G. (1996) Structure 
and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding 
cassette transporter. Mol. Pharmacol. 49, 962-971. 
Tame, J. R. H., Murshudov, G. N., Dodson, E. J., Neil, T. K., Dodson, G. G., Higgins, C. F. and Wilkinson, A. J. 
(1994) The structural basis of sequence-independent peptide binding by OppA protein. Science 264, 1578-
1581. 
 
Trakhanov, S., Vyas, N. K., Luecke, H., Kristensen, D. M., Ma, J., and Quiocho, F. A. (2005) Ligand-free and –
bound structures of the binding protein (LivJ) of the Escherichia coli ABC leucine/isoleucine/valine transport 
system: trajectory and dynamics of the interdomain rotation and ligand specificity. Biochemistry 44, 6597-6608. 
 
Treptow, N. A., and Shuman, H. A. (1985) Genetic evidence for substrate and periplasmic-binding-protein 
recognition by the MalF and MalG proteins, cytoplasmic membrane components of the Escherichia coli maltose 
transport system. J. Bacteriol. 163, 654-660. 
 
Tusnády, G. E., Bakos, E., Varadi, A., and Sarkadi, B. (1997) Membrane topology distinguishes a subfamily of 
the ATP-binding cassette (ABC) transporters. FEBS Lett. 402, 1-3. 
van der Does, C., and Tampé, R. (2004) How do ABC transporters drive transport? Biol. Chem. 385, 927-933. 
 
van der Heide, T., and Poolman, B. (2000) Osmoregulated ABC-transport system of Lactococcus lactis senses 
water stress via changes in the physical state of the membrane. Proc. Natl. Acad. Sci. U.S.A. 97, 7102-7106. 
 
van der Heide, T., Stuart, M. C., and Poolman, B. (2001) On the osmotic signal and osmosensing mechanism of 
an ABC transport system for glycine betaine. EMBO J. 20, 7022-7032. ABC transporters 
    33
van der Heide, T., and Poolman, B. (2002) ABC transporters: one, two or four extracytoplasmic substrate-
binding sites? EMBO Reports 3, 938-943. 
 
van Veen, H. W., Venema, K., Bolhuis, H., Oussenko, I., Kok, J., Poolman, B., Driessen, A. J. M., and Konings, 
W. N. (1996) Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. 
Proc. Natl. Acad. Sci. U. S. A. 93, 10668-10672. 
 
Verdon, G., Albers, S.V., Dijkstra, B.W., Driessen, A.J., and Thunnissen, A.M. (2003) Crystal structures of the 
ATPase subunit of the glucose ABC transporter from Sulfolobus solfataricus: nucleotide-free and nucleotide-
bound conformations. J. Mol. Biol. 330, 343-358. 
 
Walker, J. E., Saraste, M., Runswick, M. J., and Gay, N. J. (1982) Distantly related sequences in the α- and β-
subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding 
fold. EMBO J. 1, 945-951. 
 
Wang, R., Seror, S. J., Blight, M., Pratt, J. M., Broome-Smith, J. K., and Holland, I. B. (1991) Analysis of the 
membrane organization of an Escherichia coli protein translocator, HlyB, a member of a large family of 
prokaryote and eukaryote surface transport proteins. J. Mol. Biol. 217, 441-454. 
 
Wang, S., Yue, H., Derin, R.B., Giggino, W.B., and Li, M. (2000) Accessory protein facilitated CFTR-CFTR 
interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 103, 169-179. 
 
Westlake, C. J., Qian, Y. M., Gao, M., Vasa, M., Cole, S. P., and Deeley, R. G. (2003) Identification of the 
structural and functional boundaries of the multidrug resistance protein 1 cytoplasmic loop 3. Biochemistry 42, 
14099-14113. 
Westlake, C. J., Cole, S. P., and Deeley, R. G. (2005) Role of the NH2-terminal membrane spanning domain of 
multidrug resistance protein 1/ABCC1 in protein processing and trafficking. Mol. Biol. Cell 16, 2483-2492. 
Wu, K.-H., and Tai, P.C. (2004). Cys32 and His105 are the critical residues for the calcium-dependent cysteine 
proteolytic activity of CvaB, an ATP-binding cassette transporter. J. Biol. Chem. 279, 901-909. 
 
 
  
  34Specificity of the oligopeptide ABC transporter 
    35
Chapter 3 
The binding specificity of OppA determines the 
selectivity of the oligopeptide ABC transporter 
Mark K. Doeven, Rupert Abele, Robert Tampé, and Bert Poolman 
Abstract 
The purification and functional reconstitution of a five-component oligopeptide ATP-
binding cassette (ABC) transporter with a remarkably wide substrate specificity is 
described. High affinity peptide uptake was dependent of liganded substrate-binding 
protein OppA, which interacts with the translocator OppBCDF with higher affinity than 
unliganded OppA. Transport screening with combinatorial peptide libraries revealed 
that i) the Opp transporter is not selective with respect to amino acid side chains of the 
transported peptides; ii) any peptide that can bind to OppA is transported via Opp, 
including very long peptides of up to at least 35 residues; and iii) the binding specificity 
of OppA largely determines the overall transport selectivity. 
 
Introduction 
 
ATP-binding cassette (ABC) transporters belong to a large superfamily of membrane proteins 
that are abundantly present amongst all kingdoms of life. Members of this family share a 
common four-domain architecture composed of two transmembrane domains which span the 
membrane several times in α-helical conformation and two membrane-associated nucleotide-
binding domains (NBDs) which fuel the translocation process at the expense of ATP. The 
existence and arrangement of this four-domain structure has been confirmed by the high-
resolution crystal structure of the vitamin B12 ABC transporter BtuCD from Escherichia coli 
(Locher  et al., 2002).  In addition bacterial ABC importers use substrate-binding proteins 
(SBPs), located at the extracellular surface or in the periplasmic space, to scavenge for 
substrate and subsequent delivery to the translocator. The individual subunits of ABC 
transporters can be present as separate proteins or fused together in almost any possible 
combination (Higgins, 2001; van der Heide and Poolman, 2002). 
The oligopeptide transport system (Opp) from Lactococcus lactis is a five-component ABC 
transporter composed of a membrane-anchored SBP, OppA, two transmembrane proteins, 
OppB and OppC, and two NBDs, OppD and OppF (Tynkkynen et al., 1993). OppA binds a 
peptide and delivers it to the translocator complex where upon ATP hydrolysis the peptide is 
The abbreviations used are: ABC, ATP-binding cassette; ARS: ATP-regenerating system; NBD, nucleotide-
binding domain; SBP, substrate-binding protein; DDM, dodecyl-β-D-maltoside; MALDI-TOF, matrix-assisted 
laser desorption/ionization-time-of-flight; MS, mass spectrometry. Chapter 3 
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transported into the cell. Next to nutrition of the cell, in microorganisms the Opp system is also 
involved in various signalling processes including regulation of gene expression, chemotaxis, 
competence development, sporulation, DNA transfer by conjugation, and virulence 
development (for a review see Detmers et al., 2001). In Lactococcus lactis  (and other lactic 
acid bacteria), the Opp system is an essential part of the proteolytic system as it transports into 
the cell β-casein-derived peptides formed by the cell wall-associated protease PrtP, enabling 
the organism to grow in milk. On the basis of intracellular amino acid accumulation in peptide-
containing media, the lactococcal Opp system has been proposed to transport peptides in the 
range of 4 up to at least 18 residues (Detmers et al., 1998).  
The mechanism of peptide binding to OppA has been examined in detail using combinatorial 
peptide libraries and fluorescence techniques (Lanfermeijer et al., 1999, 2000; Detmers et al., 
2000). OppA from L. lactis binds oligopeptides as long as 35 residues and has the highest 
affinity for nonameric peptides. OppA is not able to completely enclose peptides longer than 6 
amino acid residues. The remaining residues stick out and interact with the protein surface 
actively, thereby contributing to the peptide binding affinity. This mechanism of substrate 
binding by OppA is different from that proposed for other SBPs which, on the basis of crystal 
structures, are thought to enclose the substrate completely (Tame et al., 1994). Recently, 
Charbonnel et al. (2003) concluded, on the basis of OppA sequence comparisons and peptide 
utilization patterns of six Lactococcus lactis strains, that OppA is not the main determinant of 
peptide transport specificity of Opp. However, in vivo peptide uptake experiments are often 
complicated by rapid breakdown of internalized peptides by peptidases, subsequent efflux of 
labeled amino acids and binding of peptides to the cell wall (Kunji et al., 1996; Detmers et al., 
1998). These complications prohibit any detailed analysis of transport kinetics, translocation 
mechanism and substrate specificity of Opp.  
Here, we describe an in vitro system for the study of peptide uptake via Opp. The purification 
and functional reconstitution in artificial membranes of this five-component ABC transport 
system enabled the analysis of the interaction of liganded and unliganded OppA with 
OppBCDF and determination of the overall transport specificity of Opp. Using radiolabeled 
combinatorial peptide libraries, we now demonstrate that the transport selectivity of Opp 
matches the binding specificity of OppA.  
 
Materials and methods 
 
Bacterial strain and growth conditions. Plasmid pAMP42 is a pNZ8048-derivative with a 3804 bp NcoI-
BamHI insert containing the oppDFBC genes under control of the nisin A promoter, yielding OppD, OppF, OppB 
and C-terminal His6-tagged OppC (A. Picon, unpublished result). L. lactis NZ9000 was used as a host for 
pAMP42. Cells were grown in 5 % (w/v) whey-permeate, 0.5 % (w/v) yeast extract, 0.5 % (w/v) glucose and 65 
mM KPi pH 7.0, supplemented with 5 µg/mL chloramphenicol in a 10 L fermentor with pH control (ADI 1065 
fermentor; Applikon Dependable Instruments B.V., Schiedam, The Netherlands). The pH was kept constant at 
pH 6.5 by titrating with 2 M KOH. Transcription was  induced at an O.D.660 of 2 by adding 1:1000 (v/v) of the 
culture supernatant of L. lactis NZ9700. Cells were harvested by centrifugation, washed with 100 mM KPi, pH 
7.0,  resuspended in 100 mM KPi, pH 7.0 plus 20 % (v/v) glycerol and stored at -80°C.  OppA was produced by 
L. lactis AMP2/pAMP31 as described (Detmers et al., 2000).  
 
Purification of Opp. Membrane vesicles were prepared by rupturing the cells with a high pressure 
homogenizer (Kindler Maschinen AG, Zürich, Switzerland) in the presence of 20 % (v/v) glycerol. OppBCDF-
containing membranes were resuspended to 5 mg/mL of total membrane protein in 50 mM KPi, pH 8.0, 200 mM 
KCl and 20 % (v/v) glycerol (buffer A) and solubilized with 0.5 % (w/v) DDM. Following 12 minutes of 
centrifugation at 280,000 x g, the supernatant was diluted 5 times with buffer A and incubated with Ni2+-NTA Specificity of the oligopeptide ABC transporter 
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resin (0.05 mL/mg total membrane protein) for 1.5 hours at 4°C while shaking. Subsequently, the resin was 
poured into a column and washed with 20 column volumes buffer A, supplemented with 0.05 % (w/v) DDM and 
10 mM imidazole. The proteins were eluted with 100 mM histidine, 0.05 % (w/v) DDM in buffer A, pH 7.0. OppA 
was purified as described (Detmers et al., 2000), except that DDM was not exchanged for Triton X-100 during 
the washing and elution steps.  
 
Immunoblotting and MALDI-TOF MS. Proteins were separated by SDS-PAGE (12.5 % polyacrylamide) and 
transferred to polyvinylidene difluoride membranes by semidry electrophoretic blotting. Immunodetection was 
done using monoclonal antibodies raised against the His6-tag (Sigma) or polyclonal anti-OppD antibodies at 
titers of 1:3,333 and 1:10,000, respectively. Detection was performed by using the Western-LightTM 
chemiluminescence detection kit with CSPDTM as a substrate according to the manufacturers instructions 
(Tropix Inc., Bedford, MA). Protein identification by peptide mass fingerprinting using MALDI-TOF MS was done 
by performing in-gel tryptic digestion in combination with CNBr cleavage as described previously (van Montfort 
et al., 2002). 
 
Membrane reconstitution of the Opp system. Reconsitution of Opp was done in three steps. i) Liposomes 
(20 mg/mL in 50 mM KPi, pH 7.0) of acetone/ether washed E. coli lipid and L-α-phosphatidyl choline from egg 
yolk in a ratio of 3:1 (w/w) were extruded through 400 nm polycarbonate filters, diluted to 4 mg/mL and titrated 
using Triton X-100 (Knol et al., 1996). Purified OppBCDF in elution buffer was added at a 1:100 (w/w) 
protein:lipid ratio, and the mixture was incubated for 30 minutes at RT while shaking gently. To remove the 
detergent, 40 mg/mL wet weight polystyrene beads (BioBeads SM2) was added, followed by a 15 minutes 
incubation at RT. Biobeads SM2 were added four more times and the incubation times were 15 minutes, 30 
minutes, overnight and 1 hour at 4°C. After 5 times dilution with 50 mM KPi, pH 7.0, proteoliposomes containing 
OppBCDF were collected by centrifugation for 1.5 hours at 150,000 x g and 4°C and stored in liquid nitrogen. ii) 
OppA was anchored to the liposomes via its lipid moiety, and the final concentration of OppA after membrane 
reconstitution was estimated from the binding of peptide, as described by Detmers et al. (2000). Unless stated 
otherwise (see legend to Fig. 2), an OppA concentration of ~ 0.35 nmol/m2 of membrane surface was used. iii) 
An ATP-regenerating system, composed of 9 mM ATP, 9 mM MgSO4, 24 mM creatine-phospate and 2.4 
mg/mL creatine kinase, was included into Opp-containing proteoliposomes by two freeze-thaw cycles. Following 
extrusion through 400 nm polycarbonate filters, the proteoliposomes were washed twice and resuspended in 50 
mM KPi, pH 7.0, to a concentration of 20 mg/mL lipid.  
 
Uptake of bradykinin. Transport assays were started by diluting proteoliposomes into 200 µL 50 mM KPi, pH 
7.0 (4 mg/mL final lipid concentration) containing [3H]-bradykinin at various concentrations. Uptake experiments 
were performed at 30°C. At given time-points, 40 µL samples were taken and mixed 1:1 with 200 µM unlabeled 
bradykinin in 50 mM KPi, pH 7.0. The sample was then diluted with 2 mL ice-cold 8 % (w/v) PEG-6000, filtered 
over 0.15 µm pore-size cellulose acetate (OE65) filters (Schleicher & Schuell, Dassel, Germany) and washed 
twice with 2 mL ice-cold 8 % (w/v) PEG-6000. The amount of radioactivity retained on the filter was determined 
by liquid scintillation counting. The concentrations of bound and free bradykinin and of liganded and unliganded 
OppA were calculated from the total concentration of OppA, the total concentration of bradykinin and the KD for 
bradykinin binding of 0.1 µM (Lanfermeijer et al., 1999; Detmers et al., 2000). For the calculation of peptide 
accumulation levels an internal volume of 0.5 µL/mg lipid was used, which corresponds to 50 µL/mg OppBCDF. 
 
Screening of combinatorial peptide libraries. Uptakes were done in a custom made micro-well filtration unit 
(8 x 6 wells, 300 µL volume each) which allowed a 4-fold scaling down of the assay volumes as compared to 
the setup described above. After filtration over 0.15 µm pore-size cellulose acetate (OE65) filters (Schleicher & 
Schuell, Dassel, Germany) samples were washed twice with 200 µL 50 mM KPi, pH 7.0. The amount of 
radioactivity retained on the filter was determined with γ-counting. Randomized peptide libraries used in this 
study have been described previously (Uebel et al., 1997; Detmers et al., 2000). Peptides were iodinated as 
described (Chen et al., 2003) using Chloramin T, and free iodine was removed by DOWEX 1X8 (Serva). 
 
Concentration of OppA at the membrane surface. The two-dimensional concentration of lipid-anchored 
OppA (in nmol/m2) at the membrane surface was calculated from the lipid and OppA concentration, and a lipid 
surface area of 0.6 nm2. For comparison of affinities with other SBP-dependent ABC transport systems, this Chapter 3 
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two-dimensional concentration was converted into a local concentration of OppA (in µM). For this, a shell of ~ 
3.4 nm around the liposomal surface was used (estimated from the crystal structure of OppA from Salmonella 
typhimurium; Tame et al., 1994).  
 
Miscellaneous. Protein concentrations were determined according to the method of Lowry et al. (1951), using 
bovine serum albumin as a standard. Peptide concentrations were determined using the bicinchoninic acid 
assay (Pierce). The concentrations of purified OppBCDF or OppA were determined spectrophotometrically by 
measuring the absorption at 280 nm and using extinction coefficients of 0.990 and 1.605 (mg/mL)-1cm-1, 
respectively.  
 
Results 
 
Purification of OppBCDF. The components of the oligopeptide translocator complex were 
amplified in Lactococcus lactis, using the nisin expression system (Kuipers et al., 1993; Kunji 
et al., 2003). OppBCDF was overproduced to an estimated level of  ~ 5 % (w/w) of total 
membrane protein content after two hours of induction (Fig. 1A). Membrane solubilization and 
purification was done with DDM as detergent.  Initial conditions for maintaining an intact 
OppBCDF complex during purification were screened for ionic strength (0-500 mM KCl) and 
pH (6.0-8.0) using 20 mM imidazole, 0.05 % DDM and 20 % (v/v) glycerol as basal medium. 
This did not lead to purification of the complete translocator but resulted in purification of the 
His6-tagged component OppC only (data not shown). However, when imidazole was omitted 
from the buffer during binding of the complex to the Ni2+-NTA resin, the OppBCDF proteins 
could be obtained in an approximate 1:1:1:1 ratio (Fig. 1B). Varying the glycerol concentration 
from 0 to 40 % (v/v) did not have any effect on the domain stoichiometry obtained after 
purification (data not shown). The individual translocator subunits were identified by Western 
blotting, using monoclonal anti-His-tag or polyclonal anti-OppD antibodies for detection of 
OppC or OppD, respectively (data not shown). OppF was identified by peptide mapping with 
MALDI-TOF MS using an in-gel digestion procedure developed for integral membrane proteins 
(van Montfort et al., 2002). The mass spectrum of the putative OppB band did not yield enough 
peaks to unambiguously confirm the identity of this protein.  
 
Fig. 1. Amplification and purification of the Opp system. (A) Overexpressed (membrane vesicles, lane 1 
and 3) and purified (lane 2 and 4) OppBCDF and OppA are shown, respectively. The positions of molecular 
weight marker proteins are indicated (kDa). (B) Purification of OppBCDF with 10, 5, 2.5 and 0 mM imidazole 
present (lanes 1, 2, 3 and 4, respectively) during binding to the Ni2+-NTA column.  
 Specificity of the oligopeptide ABC transporter 
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Functional reconstitution of the Opp system. Membrane reconstitution of the oligopeptide 
transporter was done via a three step procedure. First, the purified translocator complex 
OppBCDF was incorporated into Triton X-100 destabilized liposomes. Thereafter, purified 
OppA was anchored to the outside of OppBCDF containing liposomes via its N-terminal lipid 
modification by absorbing the purified protein in 0.05 % (w/v) DDM to the (proteo)liposomes 
and removal of residual detergent with BioBeads. This resulted in proteoliposomes containing 
all five proteins of which the Opp system is composed. Next, after inclusion of ATP and the 
ATP-regenerating system (ARS) into the vesicle lumen by two freezing-thawing cycles, 
bradykinin transport could be measured (Fig. 2A). Control experiments indicated that 
bradykinin does not interact aspecifically with the liposomes and uptake was not observed 
when AMP-PNP, a non-hydrolyzable ATP-analogue, was used instead of ATP, ruling out 
aspecific effects on the membrane of the components of the ARS (Detmers et al., 2000; 
Patzlaff et al., 2003). To increase the signal-to-noise ratio, background binding of radiolabeled 
substrate to OppA was diminished by chasing with a large excess (~ 100 fold) of unlabeled 
bradykinin. Chasing background binding did not lead to an increase of the amount of label 
inside or efflux of accumulated [3H]-bradykinin from the proteoliposomes (Fig. 2A). The 
apparent KM of transport for bradykinin was 0.9 ± 0.2 µM (Fig. 2B). To verify that bradykinin 
uptake had taken place, the accumulation level ([bradykinin]in/[bradykinin]out) was calculated 
(see ‘materials and methods’ section for details). At a bradykinin concentration of 1.5 µM the 
accumulation level was ~ 50 after 4 minutes of uptake, indicating that the peptide was 
transported against the concentration gradient. 
 
Peptide uptake as a function of OppA concentration. Since liganded OppA rather than the 
free peptide is the actual substrate of OppBCDF, the effect of increasing the amount of OppA 
on the transport rate was determined. For easy comparison with other ABC transporters that 
employ a soluble SBP, the local concentrations of OppA at the membrane surface (in µM) 
were calculated as described in the ‘materials and methods’ section. A concentration of OppA 
in the assay of 0.36 µM equals 0.35 nmol/m2 of membrane surface, which corresponds a local 
concentration at the membrane of about 100 µM. At a bradykinin concentration of 1.5 µM (a 
concentration more than 10-fold above the KD for bradykinin binding; KD = 0.1 µM), the KM of 
the translocator OppBCDF for liganded OppA was ~ 50 µM (Fig. 2C). At low substrate 
concentration, that is, with 0.1 µM bradykinin, the uptake rate increased linearly with the 
concentration of OppA and no inhibition due to the large excess (up to 4-fold) of unliganded 
OppA was observed (Fig. 2C). Fig. 2D shows how the ratio of liganded vs. unliganded OppA 
varied in the titration and confirms that at the highest level of OppA a 4-fold excess of 
unliganded over liganded OppA was present. These results indicate that the translocator has a 
much higher affinity for liganded than for unliganded OppA. 
  
Uptake of randomized peptides via Opp. Because unliganded OppA does not inhibit the 
uptake of peptides, at least under our experimental conditions, the specificity of Opp for 
peptides can be estimated directly from the rate of uptake. Since the peptide libraries were 
available in relatively small quantities, a micro-well plate setup was used for these transport 
assays. The peptide libraries were used at concentrations ranging from 3.2 to 5.0 µM. 
Randomized peptides were labeled at tyrosine residues with tracer amounts of 125I to monitor 
the transport reaction. Control experiments showed that uptake and (a)specific binding of 
randomized peptides could be specifically blocked by the addition of 100 µM bradykinin (Fig. Chapter 3 
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3). The chase with a large excess of bradykinin allowed us to separate transport from possible 
non-specific interaction of the peptides with the liposomes.  
 
 
 
 
 
Fig. 2. Functional reconstitution and characterization of the Opp system. (A) [3H]-bradykinin (0.7 µM) 
uptake was assayed in the presence (●) and absence (▼) of ATP plus ATP-regenerating system enclosed in 
the proteoliposomes. The open circles denote samples to which 100 µM of unlabeled bradykinin was added 
after 2 minutes of  [3H]-bradykinin uptake. (B) Kinetics of [3H]-bradykinin uptake. Initial rates of uptake were 
calculated from the linear part of the curves as depicted in panel A. Data were fitted with the Michaelis Menten 
equation. (C) Uptake rates at increasing OppA levels were determined in the presence of saturating (1.5 µM, 
○) and low (0.1 µM, ●) [3H]-bradykinin concentrations. The concentration of membrane-anchored OppA was 
varied from 0 - 0.36 µM, which corresponds to two-dimensional concentrations of 0 - 0.35 nmol/m2 of 
membrane surface (top-axis) and local concentrations at the membrane of 0 - 100 µM OppA (bottom-axis; 
see ‘materials and methods’ section for details of the calculations). The error bars indicate the standard 
deviation of experiments performed in duplicate. (D) Calculation of the concentrations of liganded (●) and 
unliganded (○) OppA at a bradykinin concentration of 0.1 µM. The total OppA concentration (▼)  was varied 
from 0 - 0.36 µM (as in panel C). For easy comparison, the local concentration of OppA at the membrane is 
shown on the top-axis. 
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Fig. 3. Uptake of the randomized nonapeptide X4AX4 into Opp containing proteoliposomes. Transport 
of 3.2 µM peptide in the absence (●) or presence (○) of 100 µM bradykinin is shown. 
 
Length specificity. To determine the length dependence of transport, randomized peptide 
libraries ranging from 5 up to 35 amino acid residues were used. All peptides, even the 
extremely long ones of up to 35 residues, were transported by the Opp system (Fig. 4A). The 
inhibition of bradykinin binding to OppA by the combinatorial peptide libraries, determined 
previously by Detmers et al. (2000), is shown for comparison. Peptides with nine amino acid 
residues showed the highest uptake rates and the best binding to OppA. Longer and shorter 
peptides were transported with slower rates compared to the X9 library, but, overall, the 
longest and shortest peptides were transported better than expected on the basis of the 
binding data. Since partly translocated peptides might be trapped in the transporter (and not be 
chased by the excess of bradykinin), we calculated the uptake of the largest peptides in terms 
of accumulation levels and number of peptides translocated per transporter. The accumulation 
level of X35 ([X35]in/([X35]out) was 2.5 and at least 30 peptides were transported per translocator 
after 5 minutes of uptake (see ‘materials and methods’ section for details). These numbers, 
and the fact that X35 uptake still increased linearly with time after 5 minutes (not shown), 
demonstrate that even the largest peptides could be fully translocated. 
 
Influence of D-amino acids. The effect of D-amino acids on transport was determined with 
randomized nonameric peptide libraries containing D-amino acids at a single position. The D-
amino acid containing peptides showed lower uptake rates compared to the all L-amino acid 
containing X9 library (Fig. 4B). Whereas in previous binding assays the negative effect of the 
D-amino acids were significant for the positions 4, 5 and 6, the differences in transport were 
less pronounced. 
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Fig. 4. Transport of randomized peptide libraries of different length and nonamers with D-amino 
acids at a defined position. The peptide concentration was 3.2 (A) or 5 µM (B). Each rate determination 
was based on four data points, samples taken after 1, 2, 3.5 and 5 minutes, and carried out at least twice; 
error bars indicate the standard deviation. The transport data are shown as black bars; the binding data are 
shown for comparison (white bars; taken from Detmers et al., 2000).  
 
 
 
 
Fig. 5. Transport of randomized peptide libraries with modified termini. The peptide concentration was 
3.2 µM. For further details, see legend to Fig. 4. 
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Transport of peptides with modified termini. Randomized peptides with modified termini 
were used to test whether a free N- or C-terminus was required for transport via Opp.  Uptake 
rates of octameric peptides (X8) with an acetylated N- or amidated C-terminus or both were 
compared with the uptake rate of the unmodified randomized octameric peptide. The results 
indicate that free N- or C-termini are not essential for transport (Fig. 5). Acetylation of the N-
terminus had no effect, whereas amidation of the C-terminus reduced the uptake rate by a 
factor of two. In addition, a nonameric randomized peptide library with a formylated N-terminal 
methionine, fMX8, was transported equally well as MX8.  
 
Nonameric randomized peptides. Nonameric randomized peptide libraries were used in 
which amino acids at all but one position were random. This position contains one of 19 
different amino acids (cysteine was excluded from the libraries). In this way, the effect of a 
single amino acid at a given position can be determined independent of the sequence context 
of the rest of the peptide. For comparison the transport via Opp and binding to OppA were 
screened for two positions. Generally, the transport data differed little from the binding results 
(Fig. 6A and B). All peptides tested were transported and peptides that bound best to OppA 
showed the highest transport rates. At position one, bulky and hydrophobic amino acids were 
somewhat disfavored (His, Leu, Val, Trp, Tyr). At position five, no clear differences between 
the binding specificity of OppA and the transport selectivity of the Opp system as a whole 
could be discerned. 
 
 
Fig. 6. Transport of randomized nonameric peptide libraries with a defined amino acid at position 1 
or 5. Peptides were tested at 3.2 µM. For further details, see legend to Fig. 4. Chapter 3 
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To investigate further if the overall transport specificity differs from the binding selectivity of 
OppA, two amino acids, methionine and valine, were chosen for screening using randomized 
nonameric peptide libraries. These two amino acids showed almost no differences in binding 
specificity, irrespective of the position in the peptide (Detmers et al., 2000). Transport 
specificity of the methionine containing libraries matched perfectly with the binding selectivity 
(Fig. 7A). In the case of valine, some differences were observed (Fig. 7B), of which the 
negative effects of valine at position 1, 4 and 9 on the transport rates were most pronounced. 
However, again all peptides could bind to OppA and were well transported by the Opp system. 
 
 
Discussion and conclusions 
 
We developed an in vitro assay system for the analysis of the kinetics, mechanism and 
specificity of peptide transport, and we present the unique selectivity properties of the 
oligopeptide (Opp) ABC transporter from Lactococcus lactis.  
Opp transporters in microorganisms are more complex than most other ABC systems because 
they are composed of five separate polypeptides, and this has hampered their purification and 
membrane reconstitution for many years. The translocator complex OppBCDF is embedded in 
 
 
Fig. 7. Transport of randomized nonameric peptide libraries with Methionine or Valine at a defined 
position. Peptides were tested at 3.2 µM. For further details, see legend to Fig. 4. 
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the membrane, whereas the oligopeptide-binding protein is tethered to the external surface of 
the membrane. The Opp translocator was produced in Lactococcus lactis and purified as a 
complex using a single His6-tag on OppC. Although Ni2+-NTA based purification protocols 
generally employ low concentrations (5-30 mM) of imidazole in the protein binding to the resin 
and washing steps, imidazole severely compromised the translocator stability. All four proteins 
could only be co-purified when imidazole was absent in the binding step and histidine was 
used for the elution of the complex.  
Membrane reconstitution of Opp was done by inserting the OppBCDF complex into detergent-
destabilized liposomes, after which OppA was anchored to the outside of the membranes via 
its N-terminal lipid modification. Because of the high affinity of OppA for the reporter substrate 
bradykinin (KD = 0.1 µM) and the use of relatively high concentrations of OppA, a ~ 100 fold 
excess of unlabeled bradykinin was used to stop the transport reaction and chase all OppA-
bound [3H]-bradykinin. The bradykinin accumulated inside the proteoliposomes was not 
affected by the chase with unlabeled bradykinin, because the transporter functions 
unidirectionally.  
The affinity of the translocator for its substrate, that is liganded OppA, was determined by 
measuring uptake rates at increasing OppA concentrations at the membrane surface and 
saturating amounts of bradykinin. The KM of the translocator for liganded OppA was ~ 50 µM, 
which is in the same range as the values of ~ 65 µM determined for the histidine system 
HisJQMP2 (Prossnitz et al., 1989) and  25-50 µM for the maltose system MalEFGK2 (Dean et 
al., 1992). The translocator could already be saturated at relatively low absolute amounts of 
OppA because OppA is attached to the membrane. Even at an OppA concentration in the 
assay of only 0.36 µM, which corresponds to ~ 0.35 nmol/m2 of membrane surface, the local 
concentration of OppA at the membrane could be as high as 100 µM. Inhibition of transport 
activity by unliganded SBP has been observed for the periplasmic binding protein-dependent 
histidine and maltose ABC transport systems (Prossnitz et al., 1989; Merino et al., 1995), and 
this has been ascribed to competition between unliganded and liganded SBP for the 
translocator. In the case of the histidine permease, it even was suggested that liganded and 
unliganded HisJ interact with equal affinity with the translocator complex (Ames et al., 1996). 
We observed no inhibition at low peptide concentrations, corresponding to local concentrations 
of 20 µM liganded and 80 µM unliganded OppA, which indicates that the affinity of the 
translocator for liganded OppA is much higher than for unliganded OppA.  
It is often assumed that the SBP of bacterial ABC transporters determines the overall transport 
selectivity of the system, but, unlike Opp, the specificity of most systems is narrow and binding 
and transport of only a few substrates have been compared. Recently, Charbonnel et al. 
(2003) proposed, by comparing the peptide utilization patterns of six different Lactococcus 
lactis strains, that OppA is not the main determinant of peptide transport specificity. It was 
claimed that the translocator OppBCDF plays an important role in determining the overall 
transport selectivity. It must be noted, however, that several of the used strains were not well 
characterized and other factors (for example other peptide transporters or lack of certain 
peptidases) might have interfered with the observed peptide utilization patterns. The 
sequences of the opp genes of two of the used strains, L. lactis MG1363 and IL1403, differ for 
the transmembrane proteins OppB and OppC at only two positions (Tynkkynen et al., 1993; 
Bolotin et al., 2001; the system studied by us is from the MG1363 strain). This makes it 
unlikely that the observed differences in peptide transport can be ascribed solely to different 
properties of the transmembrane moieties of the Opp systems. In a follow up paper (Helinck et Chapter 3 
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al., 2003), Juillard and colleagues proposed that some peptides bind to OppA without 
subsequently being transported, but, with the exception of one tetrapeptide, there is no real 
evidence for this notion. By using combinatorial peptide libraries, we now clearly show that the 
binding specificity of OppA compares well with the overall transport selectivity of the Opp 
system. For the specificity studies, we used saturating OppA concentrations, implying that 
substrate binding or delivery to the translocator is not rate-determining. This mimicks the in 
vivo situation where overexpression of OppA in wild-type L. lactis cells increased the amount 
of peptide binding but did not affect the rate of uptake (Picon et al., 2000). Furthermore, the KM 
for bradykinin transport in vivo (0.27 ± 0.03 µM; Picon et al., 2000) and in vitro (0.9 ± 0.2 µM) 
are in the same range. Thus, both in vivo and in vitro there is a large excess of OppA over 
OppBCDF and the rate-determining step for bradykinin uptake is in translocation and not in 
peptide binding.  
A striking feature of the Lactococcus lactis Opp system is that it binds and transports 
exceptionally long peptides. Here, we show that the Opp ABC transporter is capable of 
transporting peptides as long as at least 35 residues. Peptides shorter or longer than nine 
residues are transported relatively better than expected solely on the basis of the binding data. 
This fits well with the previously made observation that small peptides are bound relatively 
poorly but transported rather well (Detmers et al., 1998). On the basis of these experiments 
and pre-steady state peptide binding kinetics, it was suggested that the dissociation rate 
constant (k-1) is an important determinant of the rate of transport. Tight binding to OppA was 
associated with low k-1 values which might limit the transfer of peptide from OppA to the 
translocator and yield a low rate of transport. On the other hand, poorly binding peptides had a 
high k-1 and were transported relatively well. A similar explanation may hold for the difference 
in binding and transport of the penta- and hexameric peptides.  
In a previous report, we showed that there is no strict requirement for a free amino- and 
carboxyl-group for a peptide to bind to OppA (Lanfermeijer et al., 2000). Acetylation of the N-
terminal amino group or amidation of the C-terminal carboxyl group of the peptide 
SLSQSLSQS decreased the binding affinity only 4 and 7 fold, respectively. Here, we show that 
a free amino or carboxyl group is also not essential for peptide transport by Opp.  
To further analyze the transport specificity of the Opp system, randomized nonameric peptides 
containing D-amino acids or a particular residue at one single position were used. The uptake 
rate of D-amino acid containing libraries was 2-3 fold lower than the X9 library. This is in 
agreement with the binding studies in which a 5-fold higher peptide concentration had to be 
used to obtain similar levels of inhibition of bradykinin binding as with all L-amino acid 
containing libraries. Overall, there are only small differences between the binding and transport 
profiles. Position 7 and 8 seem a little more selective than expected on the basis of the binding 
to OppA. The screening of position 1 and 5 of the randomized nonameric libraries revealed 
little differences between binding and transport specificity. In general, it appears that any 
peptide that can bind to OppA can also be transported by Opp. There are no indications for 
any amino acid causing a peptide to be completely excluded from transport.  
The fact that some peptides with bulky and hydrophobic amino acids (His, Leu, Trp, and Tyr at 
position 1 and Val at position 1, 4 and 9) show somewhat reduced uptake rates can be 
explained in two ways. Either these peptides bind relatively strong to OppA, resulting in low k-1 
values and consequently lower transport rates, or a peptide-binding site within OppBCDF 
disfavors these amino acids at the positions 1, 4 and 9.  Specificity of the oligopeptide ABC transporter 
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In conclusion: the affinity of OppBCDF for liganded OppA is in the same range as the 
corresponding interaction in other SBP-dependent ABC transporters, but because OppA is 
membrane-anchored much lower amounts are needed to saturate the translocator than with 
soluble SBPs. The affinity of the transmembrane complex for liganded OppA is much higher 
than for unliganded OppA. The Opp system has the remarkable capacity to transport peptides 
ranging from 4 up to at least 35 residues. Overall, the transport selectivity seems to be 
determined by the binding specificity of OppA.  
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Chapter 4 
Specificity and selectivity determinants of peptide 
transport in Lactococcus lactis and other 
microorganisms 
Mark K. Doeven, Jan Kok, and Bert Poolman 
Abstract 
Peptide transport in microorganisms is important for nutrition of the cell and various 
signaling processes including regulation of gene expression, sporulation, chemotaxis, 
competence, and virulence development. Peptide transport is mediated via different 
combinations of ion-linked and ATP-binding cassette (ABC) transporters, the latter 
utilizing single or multiple peptide-binding proteins with overlapping specificities. The 
paradigm for research on peptide transport is Lactococcus lactis, in which the uptake of 
peptides containing essential amino acids is vital for growth on milk proteins. 
Differential expression and characteristics of peptide-binding proteins in several 
Lactococcus lactis strains resulted in apparent conflicts with older literature. Recent 
developments and new data now make the pieces of the puzzle fall back into place 
again and confirm the view that the oligopeptide-binding proteins determine the uptake 
selectivity of their cognate ABC transporters. Besides reviewing the current data on 
binding specificity and transport selectivity of peptide transporters in L. lactis, the 
possible implications for peptide utilization by other bacterial species are discussed. 
Introduction 
Lactic acid bacteria (LAB) contain a proteolytic system that enables them to grow in milk. The 
milk proteins, α-, κ-, and β-casein, are degraded by the cell wall-associated proteinase PrtP 
and the resulting peptides, of which the transport of oligopeptides is most important for 
nutrition (Kunji et al., 1998), are taken up by the cell. Oligopeptides are defined here as 
peptides of 4 to 35 residues. Internalized peptides are further hydrolyzed by a large array of 
peptidases (Kunji et al.,  1996). Regulation of peptide transport is accomplished via the 
pleiotropic transcriptional repressor CodY, which senses the intracellular pool of branched-
chain amino acids  (Guédon et al., 2001b). 
L. lactis MG1363 is a plasmid-free derivative of strain NCDO712 and the best characterized 
LAB in terms of proteolysis, peptide transport, and regulation thereof (Tynkkynen et al., 1993;  
The abbreviations used are:  ABC, ATP-binding cassette; CDM, chemically defined medium; LAB, lactic acid 
bacteria. Chapter 4 
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Hagting et al., 1994; Foucaud et al., 1995; Kunji et al., 1995; Kunji et al., 1996; Detmers et al., 
1998; Kunji et al., 1998; Guédon et al., 2001a; Guédon et al., 2001b; Kok and Buist, 2003; 
Sanz et al., 2003; Sanz et al., 2004). The genome sequence of L. lactis MG1363 will be 
published in the coming year.  The chromosome of L. lactis IL1403 was the first lactococcal 
genome to be sequenced (Bolotin et al., 2001), and the genomic data from this strain have 
been combined with experimental data of MG1363. However, the IL1403 and MG1363 
genome sequences are on average only ~ 85 % identical, and the percentages identities vary 
strongly when individual genes are compared (unpublished result). In recent years, several L. 
lactis  strains other than MG1363 have been used in studies of (oligo)peptide transport 
(Charbonnel et al., 2003; Lamarque et al., 2004). Apparent discrepancies have arisen in the 
literature due to i) the assumption that there is only one oligopeptide transporter (Opp) that is 
solely responsible for uptake of oligopeptides in all lactococcal strains, ii) erroneous annotation 
of the Dpp system of IL1403 as Opt (the dppAPBCDF and optSABCDF gene products are on 
average 97 % identical at the amino acid level), and iii) differential expression of (oligo)peptide 
transporters in the studied L. lactis strains.  
Although at the moment not recognized as such, recent work (Sanz et al., 2003; Lamarque et 
al., 2004; this work) provides an explanation for apparent discrepancies in published papers 
(Charbonnel et al., 2003; Helinck et al., 2003; Doeven et al., 2004). In this chapter, we present 
an overview of peptide transport and regulation in L. lactis species, and provide alternative 
explanations for published works. In addition, data is presented that supports our current view 
that the oligopeptide-binding proteins determine the uptake selectivity of the oligopeptide ATP-
binding cassette (ABC) transporters. 
 
Peptide transport in Lactococcus lactis MG1363 
 
Biochemical analysis indicated that L. lactis MG1363 has at least three functional peptide 
transport systems (Fig. 1). The opp and dtpT genes were cloned and characterized first and 
the corresponding transport proteins (Opp and DtpT) were shown to catalyze the uptake of 
oligo-  and di/tripeptides, respectively (Tynkkynen et al., 1993; Hagting et al., 1994). The Opp 
system belongs to the ABC transporter superfamily and is composed of five proteins: an 
oligopeptide-binding protein, OppA, two integral membrane proteins, OppB and OppC, and two 
nucleotide-binding proteins, OppD and OppF. DtpT is a secondary transporter belonging to the 
PTR family of peptide transporters. An opp knockout strain was completely blocked in the 
uptake of β-casein-derived oligopeptides, indicating that the Opp system is essential for the 
organism to grow on milk (Tynkkynen et al., 1993).   
Analysis of opp and/or dtpT single or double knockout mutants revealed the presence of a third 
peptide transport system with preference for hydrophobic (branched-chain amino acid-
containing) di- and tripeptides (Foucaud et al., 1995). Peptide transport via this third system 
was dependent on ATP, or a related energy-rich phosphorylated intermediate, and the system 
was initially designated DtpP. The genes belonging to the DtpP system were cloned, 
characterized, and named Dpp (Sanz et al., 2001; Fig. 1). The Dpp system, like Opp, is an 
ABC transporter. In MG1363, six dpp genes are present coding for two peptide-binding 
proteins, DppA and DppP, two integral membrane proteins DppB and DppC, and two 
nucleotide-binding proteins DppD and DppF. In L.  lactis MG1363, the dppP gene is not 
functional due to a nonsense mutation and  a  frame-shift (Sanz et al., 2001). Peptide transport in microorganisms 
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Recently, a second set of oligopeptide transporter genes was found in L. lactis MG1363, 
presumably originating from a duplication of the opp operon, and the genes were designated 
oppD2F2B2C2A2 (Sanz et al., 2004; Fig. 1). An oppA deletion mutant was fully impaired in 
oligopeptide utilization, indicating that in MG1363 this second Opp system is either not 
expressed or not functional. Interestingly, complementation of an oppA  knockout with the 
putative peptide-binding protein OppA2, expressed from a plasmid, restored the ability of the 
strain to utilize oligopeptides. This indicates that the OppA2 protein can interact functionally 
with the OppBCDF translocator. Genome analysis of L. lactis MG1363 revealed that, next to 
opp and opp2, MG1363 contains another dipeptide/oligopeptide/nickel transporter homologue 
 
 
Fig. 1. Schematic overview of function, regulation and genetic organization of peptide transporters in 
Lactococcus lactis MG1363. Three functional peptide transport systems have been identified in L. lactis 
MG1363. The ion-linked transporter DtpT and the ABC transporter Dpp facilitate the uptake of di- and 
tripeptides. A second ABC transporter, Opp, catalyzes the uptake of oligopeptides containing 4 up to and 
including 35 amino acid residues.  The (oligo)peptide-binding proteins (DppA and OppA) are anchored to the 
membrane via lipid modification of the N-terminal cysteine residue and deliver peptides to their cognate 
membrane complexes. Internalized peptides are hydrolyzed by intracellular peptidases. The transcriptional 
repressor CodY senses the internal pool of branched-chain amino acids (I, L and V), and inhibits the 
transcription of, among others, the opp genes. In MG1363, the gene coding for the second peptide-binding 
protein of the Dpp system, dppP, contains nonsense and frame-shift mutations, which are indicated by 
asterisks. Recently, a second set of oligpeptide transporter genes, designated oppD2F2B2C2, and a novel 
dipeptide/oligopeptide/nickel transporter homologue (genetic organization ABCDF) have been found. The 
Opp2 system and the novel dipeptide/oligopeptide/nickel transporter homologue are either not functional in 
peptide transport or not expressed.  
 Chapter 4 
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(Fig. 1). At present, it is not clear if this system is expressed and whether or not it is functional 
as a peptide transporter. On the basis of the oligopeptide null phenotype of the ∆opp strains, it 
is clear that this system does not play a significant, if any, role in oligopeptide uptake. 
 
Regulation of peptide transport in MG1363 
 
Transcription of the genes coding for the proteinase (prtP), the oligopeptide transporter 
(oppDFBCA) and several peptidases (pepC, pepN, and pepO) is repressed 5- to 150-fold upon 
the addition of peptides to the growth medium, which indicates a negative feedback 
mechanism of regulation (Detmers et al., 1998; Guédon et al., 2001a). A systematic study, 
using 67 dipeptides, showed that regulation of peptide transport was accomplished via a 
pleiotropic transcriptional repressor, CodY, which senses the internal branched-chain amino 
acid pool (Guédon et al., 2001b). In accordance, deletion of the dtpT gene resulted in an 
upregulation of Opp activity (Kunji et al., 1995), suggesting that di/tripeptide transport indeed 
plays an important role in the regulation of the proteolytic system. Moreover, expression of 
Opp was optimal in chemically-defined medium (CDM) containing free amino acids, 
presumably because these are less efficiently internalized than peptides. In vitro experiments 
confirmed that CodY binds upstream of its target genes, i.e. pepN, pepC, opp-pepO1, prtPM, 
and probably pepX, and pepDA2 (den Hengst et al., 2005). Binding of CodY to the promoter of 
the  opp system is strongly affected by the addition of branched-chain amino acids. DNA 
binding is not influenced by GTP, contrary to what was shown for CodY from Bacillus subtilis 
(Shivers and Sonenshein, 2004). A schematic overview of the different peptide transporter 
genes, their corresponding transport systems, and the regulation of peptide tranport in L. lactis 
MG1363 is presented in Figure 1.  
 
Peptide transport in Lactococcus  lactis strains other than MG1363 
 
Homologues of all the peptide transporters that are functional in L. lactis MG1363 (DtpT, Dpp 
and Opp) have been found in the sequenced strain IL1403 (Bolotin et al., 2001; Fig. 2A). 
Interestingly, the gene coding for the second peptide-binding protein of the Dpp system of 
IL1403, dppP, does not contain the nonsense and frame-shift mutations present in dppP from 
MG1363 (Bolotin et al., 2001; Sanz et al., 2001). Peptide binding experiments showed that 
DppP bound di-, tri- and tetrapeptides, with highest affinity for tripeptides (Sanz et al., 2003). 
Peptides longer than four residues were not tested in this study. Importantly, in vivo analysis of 
Dpp in L. lactis IL1403 suggests that DppP allows the Dpp system to transport peptides 
containing up to and including nine amino acid residues (Lamarque et al., 2004). Moreover, 
Western blotting confirmed that DppP is not produced in MG1363, whereas IL1403 does not 
appear to synthesize the oligopeptide-binding protein (OppA) of the Opp system. This 
suggests that the critical activity of oligopeptide uptake in IL1403 is not specified by Opp but 
rather by Dpp (Fig. 2B). Three other L. lactis strains (SK11, SKM6, and Wg2) were also tested 
for their capacity to express (oligo)peptide transport systems. SK11 and Wg2 produced both 
DppP and OppA whereas SKM6, like IL1403, only synthesized DppP (Fig. 2B, C). Thus, L. 
lactis SK11 and Wg2 are equipped with at least two functional oligopeptide transport systems. 
It is not clear whether IL1403 fails to produce only OppA or also its cognate membrane 
complex OppBCDF. If OppBCDF is expressed, DppP might function not only with the 
DppBCDF complex but also with OppBCDF, thereby providing the cell with a higher capacity to Peptide transport in microorganisms 
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transport oligopeptides. An overview of the genetic organization and the types of (oligo)peptide 
transporters in L. lactis IL1403 and other lactococcal strains is presented in Figure 2. 
 
In vivo or in vitro studies of peptide transport? 
 
The specificity of peptide transport via the different uptake systems is often evaluated in 
growth experiments using either wild-type or transport-null strains (Tynkkynen et al., 1993; 
Foucaud et al., 1995; Sanz et al., 2001; Charbonnel et al., 2003). Since L. lactis is auxotrophic 
for several amino acids such as Glu (Gln), Met, His, Leu, Ile and Val, the ability to grow in 
CDM with one of these amino acids in the form of a peptide is an indication that the peptide is 
transported. Complications might arise when peptides are (partly) degraded outside the cell or 
contain the branched-chain amino acids Leu, Ile or Val. In the latter case, a reduced growth 
rate can be explained in two ways: either the peptide is not efficiently transported, or the 
expression of the transport system is reduced via the action of CodY (see above). Colonies of 
an L. lactis MG1363 strain containing a transcriptional fusion of the oppA promoter with E. coli 
lacZ are, for example, blue on CDM whereas they are white on M17, which reflects a 150-fold 
repression of transcription from PoppA when the cells grow in peptide-rich media such as M17 
(Guédon et al., 2001a, Guédon et al., 2001b).  
Peptide transport assays in whole L. lactis cells are done either by measuring the increase in 
the internal amino acid pool by reversed-phase high-performance liquid chromatography (Kunji 
et al., 1993) or by using radiolabeled peptides (Detmers et al., 1998; Picon et al., 2000). In vivo 
uptake experiments, however, are complicated by rapid breakdown of internalized peptides by 
intracellular peptidases, subsequent efflux of (labeled) amino acids, and binding of peptides to 
the cell wall (Detmers et al.,  1998; Picon et al.,  2000). Accumulation of leu-enkephaline 
(YGGFL) via Opp, for example, was followed by a rapid efflux of radiolabeled amino acids from 
the cells (Detmers et al., 1998). These complications prevent any detailed kinetic analysis of in 
vivo peptide transport in L. lactis. For these reasons, in vitro approaches using purified proteins 
are critical for a comprehensive understanding of all aspects of peptide transport and utilization 
(Lanfermeijer et al., 1999; Detmers et al., 2000; Fang et al., 2000; Sanz et al., 2000; Sanz et 
al., 2003; Doeven et al., 2004). 
 
The oligopeptide-binding protein determines the selectivity of the Opp 
system 
 
To determine the factor(s) that impose peptide uptake selectivity, Charbonnel et al. (2003) 
expressed OppA proteins from four distinct L. lactis strains in a L. lactis MG1363∆oppA strain. 
Surprisingly, irrespective of the strain from which the OppA protein originated, the peptide 
utilization patterns were similar to that of the host strain. This suggested that the oligopeptide-
binding protein does not play a significant role in determining the transport selectivity of its 
corresponding ABC uptake system. It was therefore proposed that the membrane complex, 
OppBCDF, imposes specificity on the transport process. On the contrary, an in vitro study, 
using purified and membrane-reconstituted Opp, clearly showed that OppA determines the 
uptake selectivity of the Opp ABC transporter (Doeven et al., 2004). Binding and transport 
profiles with combinatorial peptide libraries matched perfectly.  
The finding that several of the strains used by Charbonnel et al. (2003) employed DppP in 
stead of OppA for the uptake of oligopeptides (Lamarque et al., 2004; strains IL1403 and Chapter 4 
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SKM6), or use both Opp and Dpp (strains SK11 and Wg2), clarifies why, in these in vivo 
experiments, OppA was not identified as the main determinant of oligopeptide transport 
selectivity. The additional transporter (Dpp) transported the oligopeptides. In fact, the 
observation that an additional peptide-binding protein (DppP) in L. lactis IL1403 enables the 
Dpp system to transport oligopeptides, in addition to di- and tripeptides (as is the case in 
MG1363), is a further argument that (oligo)peptide-binding proteins determine the uptake 
selectivity of their cognate ABC transporters. 
 
Competitive inhibition of peptide binding or transport  
 
An indirect way of evaluating binding and/or transport of peptides is to measure competitive 
inhibition of a reporter peptide, as has been done for the Opp system (Detmers et al., 1998; 
Detmers et al., 2000; Helinck et al., 2003).  Impairment of peptide binding to OppA, leading to 
 
 
Fig. 2. Schematic overview of genetic organization of peptide transporter genes and function 
in Lactococcus lactis IL1403 and other lactococcal strains. Genetic organization of peptide 
transporter genes in L. lactis IL1403 (A). The dppP gene does not contain the nonsense and 
frameshift mutations observed in MG1363. In IL403 and SKM6 the Dpp system is used for the 
uptake of di/tripeptides (DppA) and oligopeptides (using DppP)(B). The Opp system is not used 
due to lack of OppA production. L. lactis strains SK11 and Wg2 are equipped with at least two 
functional oligopeptide transporters, that are Opp and Dpp; the latter employing DppP as an 
oligopeptide-binding protein (C). DtpT is presumed to be functional in all lactococcal strains. 
 Peptide transport in microorganisms 
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reduced transport rates, is the result of competition between the peptide of interest and the 
reporter peptide for the peptide-binding site of OppA. In one remarkable case however, a 
tetrapeptide (VGDE) was found that binds to the oligopeptide-binding protein OppA, inhibits 
transport of the reporter peptide Leu-enkephaline (YGGFL) but, as indicated by growth 
experiments, is not transported (Charbonnel et al., 2003; Helinck et al., 2003). In vitro binding 
studies showed that OppA has a low affinity for short peptides and that negatively charged 
residues reduce the binding affinity even further (Detmers et al., 2000). At pH 6.5, which is the 
common pH of the medium used in growth experiments, the side chains of Asp (pKa = 3.86) 
and Glu (pKa = 4.25) are anionic. Under these conditions, L. lactis MG1363 does not grow 
when VGDE is supplied at submillimolar concentrations (Charbonnel et al., 2003). However, 
upon increasing the VGDE concentration to 10 mM or when lowering the pH of the medium to 
pH 5.0 (and thereby increasing the fraction of protonated species) L. lactis was competent in 
growing on this peptide (unpublished result).  Growth on VGDE requires the opp genes and is 
specifically inhibited by the addition of 100 µM bradykinin (RPPGFSPFR), a cationic peptide 
that binds to OppA with high affinity (KD = 0.1 µM; Lanfermeijer et al., 1999; Detmers et al., 
2000) and completely blocks in vitro peptide uptake via Opp (Doeven et al., 2004). These 
observations further strengthen the notion that any peptide that can bind to OppA is 
transported via the Opp system. 
  
Length specificity and structure of peptide-binding proteins 
 
A list of peptide-binding proteins characterized to date is given in Table 1. Due to low 
sequence similarity (usually 20-30 % identity) between (oligo)peptide-binding proteins with 
known peptide-length specificity, it is difficult to predict the specificity of uncharacterized 
peptide-binding proteins solely on the basis of multiple sequence alignments. Currently, three 
high-resolution crystal structures of peptide-binding proteins are available: OppA from 
Salmonella typhimurium, DppA from Escherichia coli, and AppA from Bacillus subtilis (Tame et 
al., 1994; Dunten and Mowbray, 1995; Nickitenko et al., 1995; Levdikov et al., 2005). These 
proteins bind peptides with 2-5, 2-3, and 9 amino acid residues, respectively. The structure of 
AppA with a bound nonapeptide is shown in figure 3A. Although the three-dimensional folds of 
AppABs, OppASt, and DppAEc are similar, and the peptide-binding sites appear to be located at 
essentially the same position in each protein, structure-based predictions of peptide-length 
specificity remain difficult (Levdikov et al.,  2005). Interestingly, in AppABs, the location of 
positions 4-7 of a bound nonameric peptide corresponds to the positions 1-4 in an OppASt 
substrate (Fig. 3B, C). Similarly, positions 1 and 2 of the dipeptide bound in DppAEc 
superimpose on positions 4 and 5 in the AppABs-bound peptide (Fig. 3B, D). Residues 1-3 of 
the ligand bound to AppABs are accommodated in an enlarged binding pocket due to a 3-
residue shorter loop (residues 421-427) and displacement of an α-helix (151-156).  
Alignment of the three (oligo)peptide-binding proteins of known structure with the well-
characterized lactococcal (oligo)peptide-binding proteins OppA, DppA and DppP, and other 
peptide-binding proteins listed in Table 1 indicates that, in general, residues contributing to the 
peptide-binding site are poorly conserved (not shown; for alignments of peptide-binding 
proteins mentioned here or elsewhere, see Detmers et al., (2001) and Levdikov et al., (2005)). 
A notable exception is Asp419 of OppASt  (the equivalent of Asp408 of DppAEc), which forms a 
salt-bridge with the N-terminal amino-group of the peptide in the crystal structures (Fig. 3C, D).  Chapter 4 
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Table 1. (Oligo)peptide-binding proteins with known length specificity 
Organism Peptide-binding 
protein 
Length of bound 
peptides 
Reference(s) 
OppA 2-5  Guyer  et al. (1986) 
DppA 2-3  Dunten  et al. (1995) 
Nickitenko et al. (1995) 
Escherichia coli1 
MppA 3 Park  et al. (1998) 
Salmonella typhimurium1  OppA 2-5  Tame  et al. (1994) 
OppA1 n.d.  Xenorhabdus nematophila1 
OppA2 3 
Orchard and Goodrich-Blair 
(2004) 
TraC 8 Nakayama  et al. (1998)  Enterococcus faecalis 
PrgZ 7  Leonard    et al. (1996) 
OppA 4-35  Detmers  et al. (2000) 
DppA 2-3  Sanz  et al. (2000) 
DppP n.d.2  Sanz et al. (2001) 
Lactococcus lactis MG1363 
OppA2 53  Sanz et al. (2004) 
OppA n.d.4  - 
DppA (OptS)  n.d.4  - 
Lactococcus lactis IL1403 
DppP (OptA)  2-95  Sanz et al. (2004) 
Lamarque et al. (2004) 
OppA1 5  Lactobacillus delbrueckii 
OppA2 n.d. 
Peltoniemi et al. (2002) 
AmiA 2-3 
AliA 2-7 
Streptococcus pneumoniae 
AliB 2-7 
Alloing et al. (1994) 
HppA 6-7 
HppG ? 
Streptococcus gordonii 
HppH 6-7 
Jenkinson et al. (1996) 
AmiA1 
 
6, 11, 226 
AmiA2 ?6 
Streptococcus thermophilus 
AmiA3 8,  22,  236 
Garault et al. (2002) 
OppA1 3-8  Streptococcus uberis 
OppA2 n.d. 
Taylor et al. (2003) 
DppA 2 
OppA1 2-6 
Streptococcus agalactiae 
OppA2 2-6 
Samen et al. (2004) 
OppA 3-5  Picon and Van Wely (2001)  Bacillus subtilis 
AppA 97  Picon and Van Wely (2001) 
Levdikov et al. (2005) 
OppA1 2-78 
OppA2 2-78 
OppA3 2-78 
OppA4 3 
Borrelia burgdorferi 
OppA5 3 
Lin et al. (2001) 
Wang et al. (2004) 
 
1In Gram-negative organisms, mostly short peptides (2-5 residues) have been tested due to the inability of longer 
peptides to pass the outer membrane and reach the transport system. 2Truncated and therefore not functional. 3Only 
one peptide was tested. Probably similar to OppA from L. lactis MG1363.  4Most likely similar to their homologues in L. 
lactis  MG1363.  5Only a few peptides longer than 4 amino acid residues were tested. 6The Ami system of S. 
thermophilus transports peptides from 3-23 residues. The length specificities of individual AmiA proteins have not been 
fully established. 7A limited number of peptides were tested. Genetic analysis indicated that AppA might bind a range 
of peptide lengths. 8Longer peptides might also be bound since binding experiments were done using phage libraries Peptide transport in microorganisms 
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Although not present in OppALl   and AppABs, this residue is conserved in many other 
characterized peptide-binding proteins (Table 1) as well as in other (putative) (oligo)peptide-
binding proteins (Detmers et al., 2001). This suggests that the ‘anchoring’ of peptides via their 
N-terminal  α-amino groups is similar in most (oligo)peptide-binding proteins. Furthermore, 
substrate-binding proteins that do not bind peptides but are homologous to (oligo)peptide-
binding proteins, for example the heme-binding protein HbpA from Haemophilus influenzae, 
the agrocinopines-binding protein AccA from Agrobacterium tumefaciens, and the nickel-
binding protein NikA from E. coli, do not contain the conserved aspartate, which thus seems to 
be specific for peptide-binding proteins (Detmers et al., 2001). The residue in AppABs that is at 
R373
N370
N367
W398
M405
Y442
N406
N491
A263
S265
K507
R508 D43
T423
T59
D154
N151
T122
R119
T41
N
C
I
II
III
-3
-2
-1
1
2
3
4
5
6
K307 H371
R413
E276
R404
N405
T438
L401
T109
H161
D419
N506
C417
V34 Y269
Y245
N247
1
2
3
4
A361
M402
Y357
R355
G22
T406
D408
Y114
1
2
A B
C D
S422
 
 
Fig. 3. Structure and binding site architecture of (oligo)peptide-binding proteins. Example of the fold of 
an (oligo)peptide-binding protein (A). The structure of AppABs with a bound nonapeptide (yellow) is shown 
(Levdikov et al., 2005). Domain I and III engulf the substrate and are common for ABC-type substrate-
binding proteins. Domain II is a specific feature of the dipeptide/oligopeptide/nickel transporter family. 
Architecture of the peptide-binding sites of AppABs (B), OppASt (C), and DppAEc (D). Colour coding is the 
same as in (A) except for charged protein residues that are involved in salt-bridging either the N- or C-
terminus of the bound peptides; these are indicated in green. Residues 4-7 of the nonameric peptide bound 
to AppABs are accommodated in pockets 1-4 (based on the structure of OppASt), and the additional pockets 
are numbered -3, -2, -1, and 5, 6 for easy comparison. Even though the role of domain II in substrate binding 
and/or transport is not clear, in AppABs a few residues contribute to the extended peptide-binding site (B). 
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the equivalent position of Asp419 in OppASt is Ser422, which is involved in hydrogen bonding with 
the N-terminus of the peptide (Fig. 3B). This serine is also present in OppALl which might 
indicate that binding of peptide N-termini in AppABs and OppALl is somewhat different from that 
in other (oligo)peptide-binding proteins. Asp154, which forms a salt-bridge with the N-terminal 
residue of the nonameric peptide bound to AppABs (Fig. 3B), is not present in OppALl. 
Charged residues that were found to form salt-bridges with C-terminal residues of the bound 
peptide (like Arg373 in AppABs, Arg413 and His371 in OppASt, and Arg355 in DppAEc; Fig. 3B-D), 
are often absent in other (oligo)peptide-binding proteins (Detmers et al., 2001; Levdikov et al., 
2005). Despite these possible differences in the interactions of the proteins with the N- and C-
termini of the peptides, the majority of the protein-peptide contacts are formed via the 
backbone C=O and N-H groups, which facilitates sequence-independent binding of peptides. 
This phenomenon occurs similarly in each of the peptide-binding proteins for which a structure 
is available. Interactions with the side-chains of the peptide would impose a high level of 
specificity toward peptides containing specific amino acid residues. The fact that the peptide-
protein interactions are preferably of a non-specific nature might explain why the peptide-
binding sites are so poorly conserved and predictions of length specificity of (putative) 
(oligo)peptide-binding proteins are so difficult. It would be important to know the binding 
mechanisms of proteins that are thought to be highly specific for certain peptides, such as the 
pheromone-binding proteins TraC and PrgZ of Enterococcus faecalis (Leonard et al., 1996; 
Nakayama et al., 1998; Clewell et al., 2000). However, detailed peptide binding studies are not 
available for any of these proteins. 
Phylogenetic analyses of characterized (oligo)peptide-binding proteins indicate that binding 
proteins belonging to different transport systems can be clearly distinguished from each other 
(Fig. 4). The lactococcal Dpp binding proteins cluster together, and appear distantly related to 
the OppA proteins from Streptococcus agalactiae, Streptococcus uberis, and the pheromone-
binding proteins TraC and PrgZ from E. faecalis. The lactococcal OppAs (including OppA2 and 
the novel dipeptide/oligopeptide/nickel-binding protein from MG1363) together with those from 
Lactobacillus delbrueckii, form a loose cluster with AppABs, DppASa, and DppAEc but, overall, 
the identity between the proteins is low. The remaining streptococcal proteins (Ami and Ali 
from S. thermophilus and S. pneumoniae and Hpp from S. gordonii) all fall in one large group. 
The borrelial OppAs seem closely related to OppA and MppA from E. coli, and OppA from S. 
typhymurium, as do OppA1 and OppA2 from Xenorhabdus nematophila. Clearly, proteins with 
different peptide-length specificities cluster together in the phylogenetic tree, again 
exemplifying the non-conservative nature of the peptide-binding sites.  The most striking 
example is probably AmiASp, which, although it binds only di- and tripeptides, clusters with 
other Ami/Ali proteins, that bind peptides of up to and including 23 amino acids. Generally, 
(oligo)peptide-binding proteins using the same membrane complex cluster closely together. 
This is emphasized by the observation that OppAs from Borrelia burgdorferi could complement 
an E. coli oppA deletion strain by functionally interacting with the E. coli OppBCDF complex 
(Lin et al., 2001) and by the fact that OppA2Ll could restore function to the Opp permease in a 
MG1363∆oppA strain (Sanz et al., 2004).  
Multiple sequence alignments of all the (oligo)peptide-binding proteins listed in Table 1 reveal 
that the lactococcal OppAs and streptococcal Ami and Ali have several extensions compared 
to the other peptide-binding proteins (not shown). These particular sites in the proteins could 
be involved in the specific recognition by their cognate membrane complexes or be involved in 
the binding of extremely long peptides (up to and including 23 or 35 amino acid residues for Peptide transport in microorganisms 
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the Ami or Opp binding proteins, respectively), which has been reported only for these two 
systems.    
Conclusions  
 
An overview of peptide transport in L. lactis species has been presented, and the implications 
of recent findings for previously proposed hypotheses were discussed. L. lactis MG1363 uses 
DtpT and Dpp for the uptake of short peptides (2-3 residues) and Opp for the uptake of 
oligopeptides. Some other lactococcal strains also use the Dpp system for oligopeptide uptake. 
Dpp appears to be a versatile peptide transporter that employs multiple peptide-binding 
proteins (DppA and DppP), at least in L. lactis IL1403, SK11, SKM6, and Wg2. This situation is 
similar to that of streptococcal and borrelial peptide uptake systems (Ami/Ali/Opp), which use 
multiple peptide-binding proteins with overlapping specificities (Alloing et al., 1994; Garault et 
al., 2002; Samen et al., 2004; Wang et al., 2004). Contrary to some recent reports (Charbonnel 
et al., 2003; Helinck et al., 2003), we provide further evidence for the notion that the specificity 
 
 
Fig. 4. Phylogenetic tree of (oligo)peptide-binding proteins with known length specificity. Bacsu: B. 
subtilis; Borbu: B. burgdorferi; Ecoli: E. coli; Entfa: E. faecalis; IL1403: L. lactis IL1403;    Lacde:  L. 
delbrueckii; MG1363: L. lactis MG1363; Salty: S. typhymurium; Strgo: S. gordonii; Strpa; S. agalactiae; 
Strpn: S. pneumoniae; Strpt: S. thermophilus; Strub: S. uberis; Xenne: X. nematophila. 
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of the peptide ABC transporters is imposed by the selectivity of the (oligo)peptide-binding 
proteins and that the membrane-embedded translocator complexes are non-selective. 
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Chapter 5 
Hydrodynamic properties and crystallization of the 
oligopeptide-binding protein OppA from Lactococcus 
lactis 
Mark K. Doeven, Dirk-Jan Slotboom, Andy-Mark W. H.  Thunnissen, and Bert Poolman 
Abstract 
OppA is the receptor that delivers peptides ranging in length from 4-35 amino acid 
residues to the ATP-binding cassette transporter involved in oligopeptide uptake in 
Lactococcus lactis. The binding mechanism of lactococcal OppA seems distinct from 
that of other peptide-binding proteins because it lacks conserved binding site residues, 
and is thought to not completely enclose peptides longer than six amino acids. 
Analytical ultracentrifugation experiments revealed that purified OppA is a monomer 
that adopts a more compact shape upon peptide-binding. To obtain direct information 
on the binding site and to establish whether or not peptides protrude out of OppA in its 
“closed” conformation, we have crystallized the protein in complex with a nonapeptide. 
Crystals grew at pH 4.0 in the presence of polyethylene glycol (PEG) 1500, and at pH 7.0 
with PEG6000 plus 0.2 M NaCl. Both crystal forms diffracted to a resolution better than 
2.9 Å.   
Introduction 
The ability of Lactococcus lactis to grow in milk critically depends on its capacity to take up 
oligopeptides from the medium (Kunji et al., 1998). To serve this purpose, lactococcal strains 
utilize transporters belonging to the ATP-binding cassette (ABC) superfamily (Doeven et al., 
2005). The translocation units of these systems are formed by complexes of two 
transmembrane domains plus two cytoplasmic nucleotide-binding domains (Higgins, 1992; 
Biemans-Oldehinkel et al., 2005). Specificity determinants are the extracytoplasmic substrate-
binding proteins (SBPs), that capture peptides and deliver them to the translocator (Doeven et 
al., 2004). Whereas in Gram-negative bacteria peptide-binding proteins float freely in the 
periplasmic space, in L. lactis and other Gram-positive organisms they are anchored to the 
membrane via lipid-modification of an N-terminal cysteine.  
Depending on the L. lactis strain, either the Dpp system, the Opp system, or a combination of 
The abbreviations used are:  ABC, ATP-binding cassette; BN-PAGE, blue native polyacrylamide gel 
electrophoresis; Gdm, guanidinium; MWCO, molecular weight cut-off; NTA, nitrilotriacetic acid; PEG, 
polyethylene glycol; SBP, substrate-binding protein. 
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both, is used for oligopeptide uptake (Lamarque et al., 2004; Doeven et al., 2005). The 
lactococcal Dpp system is equipped with a SBP for di- and tripeptides, DppA, and a second 
SBP for di-, tri-, and oligopeptides, DppP (Sanz et al., 2001, 2003; Lamarque et al., 2004). The 
Opp system is solely dedicated to oligopeptide uptake by its SBP OppA (Doeven et al., 2004). 
 
 
Fig. 1. Cartoon of the peptide-binding sites in (oligo)peptide-binding proteins for which a crystal 
structure is available. Binding pockets for the amino acid side-chains are numbered starting at the peptide 
N-terminus. Charged peptide-termini are stabilized by opposite charges in the proteins (solid lines), and the 
positioning of these protein residues determine peptide length preference. The aspartate salt-bridging the 
peptide N-terminus (A and B1/B2) is conserved in almost all (oligo)peptide-binding proteins. In addition, many 
residues hydrogen bond to the peptide backbone, but, for clarity, only those involved in binding the peptide 
termini are indicated (dotted lines). (A) Dipeptide bound in DppA from E. coli. (B1) and (B2) tri- and 
tetrapeptides bound in OppA from S. typhimurium. The C-terminus of a pentapeptide might be bound by 
Lys307. (C) Nonapeptide accommodated in AppA from B. subtilis. The peptide is shifted towards the interior of 
the protein. The conserved aspartate is replaced by a serine, which is present in OppA from L. lactis as well. 
The N-terminus is bound by an aspartate at a different position in the protein, which is not conserved and 
also not present in lactococcal OppA. 
 
 
Crystal structures of OppA homologues from Salmonella typhimurium, Escherichia coli, and 
Bacillus subtilis revealed that the peptide-bound protein is in a closed conformation, with the 
substrate buried in a cleft between two lobes (Tame et al., 1994; Dunten and Mowbray, 1995; 
Nickitenko et al., 1995; Levdikov et al., 2005). In each case, an extensive network of H-bonds 
is formed with the peptide backbone, and charged residues in the protein stabilize the peptide 
termini (Fig. 1). These latter amino acids, however, appear missing in OppA from L. lactis. 
Moreover, the residues interacting with the peptide backbone are not conserved as well, and 
studies with modified and fluorescently-labelled peptides imply a binding mechanism for OppA 
from L. lactis where the peptide C-terminus protrudes out of the protein and interacts with its 
surface (Fig. 2; Detmers et al., 2000; Lanfermeijer et al., 2000). Thus, the binding mechanism Structural analysis of OppA 
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for lactococcal OppA appears fundamentally different from that observed in crystal structures 
obtained with homologous proteins. To shed more light on this issue, we have crystallized 
OppA from L. lactis in complex with a high affinity nonapeptide ligand as an initial step to 
structure determination.  
 
Materials and methods 
 
Bacterial strain and growth conditions.  OppA was produced by Lactococcus lactis AMP2/pAMP21 as 
described (Lanfermeijer et al., 1999), yielding OppA*, the protein lacking the N-terminal signal sequence 
required for export and lipid-modification. The N-terminal cysteine that in mature OppA is lipid-modified was 
replaced by a methionine. OppA* was constitutively produced in the cytoplasm under control of the lactococcal 
p32 promoter. The protein contained a C-terminal factor Xa cleavage site followed by a His6-tag to facilitate 
purification. Cells were grown to a final O.D.660 of ~ 5 in 5 % (w/v) whey-permeate, 0.5 % (w/v) yeast extract, 0.5 
% (w/v) glucose, and 65 mM KPi, pH 7.0, supplemented with 5 µg/mL erythromycin in a volume of 10 litres in a 
fermenter with pH control (ADI 1065 fermenter; Applikon Dependable Instruments B. V., Schiedam, The 
Netherlands). The pH was kept constant at pH 6.5 by titrating with 2 M KOH. Cells were harvested by 
centrifugation, washed with 100 mM KPi, pH 7.0, and resuspended to an O.D.660 of ~ 100 in 50 mM KPi, pH 8.0, 
100 mM KCl, 10 % (v/v) glycerol (buffer A), flash frozen in liquid nitrogen and stored at -80°C. 
 
Isolation of cytoplasmic fraction. Cells were thawed and treated with 2 mg/mL lysozyme for 30 minutes at 
30°C. After adding 1 mM phenylmethanesulfonylfluoride, 0.1 mg/mL DNase, and 10 mM MgSO4, the cells were 
ruptured using a high-pressure homogenizer (Kindler Maschinen AG, Zürich, Switzerland). Following an 
incubation of 15 minutes at room temperature, 15 mM Na-EDTA was added and the cytosolic fraction containing 
OppA* was separated from the membranes and cell debris by 45 minutes centrifugation at 280,000 x g and 
4°C. The supernatant was frozen and stored at -80°C or, when used for setting up crystallization trials, directly 
purified further. 
 
Purification of OppA*. The supernatant (~ 400 mL at  11.5 mg of protein/mL) was incubated for 1.5 h at 4°C in 
buffer A, plus 15 mM imidazole with 1 mL nickel-NTA resin (Qiagen) per 10 mL supernatant. Subsequently, the 
column material was collected by centrifugation for 10 min. at 1,000 x g and 4°C and poured into 10 mL Biorad 
columns such that each contained ~ 1 mL nickel-NTA after which excess supernatant was drained. The column 
was washed three times with 10 column volumes of the same buffer, pH 7.0, containing 15, 20 and 40 mM 
 
 
Fig. 2. Proposed peptide-binding mechanism of OppA from L. lactis. Peptide residue numbering as in 
figure 1. The 6 N-terminal residues of the peptide are enclosed by the protein. Additional C-terminal amino 
acids stick out and interact with the protein surface. Peptides as long as 35 residues can be bound. Picture 
adapted from Detmers et al. (2000). 
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imidazole, respectively. OppA* was eluted by lowering the pH to 6.0 and increasing the imidazole concentration 
to 200 mM. Peak fractions (~ 30 mL in total) were pooled and dialyzed overnight against 25 mM KPi, pH 6.0, 10 
% (v/v) glycerol (buffer B). Subsequently, the protein was loaded onto 8 mL S-sepharose (Amersham 
Biosciences) and eluted with a 10 column volume gradient from 0 to 1 M KCl in buffer B. OppA*-containing 
fractions were pooled and diluted to lower the [KCl] to ~ 200 mM, and raise the pH to ~ 7.5. Endogenously 
bound peptides were removed by partially unfolding the protein with guanidinium-HCl (Gdm-HCl), according to 
Lanfermeijer  et al. (1999) with some modifications. Briefly, the purified OppA* (~ 2.5 mg of protein) was 
incubated for 1.5 h with 1 mL Ni-NTA/mg protein in a 10 mL Biorad column. The column was drained and 
washed with 4 column volumes buffer B, pH 7.5, plus 100 mM KCl (buffer C), followed by 40, 4, 4, 4, and 8 
column volumes of the same buffer plus 2.0, 1.5, 1.0, 0.5, and 0 M Gdm-HCl, respectively. After this, the protein 
was eluted from the column using buffer C, pH 6.0, plus 200 mM imidazole. The protein was concentrated on 
30,000 MWCO centricon devices (Millipore) to ~ 1.3 mg/mL and dialyzed against buffer C, pH 6.0. Removal of 
endogenously bound ligands was confirmed by intrinsic protein fluorescence studies and native cationic 
electrophoresis according to Lanfermeijer et al. (1999). 
 
Purification for crystallization. The cytoplasmic extract (~ 400 mL; see above) was incubated for 1 h at 4°C in 
buffer A plus 10 mM imidazole with 5 mL nickel-sepharose resin (Amersham Biosciences). The column material 
was collected by centrifugation for 10 min. at 1,000 x g and 4°C, suspended in a few mL of the same buffer and 
packed into a XK 16/20 column (Amersham Biosciences) after which the column was washed with the same 
buffer, using the Äkta Purifier system (Amersham Biosciences), until the absorbance at 280 nm reached a 
baseline level. OppA* was eluted by lowering the pH to 6.0 and increasing the imidazole concentration to 200 
mM. OppA*-containing fractions were pooled, concentrated on 30,000 MWCO centricon devices (Millipore), and 
further purified on a Superdex 200/10 size exclusion column (Amersham Biosciences) pre-equilibrated in 20 mM 
MES, pH 6.0, 150 mM NaCl. OppA*-containing fractions were pooled, concentrated ~ 10-fold, and diluted such 
that the final buffer composition was 10 mM MES, pH 6.0, 10 mM NaCl, and further concentrated to ~ 14 mg/mL 
of protein. 1/10 volume of 10 mM bradykinin (nonapeptide with the amino acid sequence RPPGFSPFR; 
Bachem) in milli Q water was added such that the final concentrations were ~ 12.5 mg/mL OppA*, 1 mM 
bradykinin, 9 mM MES, pH 6.0, and 9 mM NaCl. 
 
Native protein electrophoresis. Native cationic electrophoresis (Lanfermeijer et al., 1999), and blue native 
polyacryl amide gel electrophoresis (BN-PAGE; Schägger et al., 1991, 1994; Heuberger et al., 2002) were 
performed as described. 
 
Analytical ultracentrifugation. Analytical ultracentrifugation experiments were performed in a Beckman 
Optima XL-I, using an AN-50 Ti rotor with 2-channel charcoal-filled centerpieces. Sedimentation velocity 
experiments were done at 38,000 rpm and 4°C on sample volumes of 400 µL with loading concentrations 
ranging from 0.020 to 1.300 mg/mL in buffer C, pH 6.0. Absorbance data were collected at 280 and 230 nm in a 
continuous mode with a radial step size of 0.005 cm and 10 min. time intervals.  
The effective mass of a particle (Meff) is given by: 
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where M is the molar weight, υ is the partial specific volume of the protein (in dilute solute solutions, υ is the 
volume in mL that each gram of solute occupies), ρ is the solution density, and NA is Avogadro’s number. The 
definition of the sedimentation coefficient (s) of a macromolecule is given by the Svedberg equation: 
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where u is the observed radial velocity of the protein, ω the angular velocity of the rotor, r the radial position, 
and f  the frictional coefficient. s-values are reported in Svedberg units (S), that correspond to 10-13 sec. The f 
value can be determined for smooth, compact spherical proteins using the Stokes equation: Structural analysis of OppA 
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f0 = 6πηR0,                                                                                                                                              (equation 
3) 
 
where f0 is the frictional coefficient of the spherical particle, η the viscosity of the solution, and R0 the radius of 
the sphere. Observed sedimentation coefficients (sobs) can be converted to a standard state in water at 20°C 
(s20,w) using the following equation: 
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where the subscripts ‘20,w’ and ‘exp’ denote standard and experimental conditions, respectively.  
Data analysis was done using the XL-I data analysis software (Beckman). sobs values were determined using the 
second-moment method of analysis, and converted into s20,w  values using the SEDNTERP programme 
(developed by Hayes, Laue, and Philo, and available at http://www.jphilo.mailway.com/). The partial specific 
volume (υ) of OppA* was 0.7227 mL/mg at 4°C as calculated from the primary amino acid sequence using 
SEDNTERP. Values for the solvent density (ρ) and viscosity (η) of buffer C were determined using the same 
programme and were 1.03878 g/L and 2.2348 x 10-2 Poise, respectively, at 4°C. 
Sedimentation equilibrium experiments were performed at rotor speeds of 8,000, 10,000, and 12,000 rpm on 
sample volumes of 100 µL with loading concentrations of 0.020, 0.050, and 0.100 mg/mL OppA* in buffer C, pH 
6.0. The absorbance optics was used to collect data every 0.001 cm with 10 replicates at 280 nm. At 
sedimentation equilibrium, the protein concentration (c) as a function of the radial position (r) is given by: 
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with R being the gas constant, T the absolute temperature, and ω, M, υ, and ρ the same as above. The 
molecular weight of OppA* was determined from the sedimentation equilibrium experiments by global fitting of 
nine data sets, using the XL-I data analysis software (Beckman).  
 
Crystallization and X-ray diffraction analysis. Screening was done using 96 well plates designed for sitting 
drop vapour diffusion experiments (Hampton Research). The reservoir contained 100 µL of mother liquor and 
drops were made by mixing 1 µL protein solution with 1 µL precipitant solution. The commercially available 
Structure Screen 1 and 2 (both sparse matrix screens; Molecular Dimensions), and PACT premierTM  (PEG, pH, 
ion-screen; Molecular Dimensions) were used at 4°C and room temperature. X-ray diffraction analysis was 
carried out with Cu Kα radiation from a Bruker-Nonius rotating anode generator equipped with a DIP2000 image 
plate detector. 
 
Miscellaneous. Protein concentrations were determined according to the method of Lowry et al. (1951), using 
bovine serum albumin as a standard. The concentration of purified OppA* was determined 
spectrophotometrically by measuring the absorption at 280 nm and using an extinction coefficient of 1.605 
(mg/mL)-1cm-1. The pH of buffers used for crystallization were set by titrating with either NaOH or HCl. 
 
Results 
 
Purification and characterization of OppA*. A soluble version of OppA that lacks its lipid-
anchor, termed OppA*, was produced in the cytoplasm of L. lactis as a result of the removal of 
the N-terminal signal sequence that normally targets the protein for export and lipid-
modification (Lanfermeijer et al., 1999). The purification protocol used by Lanfermeijer et al. 
(1999) involved 2 steps: i) passing the protein over an anion exchange column thereby Chapter 5 
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removing the bulk of cytoplasmic proteins, followed by ii) purification of the protein by cation 
exchange chromatography. The C-terminal His6-tag was used to immobilize OppA* on a  
 
 
 
Fig. 4. Peptide-binding activity of OppA* monitored by intrinsic protein fluorescence measurements. 
Titration of Gdm-treated OppA* with bradykinin. The protein concentration was 0.5 µM. The change in 
protein fluorescence (∆F) was measured and data fitted according to Lanfermeijer et al. (1999). 
 
 
 
Fig. 3. Purification of OppA*. SDS-PAGE analysis of OppA*-containing samples before and after 
different purification steps. Proteins were visualized by Coomassie brilliant blue staining. 
Endogenously bound peptides were removed by partial unfolding/refolding of the protein using 
Gdm-HCl (Gdm-treated) according to Lanfermeijer et al. (1999). The positions at which OppA* 
(arrow) and molecular weight marker proteins (right; masses indicated in kDa) migrate are 
indicated. 
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nickel-NTA column and the protein was treated with Gdm-HCl to remove endogenously bound 
peptides. Here, we utilized the His6-tag on OppA* in the first step of our purification by 
performing metal-affinity chromatography (Fig. 3). The second and third step involved again 
cation exchange chromatography and removal of co-purified peptides by partial unfolding of 
OppA* by Gdm-HCl (Fig. 3). Protein functionality and the removal of endogenous bound 
substrate was verified by monitoring changes in intrinsic protein fluorescence upon titration 
with peptide (Fig. 4) and native cationic electrophoresis (not shown) both performed according 
to Lanfermeijer et al. (1999). The dissociation constant (KD) and maximum change in 
fluorescence (∆Fmax) upon bradykinin (RPPGFSPFR) binding were 0.26 µM and 12.3 % which 
is close to the values of 0.10 µM and 12.6 % that were obtained previously (Lanfermeijer et al., 
1999). For crystallization purposes (see below), the second purification step was chosen to be 
size-exclusion chromatography (Fig. 3) and the protein was not treated with Gdm-HCl. 
 
 
Fig. 5. Analysis of OppA* by size-exclusion chromatography and BN-PAGE. (A) Elution profile of ~ 200 
µg nickel-NTA purified OppA* (solid line) injected on a Superdex 200 gel-filtration column at room 
temperature. Molecular weight markers (dashed line) were thyroglobulin (670 kDa), Bovine gamma globulin 
(158 kDa), Chicken ovalbumin (44 kDa), Equine myoglobin (17 kDa), and vitamin B12 (1.35 kDa). The buffer 
composition was 50 mM KPi, pH 7.0, 200 mM KCl, 10 % (v/v) glycerol. The flow rate was 0.5 mL/min. (B) 
BN-PAGE analysis of nickel-NTA and S-sepharose purified, ligand-free OppA*. The protein concentration 
was varied from 0.10 – 1.30 mg/mL in buffer C as indicated on top of the gel and 3 µg of protein was loaded 
per lane (except for the 0.10 mg/mL sample that contained 2 µg). The masses of the marker proteins are 
indicated on the right of the figure (kDa). 
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Oligomeric state of OppA*. Although crystal structures of numerous SBPs have led to the 
generally accepted view that they are monomers with one substrate-binding site per molecule 
(Quiocho and Ledvina, 1996), several early experiments suggested that SBPs self-associate to 
form dimers or higher order oligomers (Rashed et al., 1976; Richarme et al., 1982, 1983), 
which might be a way to regulate their activity (Antonov et al., 1976). Moreover, in ABC 
tranporters containing multiple SBPs fused to the translocator cooperative interactions 
between these domains have been found to stimulate transport activity (Biemans-Oldehinkel 
and Poolman, 2003). On a size-exclusion column OppA* eluted at an apparent molecular 
mass of ~ 54 kDa (Fig. 5A), which is somewhat smaller than the 65,066 Da predicted for the 
monomeric protein based on its primary structure. BN-PAGE, on the other hand, showed that 
the OppA*:Coomassie G complex migrates at the position of a possible dimer (~ 130 kDa; Fig. 
5B) over the OppA* concentration range from 0.10 – 1.30 mg/mL. Addition of 30 µM 
bradykinin did not detectably alter the migration of OppA* in the BN-gel (not shown). Since 
OppA* is cationic with a pI of 8.8, it might be possible that the protein binds a lot of anionic 
Coomassie G dye, which results in an overestimation of the apparent molecular mass. To 
resolve this issue, we used sedimentation velocity and equilibrium centrifugation.  
Analytical ultracentrifugation sedimentation velocity profiles of OppA at a concentration of 0.65 
mg/mL are shown in Fig. 6A. From the sedimentation of the protein in the time period from 
100-200 min.,  sobs values were calculated using the second-moment method of analysis. The 
sedimentation behaviour of OppA* did not change significantly over the concentration range 
from 0.02 to 1.30 mg/mL (Fig. 6B), indicating that the protein was present as a single-species 
not undergoing reversible self-association. The average sedimentation coefficient (s20,w) was 
4.2 ± 0.1 S, and increased to 4.6 ± 0.2 S upon the addition of a saturating amount of 
bradykinin (Fig. 6B). The faster migration of OppA* in the centrifugal field suggests a change in 
hydrodynamic radius: the protein adopts a more compact (“closed”) shape upon peptide-
binding. The s20,w values of 4.2 and 4.6 are most consistent with OppA* being monomeric 
(Stewart and Johns, 1976). Sedimentation equilibrium experiments (Fig. 7) confirmed that 
OppA* is a monomer. The estimated molecular weight was 68 ± 2 (*103), which is close to the 
expected molecular weight for the monomer of 65,066, based on amino acid sequence. In the 
presence of bradykinin, the apparent molecular weight increased from 68 ± 2 (*103) to 69 ± 3 
(*103). This can be due to the binding of bradykinin (molecular weight is 1,060), although the 
increase in apparent molecular weight was not significant. 
 
Crystallization. To reveal how peptides are accommodated by lactococcal OppA, the protein 
was crystallized in complex with the high affinity nonapeptide ligand bradykinin. Crystals were 
obtained in approximately two weeks of incubation at room temperature with two conditions of 
the PACT premierTM  screen: 0.1 M MIB buffer, pH 4.0, plus 25 % (w/v) PEG1500 (B1), and 
0.2 M NaCl, 0.1 M Hepes, pH 7.0, plus 20 % (w/v) PEG6000 (C7) (Fig. 8). Raising the pH of 
condition B1 by one unit resulted in needles, while at higher pH values crystals were not 
observed. Replacing Na+ of condition C7 with NH4+ yielded needles as well, whereas Li+, Mg2+, 
and Ca2+ gave no crystals under otherwise identical conditions. 
 
X-ray data collection and optimization of the crystals. Crystals from both conditions (B1 
and C7) diffracted to better than 2.9 Å resolution with X-rays from an in-house rotating anode 
diffractometer (Fig. 9). Their Bravais lattice types are primitive orthorhombic with unit cell 
dimensions of a = 42.7, b = 64.3, c = 99.3 Å, and a = 42.7, b = 76.0, c = 182.3 Å for condition  Structural analysis of OppA 
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B1 and C7, respectively. Unfortunately, both crystal forms displayed high levels of mosaicity (~ 
1.2° for B1 and at least 1.5° for C7), and at room temperature in the X-ray beam the crystals 
were not stable long enough to obtain a complete data set. An attempt to optimize the crystals 
of C7 was made by varying salt concentration, pH and PEG concentration independently or in 
various combinations from 0.14-0.26 M NaCl, 0.1 M Hepes, pH 6.4-7.6, and 14-26 % (w/v) 
PEG6000, respectively, but this yielded no crystals presumably due to the use of a batch of 
PEG different from that of the manufacturer of the initial screening kit. As an alternative 
strategy seeding was tried, but this yielded no improvement of the crystals (needles). Further 
optimization was done for both conditions by using additives [mixing 90 µL of the PACT 
premierTM solutions with 10 µL of stocks from the Additive ScreenTM (Hampton Research) in 
 
 
Fig.6. Velocity sedimentation analysis. (A) Velocity sedimentation profiles of 0.65 mg/mL OppA* at 38,000 
rpm and 4°C in 25 mM KPi, pH 6.0, 100 mM KCl, and 10 % (v/v) glycerol. Time intervals were 10 min. (B) 
s20,w values plotted vs. OppA* concentration in the absence (filled symbols) or presence (open symbols) of a 
saturating concentration bradykinin. The horizontal lines indicate the average s20,w values obtained in the 
absence (long dash) or presence (short dash) of ligand. 
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the reservoir] and setting up crystallization drops with these solutions. In condition B1 plus 4 % 
(v/v) 1,4 butanediol and C7 plus 0.01 M cobalt-chloride new crystals appeared, but these still 
have to be tested for X-ray diffraction. For condition C7 cryo-conditions were established by 
raising the PEG6000 concentration to 40 % (w/v), possibly allowing full data collection as soon 
as new crystals are available. 
 
Discussion and conclusions 
 
OppA from L. lactis is the functionally best characterized (oligo)peptide-binding protein to date 
although a high resolution crystal structure is still lacking. X-ray structures obtained for three 
homologous proteins, each displaying only ~ 20 % sequence identity with lactococcal OppA 
and amongst themselves, show a closed, three domain organization with the peptide buried 
between two lobes (Tame et al., 1994; Dunten and Mowbray, 1995; Nickitenko et al., 1995; 
Levdikov et al., 2005). Closure of the protein is thought to occur upon peptide-binding, as 
structures in the absence of ligand show a conformation with the binding site exposed to 
solvent (Nickitenko et al., 1995; Sleigh et al., 1997). The peptide termini are stabilized by 
charged residues in the protein, the negatively charged aspartate salt-bridging the N-terminus 
being the most conserved binding site residue across the entire protein family (Fig. 1; Detmers 
et al., 2001). 
 
 
Fig. 7. Sedimention equilibrium analysis. Radial distribution of OppA* at 10,000 rpm and 4°C with protein 
loading concentrations of 0.02 (squares), 0.05 (inverted triangles), and 0.10 mg/mL (circles) in the presence 
of saturating concentrations of bradykinin. The solid lines represent the best fit described by global analysis 
of nine datasets collected at rotor speeds of 8, 10, and 12 krpm. Residuals are shown in the top graph. 
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L. lactis OppA has been shown to bind peptides ranging from 4 up to and including at least 35 
residues (Detmers et al., 2000), and it seems unlikely that especially these long peptides are 
completely enclosed by the protein. Furthermore, the charged residues that stabilize the 
peptide termini in other peptide-binding proteins are not conserved in lactococcal OppA 
(Detmers et al., 2001; Levdikov et al., 2005). Indeed, for L. lactis OppA, a unique binding 
mechanism was proposed in which only the six N-terminal residues are buried, whereas the C-
terminal residues of the peptide stick out and interact with the protein surface (Fig. 2; Detmers 
et al., 2000; Lanfermeijer et al., 2000). 
 
 
 
Fig. 8. Photomicrographs of OppA crystals. Crystals were grown in 0.1 M MIB buffer, pH 4.0, and 25 % 
(w/v) PEG1500 (left), and 0.1 M Hepes, pH 7.0, 20 % (w/v) PEG6000, and 0.2 M NaCl (right). Crystals grew 
at room temperature in approximately two weeks to final dimensions of about 0.1 x 0.1 x 1.0 mm and 0.1 x 
0.1 x 0.2 mm, respectively. 
 
 
 
Fig. 9. Typical X-ray diffraction patterns of OppA*:bradykinin crystals. The left image was recorded from 
an OppA* crystal grown under condition C7 using a 0.4˚ oscillation angle and a 10 minute exposure time. 
The weak spots near the edge of the detector correspond to 2.9  Å resolution. The image on the right was 
recorded from an OppA* crystal grown under condition B1 using a 1.0˚ oscillation angle and a 10 minute 
exposure time. The weak spots near the edge of the detector correspond to 2.8 Å resolution. 
 Chapter 5 
  78
On a size-exclusion column OppA* eluted at the approximate position of a monomer (Fig. 5A), 
whereas analysis by BN-PAGE suggested a dimeric quaternary structure (Fig. 5B). It should 
be noted, however, that it is not clear how the high pI of 8.8 might influence the Coomassie G 
binding to OppA* and thus the migration of the protein in the BN-gel. Analytical 
ultracentrifugation experiments (Fig. 6 and 7) confirmed that OppA is a monomer in solution 
that undergoes a conformational change upon peptide-binding, probably resembling the 
closed-liganded state observed in crystal structures for many SBPs. This is also consistent 
with previous experiments with lactococcal OppA in which the protein was shown to migrate 
faster on native cationic electrophoresis gels in the presence than in the absence of peptides 
(Lanfermeijer et al., 1999). The resolving power of the BN-gel was not high enough to visualize 
this protein conformational change (not shown). 
The crystallization of lactococcal OppA in the presence of bradykinin, as reported in the 
present study, is an important step toward determining the structure of a oligopeptide-bound 
lactococcal OppA complex and understanding its apparent distinct peptide-binding 
mechanism. Although we have not yet succeeded in collecting a complete data set, either of 
the two crystal forms might be optimized. Hopefully, we then can solve the structure by 
molecular replacement using the coordinates of OppA from S. typhimurium, DppA from E. coli, 
or AppA from B. subtilis, in their closed conformations, or, alternatively, obtain heavy atom-
substituted crystals for phasing. If the latter is required, the L. lactis nisin-induced expression 
system should be tested for its capacity to generate seleno-methionine containing proteins. In 
principle, this should be possible since L. lactis strains used for protein production are 
auxotrophic for several amino acids, including methionine.   
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Chapter 6 
Distribution, lateral mobility and function of membrane 
proteins incorporated into giant unilamellar vesicles  
Mark K. Doeven, Joost H. A. Folgering, Victor Krasnikov, Eric R. Geertsma, Geert van den 
Bogaart, and Bert Poolman 
Abstract 
Giant Unilamellar Vesicles (GUVs) have been widely used for studies on lipid mobility, 
membrane dynamics and lipid domain (raft) formation, using single molecule 
techniques like Fluorescence Correlation Spectroscopy (FCS). Reports on membrane 
protein dynamics in these type of model membranes are by far less advanced due to the 
difficulty of incorporating proteins into GUVs in a functional state. We have used 
sucrose to prevent four distinct membrane protein(s) (complexes) from inactivating 
during the dehydration step of the GUV formation process. The amount of sucrose was 
optimized such that the proteins retained 100 % biological activity and many proteo-
GUVs were obtained. Although GUVs could be formed by hydration of lipid mixtures 
composed of neutral and anionic lipids, an AC electric field was required for GUV 
formation from neutral lipids. Distribution, lateral mobility and function of an ATP-
binding cassette transport system, an ion-linked transporter and a mechanosensitive 
channel in GUVs were determined by confocal imaging, FCS, patch-clamp 
measurements and biochemical techniques. In addition, we show that sucrose slows 
down the lateral mobility of fluorescent lipid analogues, possibly due to hydrogen-
bonding with the lipid headgroups, leading to larger complexes with reduced mobility.  
  
Introduction 
Biological membranes are complex matrices mainly composed of lipids and proteins that 
separate the contents of cells or specialized compartments from the external surroundings. 
The abbreviations used are: ABC, ATP-binding cassette; AC, alternating current; DDM, n-dodecyl-β-D-maltoside; 
DiO, 3,3’-dioctadecyloxacarbocyanine perchlorate (DiOC18(3)); DOPC, 1,2-dioleoyl-sn-glycero-3-
phosphatidylcholine; DOPE, L-α-dioleoyl phosphatidylethanolamine; DOPG, 1,2-dioleolyl-sn-glycerol-3-[phospho-
rac-(1-glycerol)]; DOPS, 1,2-dioleoyl-sn-glycero-3-phosphatidylserine; FCS, Fluorescence Correlation 
Spectroscopy; GUV, Giant Unilamellar Vesicle; LSCM, Laser Scanning Confocal Microscope; LUV, Large 
Unilamellar Vesicle; NBD C6-HPC, 2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexadecanoyl 
phosphocholine; NTA, nitrilotriacetic acid; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor. 
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Giant Unilamellar Vesicles (GUVs; diameter ~ 5 – 100 µm) have proven to be useful model 
systems and have been widely used to study lipid dynamics (Korlach et al., 1999), lipid domain 
(raft) formation (Bagatolli and Graton, 2000; Kahya et al., 2003), elastic properties of 
membranes (Angelova et al., 1992; Akashi et al., 1996), lipid-DNA interactions (Angelova et 
al., 1999), vesicle shape changes (Tanaka et al., 2002), membrane tube formation (Roux et 
al., 2002), and membrane fusion (Tanaka et al., 2004). In contrast, reports on membrane 
protein dynamics in GUVs are rare since for a long time methods suitable for incorporating 
these proteins in a functional state into GUVs were not available (Kahya et al., 2001; Girard et 
al., 2004). 
The mechanism of formation and properties of GUVs have already been studied since the 
1980’s (Dimitrov and Angelova, 1986; Mueller and Chien, 1983). GUVs can be prepared by 
drying lipids dissolved in organic solvent (chloroform or choroform/methanol mixtures) followed 
by addition of distilled water. Water penetrates the dried lamellar structures and GUVs are 
formed spontaneously due to membrane fusion processes. Formation appears to be optimal if 
a fraction of anionic lipids is incorporated (phosphatidylglycerol or phosphatidylserine) or can 
be promoted by the addition of divalent cations (Ca2+  or Mg2+) when using only neutral lipids 
(Akashi et al., 1998). In addition, AC electric fields have been reported to facilitate or impede 
the formation process (Dimitrov and Angelova, 1986; Dimitrov and Angelova, 1987). 
The major bottleneck for direct incorporation of membrane proteins into GUVs is the 
dehydration step which precedes the formation process. Kahya et al. (2001) have 
circumvented this problem by using peptide-induced fusion of Large Unilamellar Vesicles 
(LUVs; diameter ~ 200 nm), containing the membrane protein of interest, with preformed 
GUVs. Although this method has been succesfully applied to study the dynamics and 
aggregation state of bacteriorhodopsin in GUVs (Kahya et al., 2002), the method is laborious 
and required the presence of some highly unusual lipids and a fusogenic peptide in the model 
membranes. Recently, we (Folgering et al., 2004) and others (Girard et al., 2004) developed 
alternative methods for incorporating polytopic membrane proteins into GUVs by (partial) 
dehydration of LUVs, containing (purified) membrane proteins, followed by rehydration in the 
presence of an AC electrical field (Angelova et al., 1992). This method was applied for the 
Ca2+-ATPase from sarcoplasmic reticulum and two highly stable membrane proteins, the light-
driven proton pump bacteriorhodopsin and the mechanosensitive channel of large 
conductance MscL. A drawback was that electroformation tolerates low (~ < 10 mM) ion 
concentrations during the GUV formation process. Bacteriorhodopsin and MscL retained their 
activity during drying of the proteoliposomes, however, activity of the Ca2+-ATPase was 
reduced by ~ 30 % (Girard et al., 2004). Bacia et al. (2004) studied two single-span SNARE 
proteins incorporated into GUVs by the same method, but the fraction of proteins that survived 
the GUV formation process was not determined. For single-molecule techniques like 
Fluorescence Correlation Spectroscopy (FCS), Fluorescence Resonance Energy Transfer 
(FRET) and Atomic Force Microscopy (AFM), it is essential that heterogeneities due to non-
productive protein conformations can be ruled out and that 100 % protein activity can be 
recovered. 
We have made use of the stabilizing properties of disaccharides on membranes and proteins 
to develop a direct and simple method by which 100 % protein activity was retained during 
incorporation of four distinct membrane protein(s) (complexes) into GUVs. The proteins 
studied were the lipid-anchored oligopeptide-binding protein OppA and the translocator 
complex OppBCDF of the oligopeptide ATP-binding cassette (ABC) transporter from  Incorporation and dynamics of membrane proteins in GUVs 
    85
Lactococcus lactis,  the mechanosensitive channel of large conductance MscL from 
Escherichia coli, and the secondary lactose transport protein LacS from Streptococcus 
thermophilus. The distribution, mobility and function of these membrane proteins from distinct 
protein families were studied in proteo-GUVs by confocal imaging, FCS, patch-clamp and 
other biochemical techniques.  In addition, the effect of sucrose on the lateral mobility of 
hydrated lipids was analysed by FCS measurements on GUVs prepared in the presence of 
high concentrations of sugar. 
 
Materials and methods 
 
GUV formation. GUVs were prepared according to standard procedures (Mueller and Chien, 1983; Akashi et 
al., 1996) with some modifications. In short, 10 µL of 4 mg/mL lipids (w/w), dissolved in chloroform, was 
deposited on a glass coverslide. For detection of GUVs by fluorescence microscopy, a fluorescent lipid probe, 
DiO (excitation and emission wavelength maxima of DiO are 484 and 501 nm, respectively), or NBD C6-HPC 
(excitation and emission wavelength maxima of NBD C6-HPC are 460 and 534 nm, respectively), was added (1 
µL of 0.5 mM probe dissolved in MeOH/mg lipid). A thin lipid film was formed by evaporating the chloroform 
under vacuum at 4°C. The lipids were rehydrated at room temperature by the addition of 0.5 mL distilled water 
or 10 mM KPi, pH 7.0, in a custom-built sample chamber. Optionally 10 mM MgCl2 was added after prehydration 
with distilled water (Akashi et al.,  1998) or  electroformation was performed (Angelova et al.,  1992). For 
electroformation, lipids were dried onto ITO-coated coverslips (custom-coated by GeSim, Dresden, Germany). A 
Pt wire was assembled 1 mm above the ITO-coated slide in the sample chamber, after which an AC electric 
field was applied (10 Hz, 1.2 V). Formation of GUVs was followed by fluorescence microscopy. 
 
Cysteine mutagenesis. Cysteine mutants of the lipid-anchored oligopeptide-binding protein from Lactococcus 
lactis, OppA I602C, the mechanosensitive channel protein from Escherichia coli, MscL K55C, and the 
secondary lactose transporter from Streptococcus thermophilus, LacS C320A / A635C were prepared by 
standard molecular biology techniques. Each protein contains a C-terminal His6-tag that was used for 
purification by Ni2+-affinity chromatography. OppA I602C was made by replacing the 368 baisepair BamHI-XbaI 
fragment of plasmid pAMP42 (Doeven et  al., 2004) with a synthetic double-stranded oligonucleotide linker (5’-
GATCCTGTATTGAGGGTCGTCATCATCACCACCATCACTGACGCGTCTGCAGT-3’ annealed to 5’-
CTAGACTGCAGACGCGTCAGTGATGGTGGTGATGATGACGACCCTCAATACAG-3’) containing three extra 
basepairs coding for cysteine (letters in bold). The linker also contained a PstI site (underlined) outside the 
coding region to facilitate restriction analysis after ligation. Next, the insert of pAMP42 (oppDFBC) was replaced 
with a 1802 basepair NcoI-BamHI fragment of pAMP31 (Picon et al., 2000) containing the oppA gene.  The 
resulting plasmid was named pNZOppA (I602C). LacS C320A / A635C was made by changing the codon 
specifying alanine 635 in pSKE8his(C320A) (Veenhoff et al., 2000) into a cysteine codon, using the Quikchange 
mutagenesis kit (Stratagene). The plasmid coding for MscL K55C was a gift from L. Dijkink from the BioMaDe 
Technology Foundation.  
 
Protein production and purification. OppA was produced in Lactococcus lactis NZ9000, using the nisin 
expression system (Kuipers et al., 1993; Kunji et al., 2003). Production of MscL K55C was done in Escherichia 
coli PB104 (Blount et al., 1996), using the pB10b expression vector (Sukharev et al., 1994). LacS C320A / 
A635C was produced by Escherichia coli HB101, using the pSKE8his expression vector (Veenhoff et al., 2000). 
Membrane vesicles were prepared by rupturing the cells with a high-pressure homogenizer (Kindler Maschinen 
AG, Zűrich, Switzerland) and solubilised by 0.5 % (w/v) DDM (OppA and LacS) or 3 % (w/v) octyl-β-glucoside 
(MscL), and the proteins were purified by nickel affinity chromatography essentially as described previously 
(Knol et al., 1996; Detmers et al., 2000; Folgering et al., 2004). Solubilisation buffers were 50 mM KPi, pH 8.0, 
200 mM KCl, 10 % (w/v) glycerol, 10 mM imidazole (OppA), 50 mM KPi, pH 8.0, 100 mM NaCl, 10 % (w/v) 
glycerol, 15 mM imidazole (LacS), and 50 mM KPi, pH 7.0, 300 mM NaCl, 35 mM imidazole (MscL). OppBCDF 
was produced and purified as described previously (Doeven et al., 2004). 
 
Protein labeling. After 12’ centrifugation at 280,000 x g the solubilized material was incubated with Ni2+-NTA 
resin for 1.5 hours at 4°C while rotating. Subsequently, the resin was drained and washed with 10 column Chapter 6 
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volumes of solubilisation buffer containing 0.05 % (w/v) DDM (OppA and LacS) or 0.2 % (w/v) Triton X-100 
(MscL). The columns with OppA and LacS were washed with another 10 column volumes of the same buffer 
with 25 mM imidazole. For FCS experiments the proteins were labeled with Alexa Fluor 488 C5 maleimide 
(Molecular Probes) by incubating the proteins after the initial washing steps, while bound to the Ni2+-NTA resin, 
with a ~ 30 times excess of label for 2 hours up to overnight at 4°C. Labeling was done in solubilisation buffer 
without imidazole supplemented with 0.05 % (w/v) DDM (OppA and LacS) or (w/v) 0.2 % Triton X-100 (MscL). 
After labeling the column was washed with 20 column volumes of the same buffer, and the proteins were eluted 
in the same buffer, pH 7.0, supplemented with 300, 400 or 200 mM imidazole for OppA, MscL and LacS, 
respectively. The degree of labeling was estimated by measuring the absorbance of Alexa Fluor 488 (extinction 
coefficient is 71,000 M-1cm-1 at 495 nm) and protein concentration and was found to be 80 – 100 % for each 
protein preparation.  
 
Functional reconstitution of membrane proteins into LUVs. Purified proteins were inserted into Triton X-100 
destabilized lipsomes as described (Knol et al., 1996). Activity of the proteins was determined by measuring 
peptide-binding (OppA; Detmers et al., 2000), peptide transport (OppBCDF plus OppA; Doeven et al., 2004), 
lactose transport (LacS; Knol et al., 1996), and channel activity (MscL; Folgering et al., 2004) as described 
previously. 
 
Formation of proteo-GUVs. LUVs (10 µL of 20 mg/mL lipids), containing Alexa Fluor 488-labeled membrane 
protein at given protein-to-lipid ratio in 50 mM NH4HCO3, pH 8.0, were dried overnight under vacuum at 4°C on 
UV-ozone cleaned glass or ITO-coated coverslips. UV-ozone cleaning was not essential for GUV formation but 
increased the wetting properties of the coverslip surface, making it easier to dry liposomes from aquaeous 
solution. Sucrose was included in the 50 mM NH4HCO3, pH 8.0, buffer at given amounts to stabilize the proteins 
during dehydration. Rehydration was done by adding 0.5 mL 10 mM KPi, pH 7.0, at room temperature. 
Optionally, 10 mM MgCl2  was added or electroformation was performed (as described above) when using 
neutral lipids only. GUV formation was monitored by fluorescence microscopy. 
 
Confocal imaging and FCS measurements. FCS measurements were carried out on a laser scanning 
confocal microscope (LSCM). The LSCM is based on an inverted microscope Axiovert S 100 TV (Zeiss) in 
combination with a galvanometer optical scanner (model 6860, Cambridge Technology). The laser beam (488 
nm, argon ion laser, Innova 99, Coherent) was focused by a Zeiss C-Apochromat infinity-corrected 1.2 NA 63× 
water immersion objective for excitation of the Alexa Fluor 488 fluorophore. The fluorescence was collected 
through the same objective, separated by a dichroic beam splitter (61003bs, Chroma Technology) and directed 
through an emission filter (HQ 535/50, Chroma Technology) and a pinhole (diameter of 30 µm) onto an 
avalanche photodiode (SPCM-AQR-14, EG&G). The fluorescence signal was digitized and autocorrelation 
curves were calculated on a PC using a multiple τ algorithm. The setup was calibrated by measuring the known 
diffusion coefficient of Alexa Fluor 488  in water (Molecular probes; D = 300 µm2/s).  Autocorrelation curves 
were fitted with a one-component two-dimensional diffusion model (Schwille, 2001) using Origin software 
(OriginLab Corporation, Northampton, MA). 
 
Miscellaneous. Mutations were confirmed by restriction analysis and DNA sequencing. Protein concentrations 
were determined according to the method of Lowry et al. (1951) using bovine serum albumin as a standard. The 
concentrations of purified OppA, OppBCDF and LacS were determined spectrophotometrically by measuring 
the absorption at 280 nm and using extinction coefficients of 1.605, 0.990, and 0.926 (mg/mL)-1cm-1, 
respectively.  
 
Results 
 
Investigation of GUV formation from different lipid mixtures. The formation of GUVs from 
lipid mixtures commonly used for reconstitution of membrane proteins in LUVs was evaluated. 
GUVs could be formed from all lipid compositions tested, although with different efficiency. 
When using neutral lipids (DOPC) formation was slow (longer than 1 hour) and GUV yield was   Incorporation and dynamics of membrane proteins in GUVs 
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relatively low (Fig. 1A). With DOPC:DOPE 1:1 (w/w) mixture thread-like structures were 
observed and GUVs were rarely formed (Fig. 1B). However, when 25 % (w/w) anionic lipids 
(DOPG or DOPS) was included, formation of GUVs was fast (within 15 minutes) and the yield 
was high (Fig. 1C, D and E). Formation of GUVs from neutral lipids (DOPC and DOPC:DOPE) 
could be enhanced by adding 10 mM MgCl2, in accordance with observations made previously 
(Akashi et al., 1998). Addition of Mg2+ collapsed excisting structures, after which many GUVs 
started to grow (Fig. 1F and G). Electroformation (Angelova et al., 1992) also dramatically 
increased the yield of GUVs formed from neutral lipids (Fig. 1H and I). For formation of proteo-
             
 
 
Fig. 1. Formation of GUVs from lipid mixtures used for proteo-LUV preparation. Membranes were 
visualized with a fluorescence microscope equipped with a Zeiss C-Apochromat infinity-corrected 1.2 
NA 63× water immersion objective and a CCD-camera. The fluorescent probe DiO was present at a 
mole ratio of 0.35 µmol DiO / mol total lipid. Scale bar (A) is 20 µm and is the same for all pictures 
shown. Formation of GUVs from neutral lipids: DOPC (A) and DOPC:DOPE 1:1 (w/w) (B). High yields 
of GUV formation were obtained when anionic lipids were incorporated: DOPC:DOPG 3:1 (w/w) (C), 
DOPC:DOPS 3:1 (w/w) (D), and DOPC:DOPE:DOPS 2:1:1 (w/w) (E). Addition of 10 mM MgCl2 after 30 
minutes of prehydration in distilled water increased the yield of DOPC (F) and DOPC:DOPE (G) GUVs. 
Application of an electric field (10 Hz, 1.2 V, distance between electrodes was 1 mm) also dramatically 
improved the formation of GUVs from neutral lipids: DOPC (H) and DOPC:DOPE 1:1 (w/w) (I).  
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GUVs (see below) a lipid mixture of DOPC:DOPS 3:1 (w/w) was used, because most 
membrane proteins studied to date require anionic lipids for (optimal) activity. 
 
Production, purification and fluorescent labeling of membrane proteins. The four model 
membrane protein(s) (complexes) used in this study are the oligopeptide-binding protein 
OppA, and the translocator complex OppBCDF of the oligopeptide ABC transporter from 
Lactococcus lactis, the mechanosensitive channel of large conductance MscL from 
Escherichia coli, and the secondary lactose transport protein LacS from Streptococcus 
thermophilus. In order to selectively label the proteins with fluorescent probes for detection by 
confocal imaging and FCS measurements, single-cysteine mutants were constructed. The 
position of the cysteine was located either near the C-terminus of the protein (OppA and 
LacS), or in an extracellular loop (MscL). Wild-type OppA contains a N-terminal cysteine 
residue that is lipid-modified and this residue could not be used for labeling; OppA is anchored 
to the membrane via this lipid-modification. The native cysteine of LacS at position 320 is 
located in the middle of a transmembrane helix and not accessible or unreactive for labeling. 
Therefore, this cysteine was replaced by an alanine and a cysteine for labeling was introduced 
near the C-terminus of the protein. The cysteines in the different proteins were labeled with 
Alexa Fluor 488 C5 maleimide, after which excess label was removed by nickel affinity 
chromatography. Figure 2 shows SDS-PAGE analysis of membrane vesicles containing the 
overexpressed cysteine mutants, the purified proteins, and the proteins labeled with Alexa 
Fluor 488. 
Membrane reconstitution and activity of the labeled mutants. The Alexa Fluor 488 labeled 
proteins were inserted into Triton X-100 destabilized LUVs (Knol et al., 1996), and protein 
activity was assayed as described previously (Knol et al., 1996; Detmers et al., 2000; Folgering 
et al., 2004). Peptide binding by OppA, channel activity by MscL, and lactose transport by 
LacS, were not affected by the mutations and the labeling of the proteins, as is shown in figure 
3. In addition, bradykinin uptake via Opp (= OppA plus OppBCDF) was also not influenced by 
labeling of OppA (not shown).  
 
 
Fig. 2. SDS-PAGE analysis of overexpressed, purified and labeled cysteine mutants. Membrane 
vesicles containing overexpressed cysteine mutants are shown in lanes 1, 4 and 7. Purified proteins labeled 
with Alexa Fluor 488 C5 maleimide (Molecular Probes) stained with coomassie brilliant blue (lanes 2, 5, and 
8) and visualised with a UV lamp (lanes 3, 6 and 9) are also shown. Mutants used were OppA I602C (lanes 
1-3), LacS C320A / A635C (lanes 4-6), and MscL K55C (lanes 7-9). 
  Incorporation and dynamics of membrane proteins in GUVs 
    89
Stabilization of membrane proteins by sucrose during dehydration. The major difficulty 
with incorporating membrane proteins in a functional state into GUVs is the dehydration step of 
the GUV formation process. During drying labile (membrane) proteins are prone to lose their 
biological activity (Crowe et al., 1984; Crowe et al., 1988; Crowe et al., 1996b). In our case, 
only the highly stable channel protein MscL was able to survive completely when water was 
removed from proteo-LUVs containing this protein (Folgering et al., 2004). OppA and LacS, on 
 
 
 
Fig. 3. Activity of labeled cysteine mutants. (A) Peptide binding by wild-type OppA and Alexa Fluor 488-
labeled cysteine mutant OppA I602C AF488. The  concentration of [3H]-bradykinin was 3 µM.   (B) 
Lactose counterflow via LacS C320A  and LacS C320A / A635C labeled with Alexa Fluor 488. The internal 
lactose and external [14C]-lactose concentrations were 10 mM and 100 µM, respectively. (C) Channel 
activity of wild-type MscL (upper trace) and MscL K55C labeled with Alexa Fluor 488 (lower trace). Patch-
clamp measurements were done in 5mM Hepes, pH 7.2, 200 mM KCl, 40 mM MgCl2, and at +20 mV 
pipette voltage. The unit conductance of a single MscL channel is about 2.5 nS as indicated by the 50 pA 
scale bar. Protein to lipid ratios were 1:50 (w/w). Proteins were inserted into DOPC:DOPS 3:1 (w/w) lipid 
mixtures. 
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the other hand, were severely affected by the removal of water, resulting in loss of protein 
activity after de- and rehydration. Protein activity could be preserved by adding sucrose during 
drying of OppA- and LacS-containing LUVs (Fig. 4A and B), and as little as 20 mg sucrose/g of 
lipid was sufficient for the recovery of full activity. Notice that during drying the sucrose 
concentration increases from 1 to an estimated several hundreds of mM. The multi-subunit 
oligopeptide ABC transporter OppABCDF could be stabilized during dehydration by the 
addition of 100 mg sucrose/g of lipid (Fig. 4C). 
 
 
Fig. 4. Sucrose stabilizes membrane proteins during dehydration. Peptide binding by OppA (A), lactose 
counterflow via LacS C320A (B), and peptide uptake by OppABCDF (C; [3H]-bradykinin concentration was 
0.7 µM) were measured after dehydration of the membranes in the presence of 0 – 0.86 g sucrose/g lipids 
and rehydration in 10 mM KPi, pH 7.0. “Control” samples were not dried and rehydrated. For further details 
see legend to figure 2. 
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Fig. 5. Confocal imaging and diffusion measurements of membrane proteins in GUVs. Confocal 
images of proteo-GUVs containing functional Alexa Fluor 488-labeled OppA I602C (A), MscL K55C (B), or 
LacS C320A / A635C (C). Scale bars are 10 µm. GUVs were prepared in the presence of 0.02 (A), 0 (B), or 
0.17 (C) g sucrose/g lipids. The protein to lipid ratio was 1:500 (w/w) and the lipid composition was 
DOPC:DOPS 3:1 (w/w). (D) Autocorrelation curves for OppA I602C (□), MscL K55C (○), and LacS C320A / 
A635C (∆) in GUVs. Curves were fit with a one-component two-dimensional diffusion model (solid lines) 
using Origin software (OriginLab Corporation, Northampton, MA); the residuals of the fits are shown in the 
panels below the figure.  
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Confocal imaging of functional membrane proteins in GUVs. After optimization of the 
amount of sucrose needed to retain 100 % biological activity for each protein (Fig. 4), proteo-
GUVs were prepared for confocal imaging. Proteo-LUVs were dried in the presence of 
stabilizing amounts of sucrose and rehydrated in aqueous buffer. GUV formation was followed 
by fluorescence microscopy. The addition of Mg2+ or application of an electric field was not 
required for the formation of GUVs, since 25 % (w/w) DOPS was included in the LUVs (see 
above). Confocal imaging confirmed that the proteins were incorporated homogeneously into 
the GUVs (Fig. 5A, B and C). Differences in brightness of the GUVs are a result of different 
amounts of labels attached to the proteins. Pentameric MscL (Fig. 5B), for example, has five 
labels attached whereas OppA (Fig. 5A) has only one. The presence of sucrose during the 
drying of the proteo-LUVs inhibited the GUV formation process. When sucrose was used at 
0.86 g/g lipid or higher concentration, GUV formation was no longer observed. Addition of Mg2+ 
or application of an electric field also could not induce GUV formation under these conditions. 
However, the minimal amount of sucrose needed for the protection of the proteins during 
dehydration was much lower (~ 0.02 g sucrose/g lipid; Fig. 4), making it possible to form GUVs 
containing fully functional membrane proteins. 
 
Lateral mobility of membrane proteins in GUVs. The mobility of OppA, MscL and LacS in 
GUVs was determined by FCS measurements. Confocal images were made of proteo-GUVs 
containing fluorescent labeled protein, and the focal volume was focused on the pole of the 
GUVs. Representative autocorrelation curves for each of the three proteins studied are shown 
in figure 5D; the experimental data could be fitted reasonably well with a one-component two-
dimensional diffusion model. Occasionally the membranes appeared to move or fluctuate 
during the autocorrelation measurements which could be observed as a decay or systematic 
deviation in the count-rate. Autocorrelation curves affected by these membrane undulations 
were not taken into account when analyzing the data. Undulations seemingly appeared more 
frequently when measuring autocorrelation curves with very large GUVs (~ 30 – 100 µm) and 
less when the GUVs were somewhat smaller (< 30 µm). The measured diffusion coefficients 
(D) are summarized in Table 1. Lipid-anchored oligopeptide-binding protein OppA diffused with 
the same speed as the fluorescent lipid DiO. The mobility of the integral membrane proteins 
MscL and LacS was lower, with LacS being the slowest. The lateral mobility of the integral 
membrane proteins was ~ 2-3 fold lower than the mobility of DiO.  
 
Table 1. Diffusion coefficients for lipid and membrane proteins in GUVs. 
 DiO1  OppA 
I602C AF488 
MscL 
K55C AF488 
LacS C320A / A635C 
AF488 
Diffusion coefficient2 
(10-8 cm2/s) 
7.7 ± 0.8  7.5 ± 0.9  3.9 ± 0.3  3.0 ± 0.3 
1Diffusion of DiO was measured in GUVs, that is, in the absence of protein. 2Diffusion coefficients represent 
the average of at least five measurements and the SD values are given. FCS setup was calibrated with Alexa 
Fluor 488.  
 
Interaction of sucrose with hydrated lipids. To investigate the effect of high concentrations 
of sucrose on the lateral mobility of lipids, we prepared GUVs in the absence and presence of 
high concentrations of sugar. Although the efficiency of GUV formation was hampered when 
sugar was present in the rehydration liquid, GUVs could still be formed with up to 1.5 M 
sucrose (or glucose) in the rehydration medium (Fig. 6A and B).   Incorporation and dynamics of membrane proteins in GUVs 
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Fig. 6. Effect of sucrose on lipid lateral mobility in GUVs. Confocal images of GUVs prepared in the 
absence (A) or presence (B) of 1.5 M sucrose. Scale bar is 10 µm. The fluorescent lipid probe DiO was used 
to visualize the membranes. (C) Autocorrelation curves of DiO in GUVs prepared in the absence of sugar (□) 
or in the presence of 1.5 M glucose (○) or sucrose (∆). Curves were fit with a one-component two-
dimensional diffusion model (solid lines) using Origin software (OriginLab Corporation, Northampton, MA); 
the residuals of the fits are shown in the panels below the figure. With high concentrations of sucrose (and 
glucose), the data points deviated significantly from the one-component two-dimensional diffusion model, 
which may reflect the clustering of the lipids. Excellent fits were obtained when anomalous or two-component 
diffusion models were used to analyse the data (not shown). The lipid composition was DOPC:DOPS 3:1 
(w/w). 
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Representative autocorrelation curves for the fluorescent lipid probe DiO in GUVs prepared in 
water or 1.5 M sugar are shown in figure 6C. It can be seen that at high sucrose concentration 
the lateral diffusion of DiO was slowed by a factor of ~ 3. This suggests that the sugar is 
binding to the lipids and cluster formation may be taking place. When glucose was used in 
stead of sucrose the effect on the lateral mobility of DiO was much smaller but still a reduction 
of ~ 2 fold was observed. In Table 2, a summary of the measured diffusion coefficients is 
given. Control experiments with another fluorescent lipid analogue (NBD C6-HPC; Molecular 
Probes) gave similar results (not shown), indicating that the results were not probe-specific. 
 
Table 2. Effect of sugars on lipid lateral mobility in GUVs. 
  Water  1.5 M Sucrose  1.5 M Glucose 
Diffusion coefficient1 
(10-8 cm2/s) 
7.7 ± 0.8  2.5 ± 0.6  4.1 ± 0.7 
1Diffusion coefficients represent the average of at least five measurements and the SD values are given. FCS 
setup was calibrated with Alexa Fluor 488. Fluorescent lipid probe was DiO. 
 
Discussion and conclusions 
 
A method for the direct incorporation of membrane proteins into GUVs without losing protein 
activity is described. Protein activity was retained by drying proteo-LUVs in the presence of 
sucrose. The distribution, lateral mobility and activity of representative membrane proteins 
from disinct families in GUVs was analysed by confocal imaging, FCS, patch-clamp and other 
biochemical techniques. Furthermore, the effect of high concentrations of sucrose on lateral 
mobility of lipids in GUVs was studied by FCS. 
First, we evaluated the formation of GUVs from lipid mixtures commonly used to reconstitute 
membrane proteins into LUVs (Fig. 1). Formation was optimal when a fraction of anionic lipids 
(DOPC or DOPS) was incorporated or could be promoted by the addition of Mg2+  or by 
performing electroformation when using only neutral lipids. These results are in accordance 
with previously made observations (Akashi et al., 1998; Angelova et al., 1992). Importantly, to 
the best of our knowledge, a systematic comparison of GUV formation in the presence or 
absence of an AC electric field using a wide range of lipid compositions has not been reported 
before.  
For the formation of proteo-GUVs, we used proteo-LUVs containing purified membrane 
proteins as starting material. However, after drying and rehydration to form GUVs, three out of 
the four protein(s) (complexes) had lost biological activity. The only protein which survived 
completely was the mechanosensitive channel of large conductance MscL, which is not 
entirely surprising since MscL is a highly stable membrane protein. The other three proteins 
studied, the lipid-anchored oligopeptide binding protein OppA, the oligopeptide translocator 
complex OppBCDF, and the secondary lactose transporter LacS, were found to be less stable. 
Rigaud and colleagues attempted to circumvent the problem of losing protein activity during 
the drying step by performing partial dehydration of the proteo-LUVs under controlled humidity 
(Girard  et al., 2004). However, of the two proteins studied, the light-driven proton pump 
bacteriorhodopsin and the Ca2+-ATPase, only the former completely survived the GUV 
formation process. The  Ca2+-ATPase had lost 30 % of its biological activity. We prevented 
OppA, OppBCDF and LacS from losing activity during dehydration by adding stabilizing 
amounts of sucrose. Only low amounts were needed to retain 100 % activity (the minimal 
amount required was 0.02 g sucrose/g lipid; Fig. 4).  Incorporation and dynamics of membrane proteins in GUVs 
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Disaccharides (for example sucrose) are known to stabilize the folded state of proteins in 
solution via a mechanism termed preferential exclusion (Lee and Timasheff, 1981; Arakawa 
and Timasheff, 1985). At high solute concentration the sugar is excluded from the protein 
surface and the native state is thermodynamically favored over the unfolded state of the 
protein. The stabilization of soluble proteins during freezing is thought to occur via a similar 
mechanism. However, stabilization of soluble proteins by disaccharides during air-drying is 
thought to occur via direct interaction (hydrogen bonding) of the sugar with polar groups of the 
protein (Crowe et al., 1988). In addition, disaccharides are known for a long time to stabilize 
membranes during freezing or drying (Crowe et al., 1984; Crowe et al., 1988; Crowe et al., 
1996a; Crowe et al., 1996b).  The transitions from liquid-crystalline to gel phase (during 
dehydration) and gel to liquid crystalline phase (during subsequent rehydration) in the absence 
of sucrose may cause aggregation of integral membrane proteins and loss of activity. Upon 
drying the sugar molecules replace water by hydrogen-bonding to the lipid headgroups, 
thereby maintaining the spacing between the headgroups and preventing the membrane from 
going from the liquid-crystalline to the gel phase. The interactions of sucrose with the proteins 
and the maintenance of the liquid-crystalline phase of the membrane are most probably the 
determining factors for the stabilization of the OppA, OppBCDF and LacS proteins. A side-
effect of high concentrations of sugars during drying is that they inhibit membrane fusion 
(Hincha et al., 2003). This may explain why at high amounts of sucrose during drying (≥ 0.86 
g/g lipid) no GUVs were formed. Addition of Mg2+ or application of an electric field also could 
not induce GUV formation under these conditions. However, there appears to be an optimum 
in sucrose concentration at which membrane protein activity is retained (minimal amount 
required is 0.02 g sucrose/g lipid) and membrane fusion is still possible (< 0.86 g sucrose/g 
lipid), which enables proteo-GUV formation. 
The distribution of the proteins in the GUVs was assessed by confocal imaging and found to 
be homogeneous. FCS experiments showed that the diffusion of lipid-anchored OppA was as 
fast as that of the lipid analogue DiO. This suggests that OppA does not have interactions with 
the membrane other than through its lipid anchor. The integral membrane proteins MscL and 
LacS diffused ~ 2-3 times slower compared to DiO.  The values found for diffusion of DiO and 
that of integral membrane proteins in GUVs are in the same range as determined previously 
(Kahya, et al., 2001; Kahya et al., 2003). The difference in mobility of DiO and the integral 
membrane proteins is in accordance with the Saffman and Delbrűck model for diffusion in 
biological membranes (Saffman and Delbrűck, 1975; equation 1):  
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,                                                                                           (equation 1) 
 
where k is the Boltzmann constant, η and ηw  are the viscosity of the membrane and of the 
surrounding aqueous medium, respectively, h is the membrane thickness, A  the cross 
sectional surface area (CSSA) of the particle and γ is Euler’s constant. The difference in 
mobility of LacS (dimer with a molecular mass of about 140 kDa and CSSA of ~ 32 nm2; 
Friesen et al., 2000; Veenhoff et al., 2001) and that of MscL (pentamer with a molecular mass 
of about 70 kDa and CSSA of ~ 20 nm2 for the “closed” state; Chang et al., 1998) was ~ 1.3 
times. This difference is expected to be this small due to the logarithmic dependence of the 
lateral mobility of membrane proteins on the cross-sectional area of the aggregate (Saffman 
and Delbrűck, 1975; Kucik et al., 1999; Lee and Petersen, 2003). Chapter 6 
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Surprisingly, GUVs could still be formed when high amounts of sugar (up to 1.5 M) were 
present during rehydration only. It has been suggested by molecular dynamics simulations that 
the lateral diffusion of lipids in membranes is reduced in the presence of high concentrations of 
disaccharides (Sum et al., 2003; Pereira et al., 2004). Clusters of a single sucrose or trehalose 
molecule bound to 2-3 (Sum et al., 2003) or even more than 5 lipids (Pereira et al., 2004) were 
observed, with the phosphate group of the lipids as the principal interaction site with the 
sugars. Consistent with this prediction, we observed a reduction of the lateral mobility of lipids 
in the presence of 1.5 M sucrose, and the data could no longer be fitted with a one-component 
two-dimensional diffusion model. However, formation of clusters of 2-3 or even 5 lipids can not 
explain a ~ 3 fold reduction in diffusion coefficient on the basis of the increased CSSA only 
(see equation 1). Based on our results, and in accordance with the molecular dynamics 
simulations, we conclude that high concentrations sucrose (or trehalose) may indeed cluster 
lipids and hydrogen bonding of sugars to the lipids increases the overall viscosity of the 
membrane thereby slowing down the lipid mobility even further. 
In conclusion, we developed a generic method to insert membrane proteins into GUVs without 
losing protein activity. Sucrose inhibited GUV formation when present during drying but the 
amount needed for protein stabilization was lower than the amount that completely blocked 
GUV formation.  
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Chapter 7 
Probing the catalytic cycle of the oligopeptide ABC 
transporter by fluorescence correlation spectroscopy 
Mark K. Doeven, Geert van den Bogaart, Victor Krasnikov, and Bert Poolman 
Abstract 
The oligopeptide transporter Opp is a five-component ATP-binding cassette (ABC) 
uptake system. Extracytoplasmic lipid-anchored substrate-binding protein OppA 
delivers peptides to an integral membrane complex OppBCDF, where, upon ATP 
binding and hydrolysis, translocation across the membrane takes place. OppA and 
OppBCDF were labeled with fluorescent probes and the catalytic cycle of the 
transporter was investigated by fluorescence correlation spectroscopy using Giant 
Unilamellar Vesicles (GUVs) as a model membrane system. Lateral mobility of OppA 
was reduced upon incorporation of OppBCDF into GUVs and decreased even further 
upon addition of peptide. Fluorescence cross-correlation measurements revealed that 
OppBCDF distinguished liganded from unliganded OppA, binding only the former. 
Addition of ATP, non-hydrolyzable ATP analogue AMP-PNP, or, to a lesser extent, ADP 
resulted in release of OppA from OppBCDF. In vanadate-trapped ‘transition state’ 
conditions, OppA was not bound by OppBCDF. A model is presented in which ATP-
binding to OppDF results in donation of the peptide to OppBC and simultaneous release 
of OppA. ATP-hydrolysis would complete the peptide translocation and reset the 
transporter for another catalytic cycle. Implications in terms of a general transport 
mechanism for ABC im- and exporters are discussed. 
 
Introduction 
 
ATP-binding cassette (ABC) transporters comprise one of the largest protein families and their 
(dys)function is in a number of cases linked to human diseases (Higgins et al., 1992; Biemans-
Oldehinkel  et al., 2006). They catalyze the unidirectional transport of a wide variety of 
substrates over cellular and organellar membranes and are widely distributed throughout all 
forms of life. Two hydrophobic transmembrane domains (TMDs) create the translocation 
pathway, and two peripherally associated nucleotide-binding domains (NBDs) fuel the 
The abbreviations used are: ABC, ATP-binding cassette; DDM. n-dodecyl-β-D-maltoside; DOPC, 1,2-dioleoyl-
sn-glycero-3-phosphatidylcholine; DOPS, 1,2-dioleoyl-sn-glycero-3-phosphatidylserine; FCS, Fluorescence 
Correlation Spectroscopy; FCCS, Fluorescence Cross-correlation Spectroscopy; GUV, Giant Unilamellar 
Vesicle; LSCM, Laser Scanning Confocal Microscope; LUV, Large Unilamellar Vesicle; NBD, nucleotide-binding 
domain; NTA, nitrilotriacetic acid; SBP, substrate-binding protein; TMD, transmembrane domain. 
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transport reaction by binding and hydrolyzing ATP. Directionality of the translocation process 
can be deduced from the presence or not of a fifth component, the extracytoplasmic substrate-
binding protein (SBP). ABC efflux systems lack this constituent, whereas in bacterial ABC 
importers the SBP is essential for function. 
A vast amount of experimental data is available for different ABC efflux systems and, although 
mechanistic details may differ in individual cases, a consensus model on how this type of 
transporters work is emerging (Higgins and Linton, 2004; van der Does and Tampe, 2004). 
Substrate is bound at a high-affinity cytoplasmic facing binding site, located within the TMDs. 
ATP-binding induces NBD dimerization and reorientation of the loaded substrate-binding site 
from a high affinity inside- to a low affinity outside-facing conformation. After substrate release 
ATP-hydrolysis resets the transporter by opening the NBDs and reorienting the empty binding 
site.  
Data on SBP-dependent ABC importers are limited to one or two systems as an experimentally 
well supported transport mechanism is currently available only for the maltose permease 
MalEFGK2 from Escherichia coli (Chen et al., 2001; Chen et al., 2003; Austermuhle et al., 
2004) and, to a lesser extent, the histidine permease HisJQMP2 from Salmonella typhimurium 
(Ames  et al., 1996; Liu et al., 1999). In a series of elegant experiments, Davidson and 
colleagues showed that liganded SBP MalE, whilst bound to the TMDs (MalF and G), opens 
upon ATP-binding to the NDBs (two copies of MalK per functional complex). In the vanadate-
trapped transition state for ATP-hydrolysis, MalE, in its open conformation, is bound tightly to 
MalFGK2, whereas the affinity for maltose is reduced. Under post-hydrolysis conditions MalE 
dissociates from MalFGK2, thereby resetting the transporter for the next catalytic cycle. These 
data contrast those of the vitamin B12 transporter Btu, where SBP BtuF binds tightly to BtuCD 
in the absence and presence of MgATP, and might not dissociate from the transporter during 
the catalytic cycle (Borths et al., 2005). 
The oligopeptide ABC transporter OppABCDF from Lactococcus lactis is composed of an 
extracytoplasmic lipid-anchored SBP, OppA, two TMDs, OppB and C, and two NBDs, OppD 
and F, bound to the cytosolic face of the TMDs (Tynkkynen et al., 1993). In vitro transport 
assays with purified proteins reconstituted in Large Unilamellar Vesicles (LUVs) suggested that 
OppBCDF specifically recognizes liganded OppA (Doeven et al., 2004). This contrasted 
observations for the maltose and histidine transporters, where unliganded SBP seemed to 
have access to the TMDs as well, thereby inhibiting transport activity (Prossnitz et al., 1989; 
Dean et al., 1992; Merino et al., 1995).  
We now used purified and fluorescent labeled OppA and OppBCDF incorporated into Giant 
Unilamellar Vesicles (GUVs) to probe the catalytic cycle of the oligopeptide ABC transporter, 
using fluorescence auto- and cross-correlation spectroscopy. Based on the results, a model for 
oligopeptide transport is presented which shows similarities but also important differences 
compared to the mechanism proposed for the maltose permease. The possible origin for the 
observed differences is discussed, thereby increasing our knowledge on the translocation 
mechanism of SBP-dependent ABC transporters.  
 
Materials and Methods 
 
Bacterial strain and growth conditions. C-terminal His6-tagged OppA, OppA I602C and OppBCDF (His6-tag 
on C-terminus of OppC) were produced in L. lactis AMP2/pAMP31, NZ9000/pNZOppA (I602C) and 
NZ9000/pAMP42, respectively, as described (Picon et al., 2000; Doeven et al., 2004; Doeven et al., 2005). 
Plasmid pAMP42 (OppC I602C) was an intermediate in the construction of pNZOppA (I602C), and was used for Catalytic cycle of the oligopeptide ABC transporter 
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production of OppBC(I296C)DF by L. lactis NZ9000. Cells were grown in 5 % (w/v) whey-permeate, 0.5 % (w/v) 
yeast extract, 0.5 % (w/v) glucose, and 65 mM KPi, pH 7.0, supplemented with 5 µg/mL chloramphenicol in 
volumes of 10 liters in a bioreactor with pH control (ADI 1065 fermentor; Applikon Dependable Instruments B. 
V., Schiedam, The Netherlands). The pH was kept constant at pH 6.5 by titrating with 2 M KOH. Trancription 
from the nisin A promoter (plasmid constructs in strain NZ9000) was induced at an O.D.660 of 2 by adding 
1:1000 (v/v) of the culture supernatant of L. lactis NZ9700. Cells were harvested by centrifugation, washed with 
100 mM KPi, pH 7.0, resuspended in 100 mM KPi, pH 7.0, plus 20 % (v/v) glycerol, and stored at -80°C.  
 
Protein purification and fluorescent labeling. OppA and OppBCDF were purified as described (Detmers et 
al., 2000; Doeven et al., 2004). OppA I605C was purified and labeled with Alexa Fluor 488 C5 maleimide 
(Invitrogen) as described (Doeven et al., 2005). Labeling of OppA I605C with Alexa Fluor 633 C5 maleimide 
(Invitrogen) was done in exactly the same way as previously described for Alexa Fluor 488 (Doeven et al., 
2005). OppBC(I296C)DF was purified and labeled with either Alexa Fluor 488 or Alexa Fluor 633 as follows. 
Membrane vesicles were prepared by rupturing the cells with a high-pressure homogenizer (Kindler Maschinen 
AG, Zürich, Switzerland) in the presence of 20 % (v/v) glycerol. OppBC(I296C)DF containing membranes were 
resuspended to 5 mg/mL of total membrane protein in 50 mM KPi, pH 8.0, 200 mM KCl, and 20 % (v/v) glycerol 
(buffer A), and solubilized with 0.5 % (w/v) DDM. After 12 min of centrifugation at 280,000 x g and 4°C, the 
supernatant was diluted five times with buffer A and incubated with nickel-nitrilotriacetic acid (Ni2+-NTA) resin 
(0.05 mL/mg of total membrane protein) for 1.5 h at 4°C while shaking gently. Subsequently, the resin was 
poured into a column and washed with 20 column volumes of buffer A, supplemented with 0.05 % (w/v) DDM 
and 10 mM imidazole. Labeling was done by incubating the purified protein while bound to the column for 2 h up 
to overnight at 4°C with a ~ 30 times molar excess of probe dissolved in five column volumes buffer A plus 0.05 
% (w/v) DDM. The column was washed with 20 column volumes buffer A plus 0.05 % (w/v) DDM to remove free 
label and the labeled OppBC(I296C)DF complex was eluted in the same buffer, pH 7.0, supplemented with 100 
mM histidine. The degree of labeling was estimated by measuring the absorbance of Alexa Fluor 488 and 633 
(extinction coefficients are 71,000 M-1cm-1 at 495 nm and 100,000  M-1cm-1 at 633 nm, respectively) and protein 
concentration and was found to be 80-100 % for each protein preparation. 
 
Reconstitution of (fluorescent labeled) Opp proteins into LUVs and GUVs. Triton X-100 mediated 
reconstitution of the (fluorescent labeled) Opp proteins into LUVs was done as described (Rigaud et al., 1995; 
Doeven et al., 2004; Poolman et al., 2005). Next, conversion of Opp-containing LUVs into proteo-GUVs was 
done essentially as described (Doeven et al., 2005). Briefly, proteo-LUVs in 50 mM  NH4HCO3, pH 8.0, were 
freeze-thawed three times in the presence of 0.1 g of sucrose/g lipids such that the sucrose concentration on 
the in- and outside of the proteo-LUVs was the same. 10 µL proteo-LUVs (5 mg/mL lipids) were dried on an 
ultraviolet-ozone cleaned cover-slide under a gentle stream of nitrogen gas followed by an overnight incubation 
under vacuum at 4°C. Rehydration was done by adding 500 µL of 20 mM K-Hepes, pH 8.0. GUV formation was 
monitored by fluorescence microscopy. Optionally, bradykinin (a nonameric peptide with the amino acid 
sequence RPPGFSPFR) and/or different nucleotides were included in the rehydration buffer. The distributions 
of peptide and/or nucleotide on the in- and outside of the GUVs after formation was assessed in control 
experiments by including tracer amounts (~ 10 nM) of Oregon Green 488 labeled RPPGFSPFC or Alexa Fluor 
647-ATP (Invitrogen) in the rehydration buffer, followed by confocal imaging of the formed GUVs (see below). At 
the concentrations of peptide and nucleotides used, e.g. 20 µM and 0.1 – 3 mM, respectively, no large 
differences between the amounts of solutes present in- and outside the proteo-GUVs could be detected. 
 
Activity of fluorescent labeled Opp. Activity of the (fluorescent labeled) proteins was determined as described 
previously by measuring peptide binding (OppA; Detmers et al., 2000) and/or peptide transport (OppABCDF; 
Doeven et al., 2004).  
 
Confocal imaging, FCS and FCCS measurements. Fluorescence Correlation Spectroscopy (FCS) 
measurements were carried out on a dual-color laser scanning confocal microscope (LSCM). The LSCM is 
based on an inverted microscope Axiovert S 100 TV (Zeiss, Jena, Germany) in combination with a 
galvanometer optical scanner (model 6860, Cambridge Technology, Watertown, MA) and a microscope 
objective nano-focusing device (P-721, PI). The two laser beams (488 nm, argon ion laser, Spectra Physics and 
633 nm, He-Ne laser, JDS Uniphase) were focused by a Zeiss C-Apochromat infinity-corrected 1.2 NA 63× Chapter 7 
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water immersion objective for excitation of the Alexa Fluor 488 and 633 fluorophores. The fluorescence was 
collected through the same objective, separated from the excitation beams by a beam-pick off plate (BSP20-A1, 
ThorLabs) and split into two channels by a dichroic beam splitter (585dcxr, Chroma Technology, Rockingham, 
VT), and finally directed through emission filters (HQ 535/50 and HQ675/50, Chroma Technology) and pinholes 
(diameter of 30 µm) onto two avalanche photodiodes (SPCM-AQR-14, EG&G). The fluorescence signals were 
digitized and auto- and cross-correlation curves were calculated using a multiple τ algorithm.  
The setup was calibrated by measuring the known diffusion coefficients of Alexa Fluor 488 and 633 in water 
(Invitrogen; D = 300 µm2/s). The lateral radii ωxy, defined as the point were the fluorescence count rate dropped 
e2 times, were 180 nm for Alexa fluor 488 and 240 nm for Alexa fluor 633. Overlap of the two confocal volumes 
for Fluorescence Cross-correlation Spectroscopy (FCCS) experiments was optimized by maximizing the cross-
correlation signal of double-labeled DNA, which was made by annealing equimolar amounts of 5’-
ATTATTGAGTGGTCACTTTAAA-3’ labeled on the 5’-end with Alexa Fluor 488 and 5’ 
TTTAAAGTGACCACTCAATAAT-3’ labeled on the 5’-end with Alexa Fluor 633 (IBA, St. Louis, MO). The overall 
efficiency of the fluorescence cross-correlation was found to be better than 80% (unpublished result). Crosstalk 
was lower then 5 %. Auto- and cross-correlation curves were fitted with a one-component three- (Aragón and 
Pecora, 1975) or two-dimensional diffusion model (Elson and Magde, 1974). 
 
Miscellaneous. Mutations were confirmed by restriction analysis and DNA sequencing. Protein concentrations 
were determined according to a modified version of the method of Lowry et al. (1951) using bovine serum 
albumin as a standard. The concentrations of purified OppA and OppBCDF were determined 
spectrophotometrically by measuring the absorption at 280 nm and using extinction coefficients of 1.605 and 
0.990 (mg/mL)-1cm-1, respectively. 
 
Results 
 
Lateral mobility of OppA is reduced in OppBCDF-containing GUVs. Previous  experiments 
showed that the lateral mobility of lipid-anchored OppA in GUVs was comparable to that of 
fluorescent lipids (Doeven et al., 2005), which is consistent with the Saffman and Delbrück 
model for Brownian motion in biological membranes (Saffman and Delbrück, 1975). Since the 
mobility of integral membrane proteins was 2-3 times lower than that of OppA (Doeven et al., 
2005), we monitored the binding of OppA to its cognate membrane complex by autocorrelation 
analysis. Binding of fluorescent labeled OppA to OppBCDF would result in a reduced mobility 
of the labeled protein. A single-cysteine mutant of OppA, OppA (I602C), was labeled with 
Alexa Fluor 488 and reconstituted at a 1:50 (w/w) protein:lipid ratio, which corresponds to ~ 3.5 
nmol OppA/m2 of membrane surface (Doeven et al., 2004). OppBCDF was co-reconstituted at 
a 1:20 (w/w) protein:lipid ratio, resulting in approximately equal amounts of OppA and 
OppBCDF complex molecules in the membranes. At these concentrations, according to the 
estimated KM of OppBCDF for liganded OppA (~ 1.75 nmol/m2 (Doeven et al., 2004)), most 
OppBCDF complexes are interacting with OppA provided the OppAs are in the peptide-bound 
state (Doeven et al., 2004). In Table 1 the results of the autocorrelation measurements are 
presented. In OppBCDF-containing GUVs, the mobility of OppA was lowered compared 
vesicles devoid of OppBCDF, which could reflect binding. The dissociation constant (KD) for 
binding of bradykinin (peptide with the sequence RPPGFSPFR) to OppA is 0.1 µM 
(Lanfermeijer et al., 1999; Detmers et al., 2000). Upon addition of 10 µM bradykinin, that is, 
when all the OppA molecules are in the ligand-bound state, OppA diffusion slowed down from 
3.1 ± 0.4 to 2.3 ± 0.5 (10-8 cm2/s). In vanadate-trapped transition state conditions, that is, in 
the presence of substrate, MgATP and Vi, OppA mobility was again as fast as without peptide 
(3.2 ± 0.3 *10-8 cm2/s). In the absence of peptide, however, no distinction could be made 
between OppA binding and a reduced lipid mobility in general as a consequence of the mere Catalytic cycle of the oligopeptide ABC transporter 
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presence of OppBCDF. A similar reduction in mobility compared to fluorescent labeled OppA 
was observed for the fluorescent lipid analogue DiO (not shown), suggesting an effect of the 
increased membrane crowding when reconstituting OppBCDF at protein to lipid ratios of 1:20 
(w/w). Therefore, we concluded that autocorrelation measurements alone were not sufficient to 
perform a detailed analysis of the OppA:OppBCDF interaction.  
 
Table 1. Lateral mobility of OppA in OppBCDF-containing GUVs. 
Protein composition of GUVs  Additions to rehydration buffer 
OppA-AF488a  OppBCDFb  10 µM 
bradykinin 
3 mM MgATP plus 0.5 
mM Vi 
Diffusion coefficient  
(10-8 cm2/s)c 
+ - -  -  7.5  ±  0.9d 
+ + -  -  3.1  ±  0.4 
+ + +  -  2.3  ±  0.5 
+ + +  +  3.2  ±  0.3 
aOppA (I602C) labeled with Alexa Fluor 488 was reconstituted at a 1:50 (w/w) protein:lipid ratio. bOppBCDF 
was reconstituted at a 1:20 (w/w) protein:lipid ratio. cDiffusion coefficients represent the average of at least 
two independent experiments of at least five measurements each, and the SD values are given. The FCS 
setup was calibrated with free Alexa probes. dTaken from Doeven et al. (2005) and confirmed in this study 
(not shown). 
 
Fluorescence cross-correlation measurements. To monitor the binding of OppA to 
OppBCDF by fluorescence cross-correlation spectroscopy (FCCS), a single-cysteine mutant of 
the OppC component of OppBCDF was constructed. OppA (I602C) and OppBC(I296C)DF  
were purified, labeled with Alexa Fluor 488 or Alexa Fluor 633 (Fig. 1), respectively, and 
functionally incorporated into GUVs. As anticipated from previous results (Doeven et al., 2005), 
all combinations of (labeled) SBPs and membrane complexes were active in peptide binding 
as well as transport (Table 2). Again, a relatively high concentration of OppA [1:50 (w/w) 
protein:lipid ratio] was used, because of the anticipated low affinity interaction of the SBP with 
its membrane complex (Doeven et al., 2004). The amount of co-reconstituted OppBCDF was 
lowered to 1:100 (w/w), such that the final concentrations of the different proteins used in the 
FCCS experiments were equivalent to those used previously in uptake assays with proteo-
LUVs and radioactive peptides (Doeven et al., 2004). This also more closely resembles the in 
vivo situation in which an excess of OppA over OppBCDF exists. The maximal fluorescence 
cross-correlation amplitude Gccmax that can be obtained in this situation, assuming that Alexa 
Fluor 633 labeled OppBCDF binds Alexa Fluor 488 labeled OppA in a 1:1 stoichiometry, is 
given by: 
 
488 2
633
2
488
2
488 max
cc 2 G G
ω ω
ω
+
= ,                                  (equation 1) 
 
where G488 is the amplitude of the green channel, and ω488 and ω633 the lateral radii of the 488 
and 633 confocal volumes, respectively. Note that this equation holds for a two-dimensional 
system, and is only valid when an excess of Alexa Fluor 488 labeled OppA is present over 
Alexa Fluor 633 labeled OppBCDF. In the reverse situation, that is with 1:50 (w/w) Alexa Fluor 
633 labeled OppA and 1:100 (w/w) Alexa Fluor 488 labeled OppBCDF, the amplitude of the 
autocorrelation curve from the 633 channel was nearly zero due to the high amount of OppA 
and cross correlation signal could not be obtained (not shown). 
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Table 2. Peptide binding and transport activity of fluorescent labeled Opp reconstituted into LUVs. 
SBPa  Membrane complexb  Binding activity (nmol [3H]-
bradykinin/mg OppA)c 
Transport activity (pmol [3H]-
bradykinin/mg OppBCDF*min)d 
OppA -  14  ±  0e  -f 
OppA-488g  - 14  ±  1e  n.d. 
OppA-633h  - n.d.  n.d. 
OppA OppBCDF  n.d.  70  ±  34 
OppA-488 OppBCDF  n.d.  74  ±  26 
OppA-633 OppBCDF  n.d.  90  ±  25 
OppA-488 OppBCDF-633i  n.d. 60  ±  4 
OppA-633 OppBCDF-488j  n.d. 90  ±  8 
aOppA and labeled variants were reconstituted at a 1:50 (w/w) protein:lipid ratio. bOppBCDF and labeled 
variants were reconstituted at a 1:100 (w/w) protein:lipid ratio. cThe concentration of [3H]-bradykinin was 3 
µM. dThe concentration of [3H]-bradykinin was 0.7 µM. Measurements were done in at least two independent 
experiments; average plus SD values are given. eTaken from Doeven et al. (2005). fTaken from Doeven et al. 
(2004).  gOppA (I602C) labeled with Alexa Fluor 488. hOppA (I602C) labeled with Alexa Fluor 633. 
iOppBC(I296C)DF labeled with Alexa Fluor 633. jOppBC(I296C)DF labeled with Alexa Fluor 488. n.d. not 
determined. 
 
OppBCDF distinguishes liganded from unliganded OppA.  Figure 2A  shows confocal 
scans of GUVs containing fluorescent labeled OppA and OppBCDF. The observation volume 
was positioned on top of a GUV using a z-scan (Fig. 2B). Fig. 2C shows representative 
autocorrelation curves measured on GUVs containing Alexa Fluor 488-labeled OppA and 
Alexa Fluor 633-labeled OppBCDF. In the absence of peptide no cross-correlation signal was 
detected indicating that, on the time scale of the experiment, OppA was not associated with 
OppBCDF. Upon addition of 20 µM bradykinin the cross-correlation signal was 48 ± 15 % with 
respect to the maximal possible signal (the latter corresponding to ~ 0.72 times the amplitude 
of the 488 channel as calculated using equation 1), suggesting that liganded OppA was bound 
to OppBCDF. These results indicate that the membrane complex OppBCDF efficiently 
discriminates between OppA in its unliganded or liganded form, binding only the latter, under 
our experimental conditions. 
 
 
Fig. 1. Purification and fluorescent labeling of single-cysteine Opp variants. Ni2+-NTA purified OppA 
I602C was labeled with Alexa Fluor 488 (lanes 1 and 5) or 633 (lanes 3 and 7). OppBC(I296C)DF labeled 
with Alexa Fluor 488 (lanes 2 and 6), or 633 (lanes 4 and 8) is also shown. The proteins were visualized with 
either Coomassie brilliant blue staining (lanes 1-4), or by illumination using UV-light (lanes 5-8). The latter 
allowed verification of the attachment of the fluorophores to the proteins. The positions of the OppABCDF 
proteins are indicated as are the masses of the molecular weight marker (M) proteins (kDa). 
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Oligomeric state of lipid-anchored OppA and OppA:OppBCDF binding stoichiometry. To 
investigate the oligomeric state of membrane-anchored OppA and the OppA:OppBCDF 
binding stoichiometry, Alexa Fluor 488- and Alexa Fluor 633-labeled OppAs were mixed 1:1 
and co-reconstituted into GUVs at a 1:100 (w/w) protein:lipid ratio [total OppA to lipid ratio of 
1:50 (w/w)], in the absence or presence of non-labeled OppBCDF. If, for example, OppA were 
a dimer, 488- and 633-labeled proteins would form 488-labeled homodimers, 488/633 labeled 
 
 
Fig. 2 Confocal scans and FCCS measurements on fluorescent Opp-containing proteo-GUVs. (A) Two 
dimensional cross-sections obtained by (x,y) confocal imaging of proteo-GUVs containing Alexa Fluor 488 
labeled OppA I602C (OppA-AF488; reconstituted at a 1:50 (w/w) protein:lipid ratio) and Alexa Fluor 633 
labeled OppBC(I296C)DF (OppBCDF-AF633; reconstituted at a 1:100 (w/w) protein:lipid ratio). Images from 
the 488 (A1) and 633 (A2) channels are shown. The scale bars are 10 µm. (B) Typical z-scan used to 
localize the proteo-GUV membranes. Signals in the 488 and 633 channels are shown (high and low intensity 
traces, respectively). An excess of OppA-AF488 over OppBCDF-AF633 was incorporated in the GUVs (see 
text for details). (C) FCCS experiment in 20 mM Hepes, pH 8.0. The observation volumes were focused on 
top of a proteo-GUV. Autocorrelation signals from OppA-AF488 (∆) and OppBCDF-AF633 (○) are shown. No 
cross-correlation signal (lower curve, □) was detected. (D) FCCS experiment in 20 mM Hepes, pH 8.0, plus 
20 µM peptide (bradykinin). The presence of a cross-correlation signal (lower curve, □) indicates that OppA-
AF488 and OppBCDF-AF633 were bound. Curves were fit with a one-component two-dimensional diffusion 
model (solid lines), and the residuals are shown below the graph. 
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heterodimers, and 633-labeled homodimers, in a 1:2:1 ratio, respectively. The heterodimers 
should give rise to a cross-correlation signal. Assuming all OppAs would be present as dimers, 
Gccmax is given by: 
 
633 2
633
2
488
2
633 max
cc 3
2
G G
ω ω
ω
+
= ,                                                                                         (equation 2) 
 
where G633 is the amplitude of the red channel, and ω488 and ω633 again the respective radii of 
the 488 and 633 confocal volumes. Note that, as with equation 1, equation 2 describes the 
situation for a two dimensional system. Thus, if OppA were dimeric, a cross-correlation signal 
would be observed with a maximal amplitude of ~ 0.24 times that of the 633 curve.  
Table 3 shows that no cross-correlation signal was obtained with proteo-GUVs containing 
‘double’-labeled OppA. Addition of 20 µM peptide had no effect on the fluorescence cross-
correlation. This indicates that the oligomeric state of both the unliganded and liganded forms 
of membrane-bound OppA is monomeric. When OppBCDF was present in the proteo-GUVs as 
well, also no cross-correlation signal was obtained both in the absence and presence of 20 µM 
bradykinin. Taken collectively, the data of this and the previous paragraph suggest that a 
single OppA, in the liganded conformation, binds to OppBCDF.   
 
Table 3. FCCS results with GUVs containing ‘double-labeled’ OppA. 
Protein composition of GUVs  Additions to 
rehydration buffer 
OppA-AF488a  OppA-AF633b  OppBCDFc  20 µM bradykinin 
Cross-correlation signal 
(%)d 
+ +  -  -  <  5   
+  +  -  +  < 5  
+  +  +  -  < 5  
+  +  +  +  < 5  
aOppA (I602C) labeled with Alexa Fluor 488 was reconstituted at a 1:100 (w/w) protein:lipid ratio. bOppA 
(I602C) labeled with Alexa Fluor 633 was reconstituted at a 1:100 (w/w) protein:lipid ratio. cOppBCDF was 
reconstituted at a 1:100 (w/w) protein:lipid ratio. dPercentage of the maximal possible cross-correlation signal 
with the combination of fluorescent labels used (equation 2). Average and SD values of at least two 
independent experiments and five measurements are shown. 
 
ATP-binding induces OppA release from OppBCDF.  In order to obtain more detailed 
information on the catalytic cycle of the Opp system, FCCS experiments were performed under 
various conditions of energy supply. Whereas in the presence of 20 µM bradykinin-liganded 
OppA bound to OppBCDF (Fig. 2C), inclusion of 3 mM ATP plus 1 mM EDTA in addition to 20 
µM of peptide dissipated the cross-correlation signal completely (Table 4). In the absence of 
Mg2+ ABC transporters bind ATP, but do not hydrolyze it (Austermuhle et al., 2004; Davidson 
and Chen, 2004; Higgins and Linton, 2004). Addition of 3 mM MgADP, or 3 mM of the non-
hydrolyzable ATP-analogue MgAMP-PNP, resulted in the same effect. 100 µM ATP plus 1 mM 
EDTA appeared more effective in dissipating the cross-correlation signal than 100 µM 
MgADP. In the latter case a larger fraction of cross-correlation remained. Cross-correlation 
was also observed in the presence of 20 µM bradykinin and 3 mM of caged-ATP, indicating 
that the mere presence of a high concentration of adenine nucleotide was not sufficient for 
dissipation of the FCCS signal. Activation of the caged-ATP by UV light unfortunately 
destroyed the Alexa Fluor 488 and 633 fluorophores, making it impossible to measure FCS Catalytic cycle of the oligopeptide ABC transporter 
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(not shown). Taken together, these results clearly suggest that binding of ATP to the NBDs 
results in a conformational change that releases OppA from the translocator (OppBCDF) 
complex. 
 
Table 4. FCCS results with GUVs containing Alexa Fluor 488 labeled OppA and Alexa Fluor 633 labeled 
OppBCDF. 
Additions to rehydration buffer 
20 µM bradykinin  (Mg-)nucleotides +/- EDTA or Vi 
Cross-correlation signal (%)a 
- -  <  5 
+ -  48  ±  15 
+  3 mM ATP + 1 mM EDTA  < 5 
+  3 mM Mg-AMP-PNP  < 5 
+  3 mM Mg-ATP + 0.5 mM Vi  < 5 
+  3 mM Mg-ADP  < 5 
+  0.1 mM ATP + 1 mM EDTA  32 ± 6 
+  0.1 mM Mg-ADP  46 ± 10 
+  3 mM caged ATPb + 1 mM EDTA  24 ± 15 
+  3 mM caged ATPb + 1 mM EDTA after 
UV illumination 
n.d. 
Protein:lipid (w/w) ratios were the same as in Fig. 2. aPercentage of the maximal possible cross-correlation 
signal with the combination of fluorescent labels used (equation 1). Averages and SD values of at least two 
independent experiments and five measurements each are given. bAdenosine 5'-triphosphate, P3-(1-(4,5-
dimethoxy-2-nitrophenyl)ethyl) ester (DMNPE-caged ATP; Invitrogen) was used. n.d.: not determined since 
UV illumination destroyed the Alexa Fluor labels. 
 
Discussion and conclusions 
 
In contrast to the wealth of biochemical data on ABC efflux systems, detailed mechanistic 
information for ABC importers is more limited. We have analyzed the mechanism of 
oligopeptide transport by the ABC uptake system Opp by FCS and FCCS measurements 
under conditions mimicking intermediate stages of the reaction cycle. Importantly, these 
experiments were carried out with the proteins in the membrane-embedded state and under 
conditions that the transporters were fully functional. Previous studies on SBP:TMD 
interactions mostly involved the use of detergent-solubilized proteins or detergent-
permeabilized proteoliposomes (Chen et al., 2001; Borths et al., 2002; Austermuhle et al., 
2004). The OppBCDF complex was not very stable in detergent solution as concluded from 
size exclusion and blue-native polyacrylamide gel electrophoresis experiments (unpublished 
results). Binding of MalE to  MalFGK2 was studied in permeabilized proteo-LUVs (Chen et al., 
2001). For Opp, this would involve the use of OppA lacking its N-terminal lipid-modification, a 
more artificial situation compared to when membrane-anchored OppA can be used. Proteo-
GUVs proved to be an ideal alternative for studying SBP:TMD interactions of the oligopeptide 
transporter in a defined, close to native model membrane system.  
Using proteo-GUVs, we previously showed that lipid-anchored OppA diffuses with the same 
speed as lipids whereas integral membrane proteins, such as OppBCDF, have a 2-3 fold lower 
lateral mobility (Doeven et al., 2005; Poolman et al., 2005). Therefore, we investigated the 
OppA:OppBCDF interaction by measuring changes in diffusion speed. Binding of fluorescent 
labeled OppA to non-labeled OppBCDF should result in a shift of the autocorrelation curve 
towards longer diffusion times. In OppBCDF-containing GUVs the mobility of OppA was indeed 
slower, and, upon addition of peptide, it reduced even further (Table 1). However, in the Chapter 7 
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absence of peptide, no distinction could be made between specific binding of OppA to 
OppBCDF and a reduced lateral mobility due to the mere presence of membrane-embedded 
protein complex. The latter option is not unlikely since it is known that the presence of integral 
membrane proteins negatively effects lipid lateral mobility at the lipid-to-protein ratios used in 
our experiments (Vaz et al., 1984; O’Leary, 1987). 
To circumvent this problem we turned to FCCS. Although this remains a technically demanding 
technique which can easily give rise to artifacts (e.g. crosstalk between the detector channels), 
experiments with double-labeled fluorescent DNA indicated that in our set-up we had a stable, 
high degree of overlap between the two laser focal volumes. The overall FCCS efficiency was 
as high as ~ 80 %. Furthermore, with the Alexa dye couple used in our experiments, the 
contribution of crosstalk to the cross-correlation signal was low (< 5 %). Single-cysteine 
mutants of OppA and OppBCDF, the latter bearing the cysteine substitution in one of the 
subunits of the integral membrane complex (OppC), were used for labeling with Alexa Fluor 
488 or 633 maleimide (Fig. 1). In each case the position of the cysteine was chosen in the C-
terminal part of the protein just in front of the His6-tag used for purification and, as expected, 
labeling had no effect on peptide binding as well as on transport activity (Doeven et al., 2005; 
Table 2).  The fluorophore attached to OppA presumably sticks out from the surface of the 
protein (based on crystal structures of OppA homologues; Tame et al., 1995; Dunten and 
Mowbray, 1995; Nickitenko et al., 1995; Levdikov et al., 2005), whereas the one attached to 
OppC is located in a short stretch of amino acids following the last helix that traverses the 
membrane back to the cytoplasmic side (Pearce et al., 1992). 
SBPs of ABC importers have been crystallized in open-unliganded, open-liganded, closed-
liganded and closed unliganded conformations (Nickitenko et al., 1995; Heddle et al., 2003; 
Karpowich et al., 2003; Trakhanov et al., 2005). In the presence of substrate, the equilibrium is 
thought to lie strongly towards the closed-liganded state, and only SBPs in this conformation 
can interact productively with the membrane components. Experiments with the histidine and 
maltose permeases however, revealed that SBPs in their unliganded form(s) might also have 
access to the membrane complex, thereby impairing transport function (Prossnitz et al., 1989; 
Dean et al., 1992; Merino, et al., 1995). BtuF, the SBP of the vitamin B12 transporter, was 
shown to bind to detergent-solubilized BtuCD even in the absence of substrate (Borths et al., 
2002), and this SBP is believed not to dissociate from the membrane complex at all during the 
catalytic cycle (Borths et al., 2005). The FCCS experiments presented in Fig. 2C and D 
revealed that OppBCDF distinguishes substrate-bound from substrate-free OppA. This in is 
line with previous results where inhibition of transport activity by high levels of unliganded SBP 
(as observed for the histidine and maltose transporters) could not be demonstrated for the Opp 
system (Doeven et al., 2004). Next to the possibility that OppBCDF discriminates liganded 
from unliganded SBP, a second explanation would be that the equilibrium in the absence of 
substrate lies more strongly towards the open conformation for OppA compared to other SBPs 
such as HisJ, MalE, and BtuF, the SBPs of the afore mentioned histidine, maltose and vitamin 
B12 transporters, respectively. This would mean that the inhibition of transport observed with 
the maltose and histidine transporters was caused by blocking of the membrane complex by 
SBPs in the closed-unliganded state. 
Although it is generally assumed that the oligomeric state of SBPs is monomeric, several early 
reports on these type of proteins suggest that they are  dimeric (Antonov et al., 1976; Rashed 
et al., 1976; Richarme, 1982, 1983). Moreover, ABC transporters have been found that have 
either one or two SBPs fused to the translocator, resulting in the presence of two or four SBPs Catalytic cycle of the oligopeptide ABC transporter 
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per functional complex (van der Heide et al., 2002). Interaction between SBPs stimulated 
transport activity of the osmoregulated ABC transporter OpuA from L. lactis (Biemans-
Oldehinkel and Poolman, 2003). Table 3 shows that a cross-correlation signal was not 
detected in proteo-GUVs with Alexa Fluor 488 and 633 labeled OppA co-reconstituted, 
strongly suggesting that lipid-anchored OppA does not form higher oligomeric aggregates. 
Addition of 20 µM peptide and/or inclusion of OppBCDF in the OppA-containing GUVs did not 
change the cross-correlation signals (not shown). Furthermore, sedimentation velocity and 
equilibrium centrifugation experiments also showed that OppA (without lipid anchor) is 
monomeric over a wide range of conditions tested (Chapter 5). These results indicate that 
monomeric OppA binds peptide, and that a single (liganded) OppA molecule binds to 
OppBCDF and is sufficient for transport.  
In case of the maltose transporter (Fig. 3A), it has been shown that upon ATP binding to the 
substrate-loaded MalE:MalFGK2 complex MalE opens (step III; Austermuhle et al., 2004). At 
this stage maltose is thought to be donated to a site in the TMDs, MalF and G, or released into 
 
 
Fig. 3. Mechanistic models for maltose (Mal) and oligopeptide (Opp) uptake and comparison to an 
ABC efflux system. Transport substrate and Mg-ATP are indicated by filled circles and ovals, respectively. 
Hydrolyzed ATP is depicted as split ovals. For explanation, see text. 
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the cytoplasm directly. ATP hydrolysis is required to dissociate unliganded MalE from MalFGK2 
to complete the transport cycle (step IV; Chen et al., 2001). Our results with the oligopeptide 
transporter (Fig. 3B) revealed that ATP binding is sufficient to dissociate OppA from OppBCDF 
(step III). This suggests that during this event the peptide must be donated to a binding site in 
the membrane. ATP-hydrolysis would then reorient this site to complete the catalytic cycle 
(step IV). The fact that OppA dissociates as soon as ATP is bound whereas MalE merely 
opens but is not released (yet) might be explained by the previously discussed observation 
that OppBCDF distinguishes liganded from unliganded SBP (Merino et al., 1995; Doeven et 
al., 2004). This in turn might be due to the possibility that unliganded OppA exclusively exists 
in the open conformation whereas MalE could exist in a closed-unliganded state as well. In 
accordance, the vitamin B12 binding protein BtuF does not appear to undergo conformational 
changes upon substrate-binding (Borths et al., 2002; Karpowich et al., 2003), and is thought 
not to dissociate from the BtuCD integral membrane complex during the catalytic cycle (Borths 
et al., 2005). 
Although the proposed mechanisms of SBP-dependent uptake systems thus appear 
somewhat variable with respect to the timing of SBP:TMD interactions during the catalytic 
cycle, a comparison with the proposed mechanism for ABC efflux systems (Fig. 3C; Higgins 
and Linton, 2004; van der Does and Tampé, 2004) reveals some conserved features. The 
largest difference is in the way substrate is bound (Fig. 3, steps I and II). ABC uptake systems 
require SBPs to signal the availability of substrate on the outside, whereas in ABC exporters 
the TMD binding site is readily accessible from the cytoplasmic face of the membrane. For 
both ABC im- and exporters, ATP-binding is thought to result in an altered accessibility of this 
TMD binding site in respect to the face of the membrane (step III). In ABC uptake systems this 
means that now substrate can enter the channel, whereas in the case of ABC export substrate 
is released into the external medium. A second common feature is that upon ATP-hydrolysis 
the transporter is thought to return to its initial conformation, thereby completing the catalytic 
cycle (step IV). For ABC uptake systems this results in the actual translocation of the substrate 
as well. 
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Chapter 8 
Summary and concluding remarks 
Introduction 
 
Our knowledge on membrane transport proteins has progressed enormously during the time-
span in which this thesis was produced, not in the least due to the determination of high 
resolution crystal structures for several representatives of important membrane transport 
protein families.  
For primary transporters these were the ATP-binding cassette (ABC) transporters MsbA, a lipid 
efflux system that was crystallized in three conformations with protein originating from 
Escherichia coli (Chang and Roth, 2001), Vibrio cholera (Chang, 2003),  and  Salmonella 
typhimurium (Reyes and Chang, 2005), and the vitamin B12 uptake system BtuCD from E. coli 
(Fig. 1A; Locher et al., 2002). The calcium ATPase (Toyoshima et al., 2000) provided a 
structural framework for P-type ATPases, whereas many catalytic intermediates of the light-
driven proton pump from Halobacterium salinarum have been solved over the past four 
decades (for recent reviews see Kühlbrandt, 2000; Lanyi, 2004). Tremendous progress in the 
past five years, in terms of structural data, has with no doubt also been made in the secondary 
transport field. The crystal structure of the paradigm for ion-linked transport, the lactose 
transporter LacY from E. coli was solved (Fig. 1B; Abrahamson et al., 2003), simultaneously 
with the glycerol-3-phosphate transporter GlpT from the same organism (Huang et al., 2003). 
The structure of the bovine mitochondrial ADP/ATP carrier was solved at a resolution of 2.2 Å, 
which is significantly better than most membrane protein structures solved to date (Pebay-
Peyroula et al., 2003). Also, the ammonium transporter AmtB was solved at the high resolution 
of 1.4 Å (Khademi et al., 2004). Two additional proteins from E. coli, the multidrug transporter 
EmrE (Ma and Chang, 2004) and the Na+/H+ antiporter (Hunte et al., 2005), followed shortly 
after, in addition to two prokaryotic homologues of the neurotransmitter transporters GltPh 
(Yernool et al., 2004) and LeuTAa (Yamashita et al., 2005). All these examples represent major 
breakthroughs in the membrane transport protein field. The structures of a number of α-helical 
channel proteins, e.g. MscL from Mycobacterium tuberculosis (Chang et al., 1998) and the K+-
channel KcsA from Streptomyces lividans (Doyle et al., 1998), and several β-barrel porins 
were already solved before 2000, but also in this field several new structures have appeared in 
recent years: the mechanosensitive channel of small conductance MscS from E. coli (Fig. 1C; 
Bass et al., 2002) and the mammalian voltage gated Shaker K+ channel (Long et al., 2005). 
One class for which no high resolution 3D structure of a complete transporter is available yet, 
The abbreviations used are: ABC, ATP-binding cassette; ECD, extracytoplasmic domain; FCS, Fluorescence 
Correlation Spectroscopy; GUV, Giant Unilamellar Vesicle; LUV, Large Unilamellar Vesicle; NBD, nucleotide-
binding domain; TMD, transmembrane domain; TMS, transmembrane segment; SBP, substrate-binding 
protein. Chapter 8 
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is formed by the bacterial group translocators (phosphoenolpyruvate:phosphotransferase 
systems).     
Although high-resolution structural models are of utmost importance for progress of research in 
the membrane transport protein field, it is important to remember that they provide only 
snapshots of the catalytic cycle. Moreover, several cases are known in which there is serious 
doubt on whether the crystallographic structure indeed represents an intermediate stage in the 
reaction pathway, or is an artificial conformation induced by the crystallization conditions. 
Functional data are still more easily obtained from genetic, biochemical and biophysical 
experiments, and vast amounts of data were available for all membrane transport protein 
classes even before any individual member was crystallized. Many times, detailed ideas about 
structure/function relationships based on functional data appeared to be consistent with and of 
major importance for the interpretation of 3D structural models.   
ABC transporters 
 
This thesis dealt with the mechanism of substrate-binding, ATP-hydrolysis, and translocation 
by ABC transporters, in particular that of the oligopeptide transport system from Lactococcus 
lactis. ABC transporters are molecular pumps with a modular architecture (Chapter 2). Two 
hydrophobic transmembrane domains (TMDs) form the translocation pathway and two water-
 
 
Fig. 1. 3D structural models of membrane transport proteins. A primary transporter, a secondary 
transporter, and a channel protein are shown. The approximate position of the membrane is indicated. The 
ABC transporter BtuCD consists of an NBD, BtuD, bound to a TMD, BtuC. Two copies of BtuCD (shown in 
black and grey) together form a functional complex. The SBP BtuF is presented in complex with its ligand 
vitamin B12 (black spheres). The secondary transporter mutant LacY C154G is shown in complex with the 
lactose analogue β-D-galactopyranosyl-1-thio-β-D-galactopyranoside (TDG; black spheres). C. Heptameric 
channel protein MscS. A single subunit is highlighted in black. The PDB accession numbers for BtuCD, BtuF, 
LacY, and MscS are 1L7V, 1N4A, 1PV7, and 1MXM, respectively. 
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soluble nucleotide-binding domains (NBDs) are associated to the cytosolic face of the TMDs. 
These ABC transporter core domains can be present as separate proteins or fused in almost 
any possible combination. The oligopeptide transporter (Fig. 2A) is composed of a substrate-
binding protein (SBP), OppA, that captures and delivers peptides to the translocation unit, 
which is formed by OppB and OppC (the TMDs) and OppD and OppF (the NBDs). The SBPs 
of prokaryotic ABC uptake systems can be considered as accessory domains that signal the 
presence of substrate via the TMDs to the NBDs, which subsequently hydrolyse ATP to fuel 
the transport reaction. In ABC exporters, substrate can bind directly to a cytoplasmic-facing 
binding site in the TMDs. Several ABC transporters have extracytoplasmic domains (ECDs), 
that can be glycosylated or have inter- or intramolecular disulfide bridges, and/or additional 
membrane embedded and cytosolic regulatory domains that modulate the transport activity or 
allow the systems to assemble into macromolecular complexes. Examples are the ECDs in the 
ABCA subfamily of ABC transporters and ABCG2 (BCRP), the extra transmembrane segments 
(TMSs) in the transporter involved in antigen processing TAP and members of the SUR/MRP 
family (ABCC), the R-domains that can be phosphorylated in ABCA1 and CFTR, and the C-
terminal regulatory extensions of MalK and OpuAA, the NBDs of the maltose and glycine 
betaine transporters, respectively. 
Substrate specificity of the oligopeptide ABC tranpsorter 
 
The oligopeptide ABC transporter is an important player in the proteolytic system of lactic acid 
bacteria that enabled the use of these industrially important microorganisms in milk 
fermentation already for thousands of years. Milk protein is degraded by cell-wall protease(s) 
and the resulting peptides are imported, degraded by cytosolic peptidases and used as a 
source of nitrogen. Although in general it is thought that the SBPs of bacterial ABC uptake 
systems determine the transport specificity, doubts arose in literature as to whether this indeed 
was the case with lactococcal OppA (Charbonnel et al., 2003; Helinck et al., 2003). It was 
postulated that the translocation unit OppBCDF played an important role in determining 
transport selectivity. Overexpression and purification of the L. lactis Opp proteins followed by a 
thorough comparison of binding and transport of radiolabeled combinatorial peptide libraries by 
 
 
Fig. 2. Architecture and substrate specificity of the oligopeptide ABC transporter. A. Cartoon showing 
lipid-anchored oligopeptide-binding protein OppA  and the membrane-embedded translocation unit 
OppBCDF. B. Comparison of binding (white bars) and transport (black bars) of combinatorial peptide libraries 
by OppA and OppABCDF, respectively. For experimental details see Chapter 3. 
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Opp components, reconstituted into artificial Large Unilamellar Vesicles (LUVs), revealed that 
the binding specificity of OppA determined the transport selectivity (Fig. 2B; Chapter 3). In 
addition, it appeared that several L. lactis strains can also use the di/tripeptide transporter Dpp 
for oligopeptide uptake by utilizing next to DppA an additional SBP DppP (Lamarque et al., 
2004). This latter result clarified apparent contradictions in the scientific literature. Thus, in vivo 
research on peptide transport proved difficult (due to rapid breakdown of internalized peptides, 
efflux of (labelled) amino acids, and poorly characterized genetic backgrounds), but the 
combination with in vitro experiments, using purified proteins, confirmed that the (oligo)peptide-
binding proteins determine the selectivity of their cognate ABC transporters (Chapter 4).  
 
Structure and binding mechanism of OppA 
 
OppA was first identified in the Gram-negative organisms Salmonella typhimurium and E. coli 
(Higgins and Hardie, 1983), where it is present as a soluble protein in the periplasm. 3D 
structural models for OppA from Salmonella  and DppA from E. coli, a dipeptide-binding 
protein, have been obtained from crystallographic analysis more than 10 years ago (Tame et 
al., 1994; Dunten and Mowbray, 1995; Nickitenko et al., 1995). In contrast to lactococcal 
OppA, which can bind peptides up to 35 amino acids long with a strong preference for 
nonapeptides (Detmers et al., 2000), a pentamer is the longest peptide that can be bound by 
these proteins. Accordingly, in the crystal structures these short peptides appeared buried 
between two lobes of the protein, whereas in case of lactococcal OppA it is believed longer 
peptides stick out and interact with the protein surface (Detmers et al., 2000; Lanfermeijer et 
al., 2000). Surprisingly, a recent publication revealed a nonapeptide bound in the active site of 
AppA, an OppA homologue from Bacillus subtilis (Levdikov et al., 2005). To resolve how 
peptides are accommodated by OppA from L. lactis, crystals were grown in the presence of 
the high affinity nonapeptide ligand bradykinin (RPPGFSPFR; Chapter 5). Although the 
obtained crystals diffracted to a resolution better than 2.8 Å, a complete data set was not yet 
recorded. Analytical ultracentrifugation experiments did confirm that monomeric OppA adopts 
a more compact shape upon peptide-binding, similar to what was observed for the other 
proteins in their crystal structures.  
 
Catalytic cycle of the oligopeptide ABC transporter 
 
The transport mechanism of ABC uptake systems has been best studied for the maltose 
permease from E. coli (Chen et al., 2001, 2003; Austermuhle et al., 2004; Fig. 3A). It is thought 
that maltose-loaded SBP MalE (step I) binds to the TMDs MalF and G (step II) and opens 
upon ATP-binding to the NBDs (two copies of MalK; step III). At this point, maltose is 
transferred to a binding site in the TMDs or released into the cytoplasm directly. ATP-
hydrolysis dissociates the MalK dimer and resets the system to its initial conformation by 
dissociating MalE from MalFG (step IV).  
In  Chapter 6, a method for the functional incorporation of membrane proteins into Giant 
Unilamellar Vesicles (GUVs; artificial membrane structures ranging in diameter from ~ 5-100 
µm) was developed. Upon addition of stabilizing amounts of sucrose to protein-containing 
LUVs (Large Unilamellar Vesicles; ~ 200 nm in diameter), these could be dried and rehydrated 
without losing biological activity. Opp-containing proteo-GUVs were used to study the catalytic 
cycle of the transporter by Fluorescence Correlation Spectroscopy (FCS; Chapter 7). The Summary 
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results suggested that only peptide-bound OppA could interact with its membrane complex 
OppBCDF (in accordance with the results obtained in Chapter 3; Fig. 3B, step I). In contrast to 
MalE dissociation from the maltose transporter (Fig. 3A, step IV), OppA was released from 
OppBC already upon ATP-binding by OppDF (Fig. 3B, step III). We argue that the observed 
variations in timing of SBP:TMD interactions, during the catalytic cycle of various ABC 
transporters (e.g. Mal, His, Btu, and Opp), could be a consequence of differences in the 
equilibria between closed and open conformations of their respective SBPs in the absence of 
ligand. 
Comparison of the translocation mechanism of SBP-dependent ABC importers (Fig. 3A and B) 
with the current general view on the catalytic cycle of ABC export systems (Higgins and Linton, 
2004; van der Does and Tampé, 2004; Biemans-Oldehinkel et al., 2006; Fig. 3C) suggests that 
the translocator conformational changes (e.g., NBD dimer association/dissociation coupled to 
alternate access of the substrate to the channel/TMD binding site) are conserved. The high- 
 
 
Fig. 3. Models for the translocation mechanism of ABC transporters. A. Maltose transporter Mal from E. 
coli. B. Oligopeptide transporter Opp from L. lactis. C. General ABC exporter. Transport substrate and Mg-
ATP are indicated by filled circles and ovals, respectively. Hydrolyzed ATP is depicted as split ovals. For 
explanation see text. 
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and low affinity binding sites of ABC exporters for substrate on the in- and outside, 
respectively, appear reversed in ABC uptake systems that, in addition, use the obligatory 
extracytoplasmic SBPs. 
 
Concluding remarks and future perspectives  
 
The purification of the OppBCDF membrane complex opened up many different possibilities 
for further research, one of which being the functional reconstitution of the oligopeptide 
transporter into artificial liposomal systems (Chapters 3 and 6). The transport selectivity of 
Opp was determined and found to match the binding specificity of OppA (Chapter 3). Apparent 
discrepancies with in vivo data could be explained by the interference of another peptide 
transporter, Dpp, in the performed analyses (Chapter 4). The catalytic cycle of the Opp system 
was investigated by fluorescence correlation spectroscopy (Chapter 7), and the results 
indicated similarities but also important differences compared to mechanistic models proposed 
for other ABC transporters. ABC transporters share a common architecture and conformational 
changes during the translocation cycle seem to be conserved between ABC im- and exporters, 
with the exception of the direction of transport and the use of SBPs by uptake systems 
(Chapters 2 and 7). 
Future research on lactococcal Opp should be focused to a large extent on obtaining high 
resolution structural information. The crystals obtained for OppA (Chapter 5) can be optimized 
and used for the elucidation of its seemingly unique peptide-binding mechanism. Although 
thought to be extremely difficult at the time the research presented in this thesis was started, 
crystal structures for complete ABC transporters are now being solved. Preliminary results 
from blue native polyacrylamide gel electrophoresis and size-exclusion chromatography 
experiments with purified OppBCDF indicated that the complex might be less stably associated 
in detergent solution compared to for example the maltose and histidine ABC transporters. 
Analytical ultracentrifugation and gel-filtration experiments could shed more light on the 
quaternary state of the complex in various detergents. The now more and more common high-
throughput strategy of cloning of homologues of a protein (complex) of interest, followed by 
screening for highly expressed variants, purification, and crystallization seems a good 
approach to obtain a structure for a representative of the oligopeptide transporter family.  
On the level of biochemical characterization of Opp there can also still be made considerable 
progress, especially when examining data obtained with some of the more intensively studied 
ABC systems, the maltose, histidine, and multidrug (e.g. P-gP) transporters. For SBP-
dependent importers it has not yet been demonstrated if, upon release by the SBP, the 
substrate is donated to a site in the TMDs or directly passed through the channel into the 
cytoplasm. SBP-independent mutants isolated for the maltose and histidine transporters plead 
for the first option (Treptow et al., 1985; Petronilli et al., 1991; Speiser et al., 1991; Covitz et 
al., 1994). Although L. lactis mutants that could grow on oligopeptides (GLGL and YGGFL) in 
the absence of OppA have been obtained (derived from AMP15, a L. lactis MG1363∆oppA 
strain; M. K. Doeven, M. van Waarden, and B. Poolman; unpublished result), the putatively 
OppA-independent OppBCDF mutants have not been further characterized yet. This was due 
to inconsistent results obtained in controls performed with the host to be used. L. lactis 
GRS164, an NZ9000∆oppA variant, grew slowly on oligopeptides in the presence of the 
inducer for gene expression, nisin A, even in the absence of mutagenized oppBCDF. Summary 
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Two other questions specific to Opp might be worth mentioning. First, how does the peptide 
substrate travel through the membrane? Does the N- or the C-terminus enter the cytoplasm 
first?  Although technically challenging, it might be possible to label for example the N-terminus 
with a fluorescent probe and the C-terminus with a bulky group that traps the peptide in the 
OppBCDF complex. Upon addition of quenchers to either side of the membrane it might be 
possible to resolve where the peptide termini reside. Peptides with a fluorescent label attached 
have been shown to be able to bind to OppA (Lanfermeijer et al., 2000), although transport 
assays with C-terminally fluorescent labeled peptides and proteo-LUVs have not been 
conclusive (M. K. Doeven, J. B. Bultema, and B. Poolman; unpublished results). The second 
issue concerns the substrate:ATP stoichiometry. Although there has been much debate on this 
issue in the past, it seems now that 2 ATP molecules are hydrolysed per translocated solute 
(Patzlaff et al., 2003). Opp substrates, however, vary in size from 4 up to and including at least 
35 amino acid residue peptides. Does a 4 amino acid long peptide require the same amount of 
ATP to be transported as a 35-mer? By performing transport assays with radiolabeled peptides 
of various lengths and sensitive ATPase assays this question should be possible to answer. 
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Chapter 9 
Nederlandse samenvatting voor geïnteresseerden buiten 
dit vakgebied 
Samenvatting 
 
ABC transporters zijn eiwitten die betrokken zijn bij de opname van voedingsstoffen en 
uitscheiding van schadelijke stoffen in de biologische cel. Defecten in ABC transporters 
kunnen bij de mens ernstige ziektes tot gevolg hebben. Te grote activiteit van ABC 
transporters kan leiden tot ongevoeligheid van kankercellen voor chemotherapie, en 
resistentie van bacteriën tegen antibiotica. Van de meest simpele bacterie tot de zeer 
ingewikkelde mens, alle levensvormen bevatten ABC transporters. In dit proefschrift is 
een bacteriële ABC transporter bestudeerd om zo meer te weten te komen over de 
werking van ABC transporters in het algemeen. Het onderzochte eiwit, genaamd de 
oligopeptide ABC transporter, is gezuiverd uit een bacterie en bestudeerd met 
biochemische en biofysische technieken. Zo is opgehelderd wat voor stoffen via de 
oligopeptide ABC transporter worden opgenomen, en wat het werkingsmechanisme van 
dit eiwit is. 
 
1.   De barrière van het leven: het celmembraan 
 
De universele eenheid waaruit alle levensvormen zijn opgebouwd is de cel. Het aantal cellen 
per individu kan van soort tot soort enorm varieren, van één enkele in het geval van bacteriën 
tot zo’n slordige 100.000 miljard bij de mens. Iedere cel bestaat uit een stroperige oplossing 
met hierin een extreem hoge concentratie aan wateroplosbare deeltjes, het cytoplasma, 
omgeven door ten minste één enkele membraan. In het cytoplasma, en in hogere organismen 
in de celkern, bevindt zich erfelijke informatie in de vorm van DNA. Coderende gebieden in het 
DNA, de genen, worden via RNA vertaald in eiwit. De celmembraan is een uit lipiden 
opgebouwde waterafstotende dubbellaag gevuld met grote hoeveelheden eiwit, en vormt een 
fysieke barrière voor wateroplosbare stoffen. Zo wordt het binnenste van de cel afgeschermd 
van de buitenwereld.  
 
2.   Transporteiwitten 
 
Om te kunnen groeien moet de cel zich delen. Hiertoe dient de hoeveelheid DNA zich te 
verdubbelen (1 kopie voor iedere dochtercel) en de biomassa moet voldoende toegenomen 
zijn. Voedingsstoffen worden daarom opgenomen door de cel via gespecialiseerde eiwitten 
aanwezig in het membraan (zie figuur 1). Deze ‘transporteiwitten’ vormen een soort 
moleculaire machientjes die het verbruik van energie koppelen aan het verplaatsen van een 
molecuul (het substraat) van de ene naar de andere zijde van het membraan (dus van buiten Chapter 9 
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de cel naar binnen of andersom). Naast hun belangrijke rol bij de opname van 
voedingsstoffen, zijn transporteiwitten ook betrokken bij de uitscheiding van afval- of andere 
schadelijke stoffen, eiwitten met een functie buiten de cel, het invoegen van (transport)eiwitten 
in het membraan, en het waarnemen en verwerken van signalen uit de buitenwereld. Kleine 
afwijkingen in genen die coderen voor transporteiwitten kunnen ernstige ziektes tot gevolg 
hebben bij de mens. Bekende voorbeelden zijn cystische fibrose en resistentie van tumor-
cellen tegen cytostatische medicijnen, veroorzaakt door mutaties in een ABC–type kanaaleiwit 
en een drug-uitscheidings eiwit, respectievelijk. Verder kunnen transporteiwitten er voor 
zorgen dat bacteriën resistent worden voor veel gebruikte antibiotica. Een van de meest 
voorkomende types transporteiwitten zijn de ABC transporters. 
3.   ABC transporters en de oligopeptide ABC transporter 
 
3.1   ABC transporters  
 
Alle levende organismen, van de simpelste bacterie tot de meest complexe plant of zoogdier 
aan toe, bevatten ABC transporters en zijn hier voor hun goed functioneren afhankelijk van. De 
opbouw van ABC transporters is opvallend genoeg in alle organismen gelijk. Ze worden 
gebruikt voor zowel opname als uitscheiding van een enorme diversiteit aan substraten (zie 
Hoofdstuk 2). Kleine ionen, suikers, lipiden, drugs, peptiden (stukjes eiwit), en zelfs hele 
eiwitten kunnen allemaal worden verplaatst over het membraan door ABC transporters. Een 
ABC transporter bestaat uit een eiwit-complex van vier eiwitten of eiwit-domeinen (figuur 2). In 
 
 
Figuur 1. Schematische weergave van een bacterie. Het binnenste van de cel, het cytoplasma, wordt 
gescheiden van de buitenwereld door een membraan (aangeduid als ‘cytoplasmic membrane’). 
Verschillende soorten transporteiwitten zijn schematisch als blokjes en/of bolletjes weergegeven. Het type 
energie dat wordt gebruikt voor het opnemen of uitscheiden van substraten (S), ATP of een 
electrochemische gradient (dit laatste is aangeduid met ‘H+’), en de transportrichting van het substraat zijn 
aangegeven. 
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het membraan vormen twee waterafstotende eiwitten samen het gat waardoor het substraat 
het membraan kan passeren. Aan de kant van het cytoplasma zitten twee wateroplosbare 
eiwitten, de zogenaamde ATP-bindende cassettes of ABC-eiwitten. Hieraan danken de ABC 
transporters hun naam. Twee ABC-eiwitten fungeren samen als de motor die de ABC 
transporter aandrijft door binding en splitsing van ATP (de brandstof voor transport van het 
substraat). Elk van de in totaal vier eiwitten kan apart voorkomen of samen als één groot eiwit 
(figuur 2). Hoewel ABC uitscheidings systemen in alle levende organismen te vinden zijn, zijn 
ABC opname systemen alleen maar aanwezig in de ‘lagere’ organismen: de bacteriën en de 
Archaea; een Archaeon is een soort ‘oer-bacterie’ die vaak bestand is tegen extreme 
condities. ABC opname systemen gebruiken een extra eiwit wat zich aan de buitenkant van de 
cel bevindt. Dit zogenaamde ‘substraat-bindingseiwit’ (in figuur 2 weergegeven als Pac-man-
achtige figuurtjes) pakt het te transporteren substraat en brengt het naar de ABC transporter in 
het membraan. Veranderingen in de vorm van de ABC transporter als gevolg van ATP binding 
en splitsing door de ATP-bindende cassettes zorgt er vervolgens voor dat het substraat-
bindingseiwit het substraat loslaat zodat het via de ABC transporter in het cytoplasma beland.   
 
 
 
 
Figuur 2. ABC transporters zoals aanwezig in de membranen van alle levende organismen. (A) en (B) 
Opname systemen gevonden in bacteriën en andere ‘lage’ organismen. (C) en (D) Uitscheidings systemen 
aanwezig in ‘lagere’ organismen (C), en in ‘hogere’ organismen (D) zoals planten en zoogdieren (inclusief de 
mens). Substraat-bindingseiwitten zijn als Pac-man-achtige figuren weergegeven, eiwit-domeinen die het gat 
in het membraan vormen waardoor een substraat kan passeren als vierkantjes, en ATP-bindende cassette 
eiwitten (ABC-eiwitten) als ovale vormen. 3-Lettercodes betreffen de naam van het transport systeem. 
Letters in de figuren duiden individuele eiwitten aan. 
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3.2   Het substraat-bindingseiwit OppA bepaalt welke substraten door de oligopeptide 
ABC tranporter worden opgenomen 
 
De oligopeptide ABC transporter bestaat uit het substraat-bindingseiwit OppA, en het 
transportdomein OppBCDF (figuur 2B; Opp). Een algemeen aanvaard beeld is dat de 
substraat-bindingseiwitten van ABC opname systemen bepalen wat voor substraat er 
opgenomen wordt door de cel. In het geval van de oligopeptide ABC transporter, een ABC 
transporter die stukjes eiwit (genaamd oligopeptiden) transporteert, is in de wetenschappelijke 
literatuur echter twijfel ontstaan omtrent dit punt. Ondanks dat verschillende OppA substraat-
bindingseiwitten werden gebruikt, bleek dat toch iedere keer dat dezelfde peptides via de 
oligopeptide ABC transporter werden opgenomen. Dit leidde tot de conclusie dat het 
transportdomein OppBCDF (figuur 2B) naast OppA mede bepaalt wat voor peptiden er 
opgenomen worden. Deze experimenten werden echter uitgevoerd met specifieke bacterie-
stammen, welke naast de oligopeptide ABC transporter ook nog vele andere transporteiwitten 
bevatten. Van deze andere transporteiwitten weten we soms niet eens wat voor substraten ze 
transporteren. In Hoofdstuk 3 van dit proefschrift staat de zuivering en herplaatsing in een 
kunstmatig membraan systeem (bolvormige uit lipiden bestaande blaasjes die ‘liposomen’ 
worden genoemd) van de vijf eiwitten behorende bij de oligopeptide ABC transporter 
beschreven. Dit behaalde resultaat stond toe om de oligopeptide ABC transporter te 
bestuderen in een gedefinieerde omgeving, zonder andere transporteiwitten die normaal 
aanwezig zijn in een cel. Wanneer nu binding van verschillende peptiden aan het gezuiverde 
substraat-bindingseiwit OppA met transport via de gezuiverde oligopeptide ABC transporter, 
dus OppA plus OppBCDF, werd vergeleken, bleek dat dit volledig met elkaar in 
overeenstemming was. Het oligopeptide-bindingseiwit OppA bond bij voorkeur peptiden van 
negen aminozuren lang, en de oligopeptide ABC transporter transporteerde deze vervolgens 
ook het beste. Deze experimenten spraken dus de eerder door andere groepen gepubliceerde 
resultaten tegen en bevestigden dat het transportdomein OppBCDF geen extra selectiviteit op 
het peptide opname proces legt.  
 
3.3   Peptide transport in micro-organismen 
 
Vrijwel gelijktijdig met de hier boven beschreven vinding dat OppA toch de belangrijkste speler 
is in het bepalen van de transport selectiviteit van de oligopeptide ABC transporter, werden 
nieuwe resultaten gepubliceerd die lieten zien dat verschillende eerder gebruikte bacteriën 
naast de oligopeptide ABC transporter ook nog een ander transporteiwit bevatten wat 
oligopeptide opname kan bewerkstelligen. Deze vinding verklaarde waarom de eerder 
behaalde resultaten met bacteriën niet overeen kwamen met die beschreven in Hoofdstuk 3 
voor de gezuiverde oligopeptide ABC transporter. Hoe dit precies allemaal in elkaar steekt 
staat beschreven in Hoofdstuk 4. De belangrijkste conclusies van dit hoofdstuk waren dat 
peptide opname proeven in bacteriën ingewikkeld zijn door de snelle afbraak van opgenomen 
substraten, uitscheiding van aminzoren afkomstig van eerder opgenomen peptiden, en, zoals 
net al vermeld, de aanwezigheid van andere transporteiwitten in voor metingen gebruikte 
bacteriën. Het voorspellen van wat voor peptiden het beste getransporteerd zullen worden 
door oligopeptide ABC transporters van minder goed bestudeerde micro-organismen, op basis 
van het vergelijken van de betrokken OppA eiwitten, was vrijwel onmogelijk vanwege een te 
lage gelijkenis.  Nederlandse samenvatting 
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3.4   Structuur van het oligopeptide-bindingseiwit OppA 
 
De 3-dimensionale vouwing of structuur van eiwitten kan met behulp van verschillende 
methoden worden bestudeerd. Eén van de op dit moment meest krachtige methoden om de 
structuur van een eiwit te bepalen houdt in dat men eiwit-kristallen maakt die vervolgens met 
röntgen straling worden belicht. Dit resulteert in een stippen-patroon wat gebruikt kan worden 
om de structuur van het eiwit te berekenen. Er zijn al structuren van OppA eiwitten van 
verschillende bacteriën beschikbaar. Door deze eiwit structuren te bekijken kan direct duidelijk 
worden welke aminozuren van het eiwit een belangrijke rol spelen bij bijvoorbeeld het binden 
van een peptide. Op basis van de verschillende structuren van OppA eiwitten, wordt in het 
algemeen verondersteld dat OppA eiwitten op zichzelf functioneren en geen grotere structuur 
vormen door bijvoorbeeld met een tweede kopie van zichzelf een interactie aan te gaan. Er 
zijn echter indicaties dat substraat-bindingseiwitten, zoals OppA, een interactie aan kunnen 
gaan met zichzelf wat van belang zou kunnen zijn voor hun functie. In Hoofdstuk 5 is aan de 
hand van het gedrag van OppA eiwitten in een centrifugaal veld bepaald dat OppA 
daadwerkelijk alleen functioneert. Vervolgens zijn eiwit-kristallen van het OppA eiwit uit de 
bacterie die wij bestuderen in complex met een 9 aminozuur lang peptide gemaakt en belicht 
met röntgen-straling om de structuur te berekenen. Deze eiwit-kristallen waren helaas nog niet 
goed genoeg om de structuur van dit OppA eiwit op te helderen, maar vormen een belangrijke 
stap in de weg hier naar toe.  
 
 
3.5   Analyse van het transportmechanisme van de oligopeptide ABC transporter  
 
In  Hoofdstuk 6 en 7 is de oligopeptide ABC transporter bestudeerd met een techniek 
genaamd ‘fluorescentie correlatie spectroskopie’, kortweg FCS. Met behulp van lasers kan 
men hier mee het diffusiegedrag van eiwitten bepalen. Een probleem met het bestuderen van 
transporteiwitten met FCS in een kunstmatig systeem zoals liposomen (zie boven), is dat deze 
kunstmatige structuren vaak veel te klein zijn. Door optische beperkingen moet het te 
bestuderen liposoom een diameter hebben van minimaal ~ 5 micrometer (1 µm = 10-6 m = 
0,000001 m), terwijl de liposomen zoals gebruikt in Hoofdstuk 3 maar ongeveer 200 
 
 
Figuur 3. Model voor het transportmechanisme van de oligopeptide ABC transporter. Eiwitten zijn 
weergegeven en aangeduid als in figuur 2. Het substraat (zwarte bol) bindt aan de buitenkant van de cel 
(out) aan het substraat-bindingseiwit OppA, wat vervolgens een interactie aangaat met het transporteiwit 
OppBCDF in het membraan. OppBCDF bindt en splitst vervolgens ATP (zwarte ovale vormen), met als 
gevolg dat het substraat van buiten de cel naar binnen (in) wordt verplaatst. 
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nanometer groot zijn (1 nm = 10-9 m = 0,000000001 m): een verschil van minstens 25 keer! In 
Hoofdstuk 6 is een methode ontwikkeld om transporteiwit-bevattende kleine liposomen van 
200 nm om te zetten in enorm grote liposomen met een diameter tussen de ~ 5 – 100 µm. Met 
behulp van FCS is vervolgens aangetoond dat het substraat-bindingseiwit OppA, wat alleen 
maar via 1 lipide molecuul vast zit aan de buitenkant van het membraan (figuur 2B, OppA), 
een hogere mobiliteit heeft dan eiwitten die volledig in het membraan zijn ingebouwd 
(bijvoorbeeld OppBCDF, zie figuur 2B). In Hoofdstuk 7 is deze techniek verder uitgebreid om 
de interactie tussen het oligopeptide-bindingseiwit OppA en het bijbehorende transporteiwit 
OppBCDF te bestuderen. Het bleek dat OppA aan OppBCDF bindt zodra het een peptide 
gepakt heeft. OppBCDF bindt en splitst vervolgens ATP waardoor het peptide van buiten de 
cel naar binnen wordt getransporteerd (figuur 3). 
 
4.   Slotopmerkingen en toekomstperspectief 
 
Dit proefschrift beschrijft structurele en functionele aspecten van ABC transporters aan de 
hand van experimenten uitgevoerd met een model systeem: de oligopeptide ABC transporter. 
Het huidige onderzoek naar membraaneiwitten richt zich zeer sterk op het verkrijgen van 
structurele informatie, met name met behulp van eiwit-kristallen. Voor de oligopeptide ABC 
transporter zal ook deze weg ingeslagen moeten worden, zeker nu er hier eiwitkristallen 
beschreven zijn voor het oligopeptide-bindingseiwit OppA. Gedurende dit promotieonderzoek 
hebben we veel geleerd over de oligopeptide ABC transporter door het uitvoeren van 
biochemische en biofysische proeven. Zoals met fundamenteel wetenschappelijk onderzoek 
echter bijna altijd het geval is, kwamen er ook weer nieuwe belangrijke vragen en uitdagingen 
naar voren. Men kan zich bijvoorbeeld afvragen hoe extreem lange peptiden van wel 35 
aminozuren lang getransporteerd worden. Welk deel van het peptide bereikt het eerste het 
cytoplasma, het eerste of het laatste aminozuur? Op welk exact moment tijdens transport 
arriveert het peptide in the cytoplasma? Zijn er voor het opnemen van een kort peptide 
evenveel brandstof (ATP) moleculen nodig als voor een zeer lang peptide? En, meer 
algemeen, hoe kan het dat ABC transporters,die allemaal dezelfde universele opbouw hebben 
in alle levende organismen, zo’n enorme verscheidenheid aan substraten, zowel qua type als 
grootte, kunnen transporteren? De bevindingen beschreven in dit proefschrift maken de 
oligopeptide ABC transporter een interessant onderwerp voor verder onderzoek, wat in de 
toekomst mogelijk zal leiden tot meer inzichten met betrekking tot deze en andere vragen.  
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Nawoord 
Na 4 jaar en een beetje ben ook ik dan nu toe aan het schrijven van het nawoord voor mijn 
proefschrift. Het was een mooie tijd. Achteraf gezien, en zeker voor degenen die het allemaal 
wat meer van een afstandje hebben waargenomen, is alles zeer vlot verlopen. Dit neemt niet 
weg dat het toch allemaal aardig wat moeite heeft gekost, en dat ik nu zeer blij ben dat het af 
is.  
Al houd ik niet van nawoorden met ellenlange opsommingen van namen, en dit hoeft u dus 
ook niet op deze plek van mij te verwachten, er zijn toch enkele mensen die ik hier even 
persoonlijk wil bedanken. Bert, vanaf het “Zo iemand als jij moet gewoon gaan promoveren” tot 
het ”Begin januari redden we wel” waardeer ik jouw steun en enthousiasme. Ik heb mij altijd 
zeer goed thuisgevoeld in het “Poolman-lab”. Special thanks as well to Rupert Abele and Prof. 
Robert Tampé. The experiments I performed in your lab in Frankfurt were highly successful, 
and provided me with a perfect set of data. “De promovendus” werd door één van mijn 
voorgangers omschreven als “een kleine zelfstandige ondernemer”.  Naar mijn mening is ook 
het deel uitmaken van een goed draaiend team onontbeerlijk voor het succesvol afronden van 
een promotieonderzoek. De collega’s waarmee ik de afgelopen jaren samen heb mogen 
werken vormden zeker een goed draaiend team, en ik wil iedereen die op welke wijze dan ook 
een bijdrage heeft geleverd aan dit boekje hartelijk bedanken.  
Buiten het lab waren natuurlijk zeer belangrijk mijn ouders en familie. De etentjes met Oma 
Dinie, het jaarlijkse kerst-diner met tegen de 20 man, het blijft altijd super gezellig. Berend en 
Wemmie, mijn Drents is nog een beetje stroef maar ik voel me altijd enorm thuis in het mooie 
Sleen. 
Verder heb ik 2 à 3 keer per week behoorlijk wat uurtjes doorgebracht ergens op een 
basketballveld, op borrels en feesten, en bij bestuursvergaderingen van “de Groene Uilen”. Dit 
was een fantastische tijd waar ik vele goede contacten aan over heb gehouden. Naast “de 
basketballers” waren er “de biologen”, “de wintersporters”, en, niet te vergeten, “de vrienden uit 
mijn middelbare school tijd”. Nu we zo goed als allemaal begonnen zijn aan ons werkende 
leven zijn de ontmoetingen vaak iets minder frequent, maar ik hoop velen van jullie de 21ste 
april of kort daarna te zien. 
Joost en Eric bedankt dat jullie m’n paranimfen wilden zijn. Het bezoekje in Oxford, de 
“mannenlab dates” met Tiemen en later ook Gert, de “interessante” muziek keuzes op het lab 
(Ria: je hebt je kranig geweerd), ik had het niet willen missen! 
Lil, wij kennen elkaar al bijna sinds het begin van mijn promotie. Na soms een wat mindere 
dag op het werk was het altijd weer fijn om bij jou thuis te komen. Laten we er iets moois van 
maken! Dikke kus! 
 
Mark  
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Curriculum Vitae 
Mark Doeven werd op 20 december 1978 geboren te Meppel. De eerste twee jaar van zijn 
middelbare school heeft hij aldaar doorgebracht op de “C.S.G. Dingstede”, en hij behaalde 
vervolgens zijn VWO diploma aan “De Waezenburg” te Leek. In 1997 ving hij aan met de 
studie Biologie aan de Rijksuniversiteit Groningen. Naast zijn studie, en tot enkele jaren 
hierna, was hij actief als speler, coach en bestuurslid van de Groninger Studenten Basketball 
Vereniging “de Groene Uilen”. Begin 2002 is hij afgestudeerd na stages in de groep van Prof. 
Dr. Bert Poolman te Groningen en de groep van Prof. Anthony Watts aan de Universiteit van 
Oxford. In ditzelfde jaar begon hij met zijn promotieonderzoek naar het moleculaire 
mechanisme van substraat-binding, ATP-hydrolyse en translocatie door ABC transporters. 
Vanaf mei 2006 zal hij werkzaam zijn voor het Farber Institute for Neurosciences van de 
Thomas Jefferson University te Philadelphia in de VS. Mark Doeven woont samen in 
Groningen met Lilian Eggens. 
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